ui.i18n.Concept.name.899c883f-3a91-11e5-b380-0050568236ae=Laboratory
ui.i18n.Concept.name.06046205-bccd-4ea8-ad75-aeac53f2660b=No
ui.i18n.Concept.name.3dc73b47-05f0-4351-8162-6e8c51b5dc74=Yes
ui.i18n.Concept.name.89e851b9-3a91-11e5-b380-0050568236ae=dosagefrequency
ui.i18n.Concept.name.89f16092-3a91-11e5-b380-0050568236ae=qd
ui.i18n.Concept.name.89fb76b6-3a91-11e5-b380-0050568236ae=bid
ui.i18n.Concept.name.89fc2ade-3a91-11e5-b380-0050568236ae=tid
ui.i18n.Concept.name.8a0bb402-3a91-11e5-b380-0050568236ae=qid
ui.i18n.Concept.name.8a0c9966-3a91-11e5-b380-0050568236ae=dosage instructions
ui.i18n.Concept.name.8a15ac57-3a91-11e5-b380-0050568236ae=ac
ui.i18n.Concept.name.8a16c67c-3a91-11e5-b380-0050568236ae=pc
ui.i18n.Concept.name.8a1d5ae7-3a91-11e5-b380-0050568236ae=hs
ui.i18n.Concept.name.8a22c3a9-3a91-11e5-b380-0050568236ae=Visit Diagnoses
ui.i18n.Concept.name.8a238795-3a91-11e5-b380-0050568236ae=Non-coded Diagnosis
ui.i18n.Concept.name.8a246971-3a91-11e5-b380-0050568236ae=Coded Diagnosis
ui.i18n.Concept.name.8a2524d9-3a91-11e5-b380-0050568236ae=Diagnosis Certainty
ui.i18n.Concept.name.8a25f090-3a91-11e5-b380-0050568236ae=Presumed
ui.i18n.Concept.name.8a267d65-3a91-11e5-b380-0050568236ae=Confirmed
ui.i18n.Concept.name.8a274dec-3a91-11e5-b380-0050568236ae=Diagnosis order
ui.i18n.Concept.name.8a281af8-3a91-11e5-b380-0050568236ae=Secondary
ui.i18n.Concept.name.8a28a9c1-3a91-11e5-b380-0050568236ae=Primary
ui.i18n.Concept.name.8a2c0c06-3a91-11e5-b380-0050568236ae=Admit Patient
ui.i18n.Concept.name.8a2cbe5b-3a91-11e5-b380-0050568236ae=Discharge Patient
ui.i18n.Concept.name.8a2d6aad-3a91-11e5-b380-0050568236ae=Transfer Patient
ui.i18n.Concept.name.8a2e1814-3a91-11e5-b380-0050568236ae=Disposition
ui.i18n.Concept.name.8a2f03b3-3a91-11e5-b380-0050568236ae=Disposition Set
ui.i18n.Concept.name.8a2fd836-3a91-11e5-b380-0050568236ae=Disposition Note
ui.i18n.Concept.name.8a324d5f-3a91-11e5-b380-0050568236ae=consultation note
ui.i18n.Concept.name.8a34acbd-3a91-11e5-b380-0050568236ae=Admission
ui.i18n.Concept.name.8a37be69-3a91-11e5-b380-0050568236ae=DISCHARGE
ui.i18n.Concept.name.8a46d32e-3a91-11e5-b380-0050568236ae=Lab departments
ui.i18n.Concept.name.8a47895e-3a91-11e5-b380-0050568236ae=Other Investigations
ui.i18n.Concept.name.8a4840ea-3a91-11e5-b380-0050568236ae=Other Investigations Categories
ui.i18n.Concept.name.8a6f6254-3a91-11e5-b380-0050568236ae=LABRESULTS_CONCEPT
ui.i18n.Concept.name.8a6fcc41-3a91-11e5-b380-0050568236ae=LAB_RESULT
ui.i18n.Concept.name.8a707bb1-3a91-11e5-b380-0050568236ae=LAB_NOTES
ui.i18n.Concept.name.8a7124ca-3a91-11e5-b380-0050568236ae=LAB_MINNORMAL
ui.i18n.Concept.name.8a71cad0-3a91-11e5-b380-0050568236ae=LAB_MAXNORMAL
ui.i18n.Concept.name.8a727049-3a91-11e5-b380-0050568236ae=LAB_ABNORMAL
ui.i18n.Concept.name.8a844ec0-3a91-11e5-b380-0050568236ae=REFERRED_OUT
ui.i18n.Concept.name.8a8bad47-3a91-11e5-b380-0050568236ae=Lab Order Notes
ui.i18n.Concept.name.8a8df82e-3a91-11e5-b380-0050568236ae=A_T_and_P
ui.i18n.Concept.name.8a95c9c7-3a91-11e5-b380-0050568236ae=Ruled Out Diagnosis
ui.i18n.Concept.name.8aa9308f-3a91-11e5-b380-0050568236ae=Bahmni Diagnosis Status
ui.i18n.Concept.name.8aa9e352-3a91-11e5-b380-0050568236ae=Bahmni Initial Diagnosis
ui.i18n.Concept.name.8aaa93df-3a91-11e5-b380-0050568236ae=Bahmni Diagnosis Revised
ui.i18n.Concept.name.8aad3eb1-3a91-11e5-b380-0050568236ae=Lab Manager Notes
ui.i18n.Concept.name.8ab24db2-3a91-11e5-b380-0050568236ae=Accession Uuid
ui.i18n.Concept.name.91af1a2a-3a91-11e5-b380-0050568236ae=Dose\n            Quantity Units
ui.i18n.Concept.name.c9f7440f-3a91-11e5-b380-0050568236ae=dosing  units
ui.i18n.Concept.name.c9f84a76-3a91-11e5-b380-0050568236ae=capsule(s)
ui.i18n.Concept.name.c9f8ec4c-3a91-11e5-b380-0050568236ae=tablet(s)
ui.i18n.Concept.name.c9f981b6-3a91-11e5-b380-0050568236ae=teaspoon
ui.i18n.Concept.name.c9fa3bb6-3a91-11e5-b380-0050568236ae=tablespoon
ui.i18n.Concept.name.c9fc1f44-3a91-11e5-b380-0050568236ae=drop
ui.i18n.Concept.name.c9fcb6cd-3a91-11e5-b380-0050568236ae=ml
ui.i18n.Concept.name.c9fd5161-3a91-11e5-b380-0050568236ae=mg
ui.i18n.Concept.name.ca181fb9-3a91-11e5-b380-0050568236ae=drug routes
ui.i18n.Concept.name.ca18edb4-3a91-11e5-b380-0050568236ae=IM
ui.i18n.Concept.name.ca19941d-3a91-11e5-b380-0050568236ae=IV
ui.i18n.Concept.name.ca1a2fcf-3a91-11e5-b380-0050568236ae=PO
ui.i18n.Concept.name.ca1af389-3a91-11e5-b380-0050568236ae=PV
ui.i18n.Concept.name.ca1bbb7a-3a91-11e5-b380-0050568236ae=SC
ui.i18n.Concept.name.ca1c8f9c-3a91-11e5-b380-0050568236ae=PR
ui.i18n.Concept.name.ca1d4e2f-3a91-11e5-b380-0050568236ae=SL
ui.i18n.Concept.name.ca28e289-3a91-11e5-b380-0050568236ae=NG
ui.i18n.Concept.name.ca2d3d01-3a91-11e5-b380-0050568236ae=duration units
ui.i18n.Concept.name.ca2e0b75-3a91-11e5-b380-0050568236ae=day(s)
ui.i18n.Concept.name.ca33a9a2-3a91-11e5-b380-0050568236ae=OD
ui.i18n.Concept.name.ca40c962-3a91-11e5-b380-0050568236ae=BiD
ui.i18n.Concept.name.ca419b51-3a91-11e5-b380-0050568236ae=TDS
ui.i18n.Concept.name.ca4f9aad-3a91-11e5-b380-0050568236ae=QD
ui.i18n.Concept.name.ca534f62-3a91-11e5-b380-0050568236ae=Dosing Instructions
ui.i18n.Concept.name.ca541d67-3a91-11e5-b380-0050568236ae=ac
ui.i18n.Concept.name.ca556f33-3a91-11e5-b380-0050568236ae=pc
ui.i18n.Concept.name.ca561fc9-3a91-11e5-b380-0050568236ae=cm
ui.i18n.Concept.name.ca574dea-3a91-11e5-b380-0050568236ae=hs
ui.i18n.Concept.name.ca657e80-3a91-11e5-b380-0050568236ae=STAT
ui.i18n.Concept.name.ca69145c-3a91-11e5-b380-0050568236ae=All Observation templates
ui.i18n.Concept.name.1732763f-3a92-11e5-b380-0050568236ae=LAB_REPORT
ui.i18n.Concept.name.17610dc1-3a92-11e5-b380-0050568236ae=hour(s)
ui.i18n.Concept.name.176252c5-3a92-11e5-b380-0050568236ae=week(s)
ui.i18n.Concept.name.17631f21-3a92-11e5-b380-0050568236ae=month(s)
ui.i18n.Concept.name.17e111e1-3a92-11e5-b380-0050568236ae=Impression
ui.i18n.Concept.name.18060cde-3a92-11e5-b380-0050568236ae=All Disease Templates
ui.i18n.Concept.name.1809352b-3a92-11e5-b380-0050568236ae=unit(s)
ui.i18n.Concept.name.180cb136-3a92-11e5-b380-0050568236ae=QH
ui.i18n.Concept.name.180d8be0-3a92-11e5-b380-0050568236ae=Q2H
ui.i18n.Concept.name.180eb574-3a92-11e5-b380-0050568236ae=Q3H
ui.i18n.Concept.name.1815f960-3a92-11e5-b380-0050568236ae=Q4H
ui.i18n.Concept.name.18211e5f-3a92-11e5-b380-0050568236ae=Q6H
ui.i18n.Concept.name.18224933-3a92-11e5-b380-0050568236ae=Q8H
ui.i18n.Concept.name.182313da-3a92-11e5-b380-0050568236ae=Q12H
ui.i18n.Concept.name.1823e0b2-3a92-11e5-b380-0050568236ae=A/D
ui.i18n.Concept.name.1824b228-3a92-11e5-b380-0050568236ae=Once a week
ui.i18n.Concept.name.182564e3-3a92-11e5-b380-0050568236ae=TiW
ui.i18n.Concept.name.182a8533-3a92-11e5-b380-0050568236ae=Thrice a week
ui.i18n.Concept.name.182b76bc-3a92-11e5-b380-0050568236ae=Every 2 weeks
ui.i18n.Concept.name.182c23ae-3a92-11e5-b380-0050568236ae=Every 3 weeks
ui.i18n.Concept.name.182ccda6-3a92-11e5-b380-0050568236ae=Once a month
ui.i18n.Concept.name.182fef8b-3a92-11e5-b380-0050568236ae=ID
ui.i18n.Concept.name.183094ff-3a92-11e5-b380-0050568236ae=IP
ui.i18n.Concept.name.1831353e-3a92-11e5-b380-0050568236ae=IT
ui.i18n.Concept.name.1831cfc0-3a92-11e5-b380-0050568236ae=IO
ui.i18n.Concept.name.189d42d5-3a92-11e5-b380-0050568236ae=tablet
ui.i18n.Concept.name.189d9672-3a92-11e5-b380-0050568236ae=capsule
ui.i18n.Concept.name.189de42e-3a92-11e5-b380-0050568236ae=TOPIC
ui.i18n.Concept.name.189e3259-3a92-11e5-b380-0050568236ae=NASAL
ui.i18n.Concept.name.189e828d-3a92-11e5-b380-0050568236ae=RESPIR
ui.i18n.Concept.name.18a0db2d-3a92-11e5-b380-0050568236ae=Five times a day
ui.i18n.Concept.name.18a1a8f7-3a92-11e5-b380-0050568236ae=Four days a week
ui.i18n.Concept.name.18a253ea-3a92-11e5-b380-0050568236ae=Five days a week
ui.i18n.Concept.name.18a2fd95-3a92-11e5-b380-0050568236ae=Six days a week
ui.i18n.Concept.name.18a9fcff-3a92-11e5-b380-0050568236ae=minute(s)
ui.i18n.Concept.name.18b1c50a-3a92-11e5-b380-0050568236ae=Deny Admission
ui.i18n.Concept.name.18b7889f-3a92-11e5-b380-0050568236ae=Order Attributes
ui.i18n.Concept.name.18beea6d-3a92-11e5-b380-0050568236ae=Undo Discharge
ui.i18n.Concept.name.18c58870-3a92-11e5-b380-0050568236ae=D
ui.i18n.Concept.name.18e54577-3a92-11e5-b380-0050568236ae=All Orderables
ui.i18n.Concept.name.36f53e2a-3f5a-11e5-b380-0050568236ae=education
ui.i18n.Concept.name.36f63821-3f5a-11e5-b380-0050568236ae=uneducated
ui.i18n.Concept.name.36f6da3c-3f5a-11e5-b380-0050568236ae=below-5th
ui.i18n.Concept.name.36f7e308-3f5a-11e5-b380-0050568236ae=6th-9th
ui.i18n.Concept.name.36fc4faf-3f5a-11e5-b380-0050568236ae=10th-pass
ui.i18n.Concept.name.36fd2b7e-3f5a-11e5-b380-0050568236ae=12th-pass
ui.i18n.Concept.name.36fe0db0-3f5a-11e5-b380-0050568236ae=graduate
ui.i18n.Concept.name.36ff11e0-3f5a-11e5-b380-0050568236ae=occupation
ui.i18n.Concept.name.3700c366-3f5a-11e5-b380-0050568236ae=government
ui.i18n.Concept.name.3702040b-3f5a-11e5-b380-0050568236ae=business
ui.i18n.Concept.name.3702a078-3f5a-11e5-b380-0050568236ae=housewife
ui.i18n.Concept.name.37033694-3f5a-11e5-b380-0050568236ae=labour
ui.i18n.Concept.name.370c2b7b-3f5a-11e5-b380-0050568236ae=Patient Document
ui.i18n.Concept.name.370ce7c7-3f5a-11e5-b380-0050568236ae=Patient file
ui.i18n.Concept.name.79ccfb3b-0f17-4c79-a552-170fdcf2e2b3=Used atleast one of the drugs in past one year</br>Cannabis</br> Cocaine</br> Prescription stimulants without a prescription</br> Methamphetamine</br> Inhalants</br> Sedatives</br> Hallucinogens</br> Street opioids
ui.i18n.Concept.name.43113593-d3bb-4114-a134-652902c0192e=Homeless within past 1 year
ui.i18n.Concept.name.f34b699b-c52d-410b-b40d-a61dfc5bcc94=Refugee or displaced person
ui.i18n.Concept.name.3786ca94-7e10-45f0-bfd1-ac62f6878ec8=type of scheduled visit
ui.i18n.Concept.name.5087AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Pulse
ui.i18n.Concept.name.52d695fe-5014-4cc7-84ab-aba7ac5efe1a=BPNS LEFT numbness
ui.i18n.Concept.name.691e8241-fe78-4937-87ea-50f1df46a2b9=BPNS LEFT pain, ache, burning
ui.i18n.Concept.name.8a61349b-ed87-4de8-9a84-25d4fa1efb97=BPNS LEFT pins needles
ui.i18n.Concept.name.93333043-4252-47a4-aa82-ef84163a2c2b=RR
ui.i18n.Concept.name.b90f2c1b-9c6e-4b41-a6c6-e30780ea2aa7=Left eye
ui.i18n.Concept.name.fbb823e8-d46c-4761-b55b-2c4a621bb503=Right eye
ui.i18n.Concept.name.83584b7d-8794-4006-9c63-38ad5aaa3b13=Colour blindness RIGHT
ui.i18n.Concept.name.883ae3b9-bbe7-4f95-90c1-9480a4a6ec60=Is new AE an SAE?
ui.i18n.Concept.name.8b5746a6-e23d-4ebc-9b6c-b6c35c56d9e8=Colour blindness LEFT
ui.i18n.Concept.name.b6daa375-2170-41db-8177-154d8bdfd63c=Colour blindness
ui.i18n.Concept.name.d5420286-1c66-48ad-915a-12a86935641c=Hospital admission since last visit?
ui.i18n.Concept.name.f7a4af5e-b291-4093-9336-6dbf430f56e7=Reporting new AE?
ui.i18n.Concept.name.582b108f-d881-4bcf-8093-d22298597289=Brief Peripheral Neuropathy Screen
ui.i18n.Concept.name.255e644a-b30e-4ec6-956d-9663d29b8892=Colorblindness Screen (Ishihara Test)
ui.i18n.Concept.name.73766466-d0e3-427c-a38b-2a01f49dd3fe=Clinical Examination
ui.i18n.Concept.name.871b95b0-aed6-4f94-bf79-19d8058f9dd3=Followup Questions For Clinician Reminder
ui.i18n.Concept.name.8e3c2631-501f-4783-8740-fcb08a691631=Followup Assessment
ui.i18n.Concept.name.aef91d6f-80e6-4b71-984b-6ae0342f2fe2=Number of Incorrect Plates
ui.i18n.Concept.name.b1a05aa9-d22c-4b81-a209-bd9663d8c7ca=Visual Acuity
ui.i18n.Concept.name.450AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Amoxicillin/Clavulanate (Amx/Clv)
ui.i18n.Concept.name.71060AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Amikacin (Am)
ui.i18n.Concept.name.72794AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Capreomycin (Cm)
ui.i18n.Concept.name.73581AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Clofazimine (Cfz)
ui.i18n.Concept.name.74123AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Cycloserine (Cs)
ui.i18n.Concept.name.75948AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Ethambutol (E)
ui.i18n.Concept.name.75976AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Ethionamide (Eto)
ui.i18n.Concept.name.78385AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Kanamycin (Km)
ui.i18n.Concept.name.78788AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Levofloxacin (Lfx)
ui.i18n.Concept.name.78879AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Linezolid (Lzd)
ui.i18n.Concept.name.80133AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Moxifloxacin (Mfx)
ui.i18n.Concept.name.160019AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Thioacetazone (T)
ui.i18n.Concept.name.81457AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Para-aminosalicylic acid (PAS)
ui.i18n.Concept.name.82772AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Prothionamide (Pto)
ui.i18n.Concept.name.82900AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Pyrazinamide (Z)
ui.i18n.Concept.name.84360AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Streptomycin (S)
ui.i18n.Concept.name.84836AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Terizidone (Trd)
ui.i18n.Concept.name.b8b122b0-9b7e-4791-b8e6-cb918f8116b9=Non-confirmed, clinically diagnosed
ui.i18n.Concept.name.6b806f15-031c-4efb-8362-cbe9c4a0b003=Consent for EndTB signed?
ui.i18n.Concept.name.8645fb7b-3a45-49d1-8c11-558d6287c12a=Prison
ui.i18n.Concept.name.a5e8cb93-8f34-4853-8eb4-2a7da25b4e65=Refugee, migrant or displaced
ui.i18n.Concept.name.a90d738e-8e55-4580-bfcb-fc6039a4b9be=Consent for New Drugs Signed?
ui.i18n.Concept.name.dee08bef-1e3d-4bd3-954c-d0c8bb9e7865=Employed
ui.i18n.Concept.name.ebac4f9f-9ba1-4ed7-bf64-f58b1cef28a9=Marital Status
ui.i18n.Concept.name.fad62460-0912-4fe0-bec6-740cc5e8e231=Homeless
ui.i18n.Concept.name.03ce6fd2-2371-4cdf-86fb-459ff131a094=Non-IV drug user
ui.i18n.Concept.name.04af9b78-733e-4ae8-8b55-45afe882a895=IV drug user
ui.i18n.Concept.name.1beb091d-2d3d-4d74-8f78-c93bbf5ef24c=How Many Drug-Resistant TB Treatments
ui.i18n.Concept.name.6851d165-c9e3-47c6-85a8-386fcf6cdfc1=Drug-Susceptible TB Treatment in the Past
ui.i18n.Concept.name.7914cd83-0eac-4c34-929a-0377e3bc02c4=Health worker
ui.i18n.Concept.name.86dac434-6da8-42a8-908c-dc29ab88d58e=Drug-Resistant TB Treatment in the Past
ui.i18n.Concept.name.915232f6-a0d3-4d42-82c6-d22a575a4ef3=Smoker
ui.i18n.Concept.name.a5ea5e64-e7cd-4da4-8229-a1d0088d5048=Year of First TB Treatment?
ui.i18n.Concept.name.c1672f36-4532-4778-9d39-1c21b4518494=Drinks/week
ui.i18n.Concept.name.cbbfadd4-cd96-4de8-839d-4e1a5ad1b6f6=How many Drug-Susceptible TB treatments
ui.i18n.Concept.name.e82a94df-6758-438b-ae9c-537546379a22=Alcohol
ui.i18n.Concept.name.341c9a57-5e84-49f2-b148-c5731fa1c4aa=HIV
ui.i18n.Concept.name.3ae6afbd-6bff-47a1-a573-a91aaae771e8=Viral load date
ui.i18n.Concept.name.650aa651-0e33-40b9-bf4c-e582b0dfd21b=Other past TB drugs > 1 month
ui.i18n.Concept.name.707d5ac6-447d-49b0-ac0d-a1a76a423209=ARV drugs treatment
ui.i18n.Concept.name.96365082-2546-4749-aa1a-a1d86d76bdaf=Past TB drugs > 1 month
ui.i18n.Concept.name.a67e143d-7ab0-44f8-9767-2f6969b9c601=What is the registration number of the most recent previous TB treatment episode?
ui.i18n.Concept.name.d7e7c5d7-a842-442d-8795-866fcd11b0ba=ARV
ui.i18n.Concept.name.04fb8437-4b45-437b-9b34-4f9be09bba63=Has other psychiatric illness
ui.i18n.Concept.name.0dda7a44-b716-4505-9a34-9540ec5c6b8c=Depression
ui.i18n.Concept.name.2f6fd5ab-31aa-46cc-a027-0c258e3c90bb=Cancer
ui.i18n.Concept.name.63b8d56d-07bd-4d58-99a1-a4f81f02c4c4=Type of psychiatric illness
ui.i18n.Concept.name.a115de59-36da-401e-8f2d-f235bc808265=Heart disease
ui.i18n.Concept.name.adadbba6-9b8d-4cf9-8101-675aa2fb210a=Seizures
ui.i18n.Concept.name.ae4ed2ff-7705-43ad-b5a5-ac1606b7bfa5=Hepatitis B
ui.i18n.Concept.name.b1c1d93a-b279-45e5-8aa5-90c131cfc8cd=Hepatitis C
ui.i18n.Concept.name.b2fb4a6f-f34c-4c7d-8b70-6f39282b0bd9=Chronic renal disease
ui.i18n.Concept.name.c261f2ca-8636-44e1-b042-8cc938fae226=Cancer type
ui.i18n.Concept.name.c8885441-ee79-42ed-aee3-7989738950cb=COPD
ui.i18n.Concept.name.c8acbb9e-a034-402b-8df4-7cc03296d2c7=Pregnant at Treatment Start
ui.i18n.Concept.name.f4c3f3fa-26e9-4adc-bc56-abd29f4d03aa=Cirrhosis
ui.i18n.Concept.name.031e5064-eb58-4e48-8870-1d69f7c6d1f3=Pre-XDR - injectable
ui.i18n.Concept.name.07ec3203-8ae2-4aa4-b5b3-0723fb17254c=Pre-XDR - fluoroquinolone
ui.i18n.Concept.name.16df006b-1e6f-4c81-82f1-0884c6e19d57=Xpert MTB/RIF result
ui.i18n.Concept.name.187faed4-0e99-4d35-9b1a-76cd6114e7d0=VA LEFT
ui.i18n.Concept.name.262a0265-e48a-4f45-881b-f750ed6f4ebf=Date eligible new drugs
ui.i18n.Concept.name.3402fffa-3c24-433b-bac4-5af994b83c4a=XDR
ui.i18n.Concept.name.34a6b6f0-1b01-4c6a-8f80-530bceca41ec=Smear result
ui.i18n.Concept.name.3f646842-0ef5-49a6-9a33-be968736cdf9=MTB confirmation
ui.i18n.Concept.name.4952fb25-34b8-4299-8572-e58611d5e165=Extrapulmonary site
ui.i18n.Concept.name.58181c7e-cce4-4ca5-bcac-9010e609b06c=VA RIGHT
ui.i18n.Concept.name.8ce260e9-7b56-414c-81e5-be0a1d38b1da=MDR-TB diagnosis date
ui.i18n.Concept.name.97b5a463-3b16-454b-ab03-233b21d9d706=Colour blindness
ui.i18n.Concept.name.a43e8a7e-264f-4d4f-8e70-6ad390751da9=Culture result
ui.i18n.Concept.name.aadac727-bb1f-4c9f-9bfc-7cd2c1f7ab47=BPNS LEFT pins needles
ui.i18n.Concept.name.b31d7b10-2888-407b-8ba0-3c0b1b400f72=Colour blindness LEFT
ui.i18n.Concept.name.bcd87b74-5c10-4414-bed6-0a1b72aba00e=DST results
ui.i18n.Concept.name.c63f079b-4fe7-484d-a8fe-72459c61fba1=Disease site
ui.i18n.Concept.name.d2e65b14-8679-41f7-b54a-f06d52220fdb=BPNS LEFT pain, ache, burning
ui.i18n.Concept.name.d680fe34-9032-4f16-80cc-96f7b6a00f22=BPNS LEFT numbness
ui.i18n.Concept.name.df579289-4e00-4aa8-925b-faad4489735c=Other patterns of resistance that are not XDR or pre-XDR
ui.i18n.Concept.name.e7d8aeae-8873-4802-a2b0-dd4fea09d2eb=WHO registration group
ui.i18n.Concept.name.fa6d4b40-0e4d-49b2-8e5a-7ac162d8a05a=Colour blindness RIGHT
ui.i18n.Concept.name.0dee3c22-aaa6-462d-88d2-3872d57c1f36=Indication for new drugs: 4 effective drugs not possible
ui.i18n.Concept.name.460e668f-c3d5-4bbd-b2bd-78d4fcac6de9=If yes, treatment start date
ui.i18n.Concept.name.65677c92-ac93-4a00-b845-bc43f05ae63c=Drug intolerance/contraindication/low BMI/HIV/ diabetes
ui.i18n.Concept.name.6ed59490-264a-447c-acf7-e06db4129c3c=Start treatment?
ui.i18n.Concept.name.6fabbcfc-057d-4883-8b48-96671f070a24=Treatment delivery method
ui.i18n.Concept.name.74fdc344-110a-46bc-b94b-0632ce0ab22d=Unable to tolerate MDR drugs
ui.i18n.Concept.name.8b009550-4f73-45a6-9669-6d46f5b32aa2=DOT Outpatient community-based
ui.i18n.Concept.name.97a64982-c4fa-4e84-be2f-fb0de018ad71=Contact with a patient with above strain
ui.i18n.Concept.name.a86c0c33-ef55-4eb7-a0d2-83b1077cadd3=Extensive or advanced disease
ui.i18n.Concept.name.c374eb7e-6bf3-44fe-824a-70c2c355bce2=DOT Inpatient
ui.i18n.Concept.name.d7cd60c2-cd5a-4a2c-aaef-fec5e7069aa9="failed" MDR regimen
ui.i18n.Concept.name.dfa1d7b1-7855-41ca-8644-871278ea82bd=Indication for new drugs: high risk of unfavourable outcome
ui.i18n.Concept.name.e07f9253-90bb-42af-82b9-0da224995f07=DOT Outpatient facility-based
ui.i18n.Concept.name.e081a67c-b413-43f2-b6a2-7884602d43a5=From areas with poor MDR-TB outcomes
ui.i18n.Concept.name.213ef0cb-cc0d-421f-a715-aa1022a02fb6=If no, reason for not starting treatment
ui.i18n.Concept.name.4ae65026-5d88-4ee2-80bc-7fec8814180b=Consent
ui.i18n.Concept.name.a63f24de-7504-4985-8e33-02baa120878a=Past TB Treatment
ui.i18n.Concept.name.2f8e53c9-abd4-4f08-8a41-a87abc453713=Past Medical History (Co-morbidities)
ui.i18n.Concept.name.37936b58-76a1-4da3-ba63-357ac72894a3=Diabetes (Type I or II)
ui.i18n.Concept.name.73894e95-a17c-48ff-a3ba-b213a863f0c1=Brief Peripheral Neuropathy Screen
ui.i18n.Concept.name.7b5e597b-a87b-4618-89d4-5ca6b84c996a=Visual Acuity
ui.i18n.Concept.name.7f52b96f-02cb-4c4a-a135-e602ec90baa2=Psychiatric Illness
ui.i18n.Concept.name.e01d8e21-47b9-4633-b9e7-3add51ff6615=HIV Serostatus
ui.i18n.Concept.name.e48995eb-a863-430e-b6d5-2a7e30d37080=Cancer
ui.i18n.Concept.name.4a5d5997-4984-4743-aa81-a0dbce497590=Physical Examination
ui.i18n.Concept.name.53793021-656c-4e3e-804e-17aea03854a1=Colorblindness Screen (Ishihara Test)
ui.i18n.Concept.name.8fa041a0-ce44-4b85-9df3-9aa1b472eff0=Number Of Incorrect Plates
ui.i18n.Concept.name.b47e7487-de8c-4bdd-a3b6-0612f8c25c4a=New Treatment Eligibility
ui.i18n.Concept.name.ccf94ca2-84ca-47e3-b17b-00adc1408428=Indication For New Drugs
ui.i18n.Concept.name.d670fc9b-83cd-4e7f-ad41-0b5656c0f870=Treatment Initiation
ui.i18n.Concept.name.f184d02e-697b-49cc-a230-1fd895e5041a=Case Definition
ui.i18n.Concept.name.87fbb021-380b-49f3-a5fd-b13ab1def072=Social History
ui.i18n.Concept.name.6c565681-b4ea-4505-b35b-c0ab1c181ad6=Baseline
ui.i18n.Concept.name.6119205c-4cad-4489-b2bf-3281382118fe=AFP
ui.i18n.Concept.name.d0caf750-318c-4637-8c9d-c92d9f2b2e63=AES
ui.i18n.Concept.name.0a45f075-afb5-4353-a657-de053e8f8638=Diagnosis Set of Sets
ui.i18n.Concept.name.67fa4313-e8c7-4c8c-8177-e7bb41d57ca9=Specimen
ui.i18n.Concept.name.8f4b2ac4-6de4-49a9-bcac-52d8153f6605=Smear
ui.i18n.Concept.name.9f2c6216-47a8-4d2a-ba87-0a87f589f8a5=Lowenstein Jensen
ui.i18n.Concept.name.5a7f3702-174e-4737-8dd9-9290d7373f2d=OGAWA
ui.i18n.Concept.name.6b805028-290e-406a-bad1-200866ed01f3=BACTEC MGIT
ui.i18n.Concept.name.c2d4fd57-a19f-430e-95de-5ddf7d3a805f=Bacteriology Fulfillment
ui.i18n.Concept.name.c18fb201-75d1-4d49-9f8e-72c396368b6c=Sample ID
ui.i18n.Concept.name.76bdeaa9-e53f-431b-9d7f-afb1a1267b9a=Sample Type
ui.i18n.Concept.name.6a8bd0f8-5e8e-4d9a-a1cd-3e1745e72182=Sample Appearance
ui.i18n.Concept.name.89a985c2-562f-4e4a-b961-7409d9736ad0=Contaminated
ui.i18n.Concept.name.dba931e1-cc61-4913-b34b-c51041953e86=Positive
ui.i18n.Concept.name.37ef6637-7ce7-4ed3-950f-6a855db9a751=Negative
ui.i18n.Concept.name.4e0c81d4-d232-4cb2-a624-4fd7737f0fa5=Result
ui.i18n.Concept.name.02e85267-cf59-4f08-bca8-7e64041b18ee=Not evaluated
ui.i18n.Concept.name.420150d4-6a24-4395-9d10-e0f73c25fc5d=Lactate (serum lactate greater than ULN)
ui.i18n.Concept.name.79b54711-3f5a-48ef-8696-a25e20544c3e=Hypomagnesemia (Mg <= 1.4 mmol/L)
ui.i18n.Concept.name.bfc919b7-7707-40b8-9fa2-64ada4d84a52=Hyperkalemia (K <= 3.4 mEq/L)
ui.i18n.Concept.name.1e127192-afd9-4463-9bd2-6c26548d857a=Oral discomfort/dysphagia
ui.i18n.Concept.name.37dbc280-08c2-40d0-afb0-cbf4a361650b=Platelets Decreased ( < 75000/mm^3 )
ui.i18n.Concept.name.3c6c46f9-e06c-4a78-9d9c-c67c52801c37=Peripheral neuropathy (neurosensory disorder or paresthesia)
ui.i18n.Concept.name.5acf1062-8005-4a71-8679-28757412d9c3=Anemia (Hb < 10.5 g/dL)
ui.i18n.Concept.name.66887183-07ae-464c-9aa5-50294ebbb136=Absolute Neutrophil Count Low (ANC <= 1500/mm^3)
ui.i18n.Concept.name.6c1e6f69-9169-439a-96c6-84a2c7a345c4=Acute kidney injury (acute renal failure)
ui.i18n.Concept.name.7b7ea5a6-8222-4eec-89d0-10cfef60cdfd=Skin hypo- or hyper-pigmentation
ui.i18n.Concept.name.a81ce84d-1995-416e-ab4e-232a2a4c9690=Mucocutaneous Symptoms (includes rash)
ui.i18n.Concept.name.ce62461d-16f7-40a6-a082-240453ffe9ac=Optic nerve disorder (optic neuritis)
ui.i18n.Concept.name.36a53008-7510-442f-9540-b108b1b6ee61=One or more TB drugs were permanently dose reduced (includes intermittent dosing)
ui.i18n.Concept.name.7011cbd7-c313-4bb6-b7b0-646cd2ecfc8e=One or more TB drugs were temporarily dose reduced (includes intermittent dosing)
ui.i18n.Concept.name.17b179c7-ca16-4c93-a00d-12f2721b17bf=QTcF Interval
ui.i18n.Concept.name.3aac848c-09fb-4c7a-840c-52fc3670b90e=Date of ECG
ui.i18n.Concept.name.ffb38957-7a0d-49d6-8777-79f4fe319abd=Rhythm
ui.i18n.Concept.name.58c46ea0-2ca9-4880-b44e-66cfc8fe3cf9=Electrocardiogram
ui.i18n.Concept.name.1f8830a9-317c-445c-a619-9265282646dc=Adverse events
ui.i18n.Concept.name.300d815a-a2dc-469e-a259-f74d032cad19=Route of administration
ui.i18n.Concept.name.35ac02a0-bb07-4ac2-9015-c7b8e2c2713b=Daily dose
ui.i18n.Concept.name.3b79a36a-2a6b-4f7f-8bc3-106b832d4a56=TB drug name
ui.i18n.Concept.name.57f29887-b1af-48b8-a786-2308260edd5c=Schedule
ui.i18n.Concept.name.0b223f47-90ee-4f52-a77c-c2ad3a25be5e=Reason for stopping
ui.i18n.Concept.name.78e5129b-bbd2-47ac-8e5c-ed00fd573787=Start date
ui.i18n.Concept.name.a47945f4-fab9-460e-b004-a168a822a141=Stop date
ui.i18n.Concept.name.b21766b5-75c3-4c12-9087-8917f25a12ca=Other reason for stopping
ui.i18n.Concept.name.0e59d508-519e-4a1f-ab67-895dadafa763=TB Treatment Changes
ui.i18n.Concept.name.288b0183-2c6a-4496-b038-5ea311dd3934=Medication Log
ui.i18n.Concept.name.2b45ee4b-d0d3-44a2-94ee-f239b8525952=Was the hematology test sample collected at this visit?
ui.i18n.Concept.name.02f856e7-fb11-49c5-8b55-66d05ca8708a=Potassium result
ui.i18n.Concept.name.05808b19-959d-4e51-ac4a-875eb351c4cd=Test done?
ui.i18n.Concept.name.1330AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Absolute Neutrophil Count
ui.i18n.Concept.name.3fd1c7ad-7f82-45d6-912f-f84b24a5b7ae=Neutrophils Count
ui.i18n.Concept.name.48ceb4b2-2a2c-4aec-882c-926e085fedf9=WBC count result
ui.i18n.Concept.name.83a0a101-6512-4bb7-bc7d-f7460b8dc984=Hemoglobin result
ui.i18n.Concept.name.a41a3f2c-3f14-4efe-b9c9-e748e911e3f3=Was the chemistry test sample collected at this visit?
ui.i18n.Concept.name.b9da8206-4b23-4d49-9a9b-93962420255c=RBC count result
ui.i18n.Concept.name.c162403c-05bb-4c4e-af19-556df8d6fb8a=Hematocrit result
ui.i18n.Concept.name.c4dea4be-c47f-4aeb-ab70-e569150f64cc=Platelet count result
ui.i18n.Concept.name.cf5be2af-08b0-4bd5-85d2-247fc85deec0=Is this result outside of normal range?
ui.i18n.Concept.name.e4a66084-9571-4b56-a79e-e0c770e8a0a5=Unit
ui.i18n.Concept.name.15705213-f6ea-4d12-8fc6-9e8e5e1a22fc=Unit
ui.i18n.Concept.name.2991f642-70f2-4727-9d0b-5eb26b465518=Was the baseline screening test sample collected at this visit?
ui.i18n.Concept.name.29a59fe2-7f9d-478a-9881-17dc0d9df16b=Creatinine : Unit
ui.i18n.Concept.name.2b82d1c2-0bde-4129-baef-3328487acd47=What is the upper limit of the normal range for this test?
ui.i18n.Concept.name.2e975663-ca98-4a5b-bdb7-3b56b1e10175=TSH result
ui.i18n.Concept.name.387e8658-17bc-408c-84db-5eec83396204=Pregnancy result
ui.i18n.Concept.name.3b16ef03-7198-4482-bd8d-971430c02f8c=Total Bilirubin result
ui.i18n.Concept.name.4114acd0-3d93-4b01-8294-cb3bb6a74193=Creatinine result
ui.i18n.Concept.name.44ebd1c0-0350-44f5-95a1-43d8d6853254=What is the upper limit of the normal range for this test?
ui.i18n.Concept.name.6ca02e44-0d5d-41cf-ad2f-866316d23f88=What is the upper limit of the normal range for this test?
ui.i18n.Concept.name.6e8108d8-b1f8-4891-bfac-1f0ff60527f4=Glucose result
ui.i18n.Concept.name.8086bd1a-48a6-4294-a5bb-c70c03c5f908=ALT result
ui.i18n.Concept.name.87876841-0e92-44e0-82c2-d11cbac91506=Unit
ui.i18n.Concept.name.8d2e1708-2b21-483e-a61b-97284ecbd247=Urea result
ui.i18n.Concept.name.9ee6c4b1-62b0-43bb-bd2c-b2442eb947da=AST result
ui.i18n.Concept.name.e2797150-b979-497f-868a-7f96a5436edd=Unit
ui.i18n.Concept.name.15ce8638-45cb-4ed3-9c54-40ed983a3c9c=HbA1c result
ui.i18n.Concept.name.5284cd1e-b849-4bc5-b63b-5ade74af76d2=Hep C Antibody
ui.i18n.Concept.name.71700424-e709-4f6a-ba4f-000bdcd12220=Unit
ui.i18n.Concept.name.affbc419-ed17-4616-b278-3406693c5927=CD4 count result
ui.i18n.Concept.name.c556ca20-63f9-485c-ab7b-067584b79ee6=Serum Albumin result
ui.i18n.Concept.name.e2e2a7c9-ba80-4375-b036-afc1c00096c5=Hepatitis B Surface Antigen
ui.i18n.Concept.name.eadb6260-0861-4c1c-b7cd-810e724b73be=RNA VL result
ui.i18n.Concept.name.ef9accb3-7384-458f-88bd-0c9541900ffa=HIV test result
ui.i18n.Concept.name.02ec1a46-fc60-4141-85e7-772023d62555=RBC Count
ui.i18n.Concept.name.bd23e366-3aea-4457-a248-9a1d0ee2d0bf=WBC
ui.i18n.Concept.name.c4214e53-fc5d-4b89-b5a7-f67b1e024a57=Hematocrit
ui.i18n.Concept.name.d7720b00-63d5-4efe-955e-42997339e228=Platelet Count
ui.i18n.Concept.name.f3eb1506-4f20-4ac1-b0b3-219759d1957c=Hemoglobin Details
ui.i18n.Concept.name.75132b86-5bd4-4fa3-ab4c-2432b55efd81=Absolute Neutrophil Count
ui.i18n.Concept.name.b6099862-331c-41cd-8336-f828963cfeaf=% Neutrophils
ui.i18n.Concept.name.09563914-ef4e-4cc2-a01a-0d963c03ab8e=Urea
ui.i18n.Concept.name.0db73750-641c-4c9d-9e50-9a5364cf3aad=TSH
ui.i18n.Concept.name.32f187fb-6610-4683-9cb3-edf99ba3ebfc=Haematology Results
ui.i18n.Concept.name.4b00343d-b85d-4fe3-9b27-69fe3dc1c201=Glucose
ui.i18n.Concept.name.6757e60a-2a17-407b-9ab5-d600722a588f=ALT (SGPT)
ui.i18n.Concept.name.7ccdaeaf-91f6-460d-850d-00d69e2e3906=Creatinine
ui.i18n.Concept.name.bb4c8d12-e60e-49f0-a335-e210e734a151=Potassium
ui.i18n.Concept.name.df450b5f-2f5d-455e-abf5-5398c3ee4f2d=AST (SGOT)
ui.i18n.Concept.name.024a2ab5-7f3a-4a47-ba1a-ae6cc9804aa4=Serum Albumin
ui.i18n.Concept.name.2adf5581-2100-4566-bcac-d105e4ae23f9=RNA VL
ui.i18n.Concept.name.30f4ed06-a3fe-4ed5-9dea-0f413db5449f=Hep B surface antigen
ui.i18n.Concept.name.34c5facb-3075-46de-ae3c-60f319eb946f=Hep C antibody
ui.i18n.Concept.name.369b3776-a18d-4008-9306-7ba7bc5a4a99=Urine pregnancy
ui.i18n.Concept.name.57719625-1a05-4092-b72b-18e4a15cea5e=HbA1c
ui.i18n.Concept.name.59c5fed9-cf33-4db6-9ef4-f05a6500e8fd=CD4 count
ui.i18n.Concept.name.776427a2-14a9-4795-9362-a6ce1f91d648=Total Bilirubin Details
ui.i18n.Concept.name.980b5f63-10de-4919-b62c-4baecf3942a2=Biochemistry Results
ui.i18n.Concept.name.baa4f03b-bf48-4bad-a3c9-797474612a73=Rapid HIV test
ui.i18n.Concept.name.38821236-90d7-4a88-aa89-2045106e8809=Serological Tests
ui.i18n.Concept.name.3bd473f8-5d1d-4c37-81b1-e09d61d093d7=Lab Results - Hematology and Biochemistry
ui.i18n.Concept.name.c07556e7-7aba-4a70-9c6f-018607bc8108=(A) The AE met the definition of an SAE and an SAE Form was submitted to the PV Unit
ui.i18n.Concept.name.edec38b3-3294-4f38-a15c-c228c1cc9bd6=(B)The AE never met the definition of an SAE and an SAE Form was never submitted to the PV Unit
ui.i18n.Concept.name.e811c342-3250-4c07-9f37-b35624319e04=Lab Results
ui.i18n.Concept.name.2fdfb62c-b6a8-4e51-a731-f19a0f9db2e1=Aerosol
ui.i18n.Concept.name.38fce9d2-609b-42d9-bb52-f7159f93e86b=IM
ui.i18n.Concept.name.b0ec1193-dee4-4aea-84ab-f0771b006b9a=IV
ui.i18n.Concept.name.df4f584d-247b-4319-835d-de38dade7fe2=PO
ui.i18n.Concept.name.f25cd3b6-efe7-4d3c-8300-8bc0edbc4714=SC
ui.i18n.Concept.name.83e44321-2551-4683-a27d-378837a13461=BMI Status
ui.i18n.Concept.name.c4065ae2-ad5d-4f89-bbe5-8711ed9ee8c6=BMI
ui.i18n.Concept.name.e5df9ed7-1783-4c46-afc5-c0154a96cf08=Single
ui.i18n.Concept.name.c455f764-c416-42c5-bc5d-e0823656d805=Date baseline assessment
ui.i18n.Concept.name.bb2d78e5-f91b-4b94-b9e0-47fd38a8ad6f=Last Drug-Resistant TB Registration Number
ui.i18n.Concept.name.54377652-3f60-41d4-b9bb-cdf83a86950a=Breast Feeding at Treatment Start
ui.i18n.Concept.name.0d7eceda-56ab-43ea-893c-0095c0c1b8dc=Method of confirmation
ui.i18n.Concept.name.74f1b5cc-6503-44de-815d-e517597b6a4e=Smear
ui.i18n.Concept.name.1044b78c-e4c4-4cbe-b9ba-724149f60f24=Xpert MTB/RIF
ui.i18n.Concept.name.15635042-cb35-4a18-a75c-2653c15eb3c8=Hain test
ui.i18n.Concept.name.7a96db15-0d98-4c0d-a615-a62a4806dccb=Culture (solid or MGIT)
ui.i18n.Concept.name.48b8d9bc-2d2d-43c0-aea9-8c10f84cbbbb=Other method of confirmation
ui.i18n.Concept.name.d631d215-692e-45fc-adbb-786c86d36dd1=Visit Date
ui.i18n.Concept.name.7a91906f-bcb0-415c-a782-4220ff3f49ba=Which month
ui.i18n.Concept.name.5748bc92-880d-4c4a-81ab-0ef3a848f92e=Facility
ui.i18n.Concept.name.95796c2d-85bd-409d-8535-1356006db69d=New SAE Case Number
ui.i18n.Concept.name.191583a9-999c-4467-a753-6d3909c92c38=New AE ID number
ui.i18n.Concept.name.ce11acd8-0729-44a4-ac98-9451ab55c8b3=Rhythm, if Other
ui.i18n.Concept.name.78eb882e-8b23-4062-af29-2890d51974c7=Heart rate
ui.i18n.Concept.name.160597a5-792e-413f-b688-4d1a73467863=RR interval
ui.i18n.Concept.name.8150435f-5694-45f7-81e2-93a23778549c=QT Interval
ui.i18n.Concept.name.1fd668d4-a9ed-44df-ae9a-0bbe04516aef=Type of regimen
ui.i18n.Concept.name.41df7135-cca7-4c37-afd2-c19b0a71098b=First line treatment type
ui.i18n.Concept.name.ffeb496f-98ca-4f92-ae91-1872b4b2ea72=Second line treatment type
ui.i18n.Concept.name.6cc75455-3474-4703-8ddf-5a8f7305fe05=Non TB drug name
ui.i18n.Concept.name.9f33c217-d742-46a6-b764-3603cb3d1463=Start date non-TB drug
ui.i18n.Concept.name.2bea1f76-f91a-4c6e-ae38-0da1cf6b52be=AE ID number
ui.i18n.Concept.name.2288cd96-60e1-4d92-9e30-879d0b917989=Reason for administration
ui.i18n.Concept.name.1f010305-cab2-43f4-88ba-c9a966e7e71c=Stop date non-TB drug
ui.i18n.Concept.name.fe1fc436-856e-4d3f-9795-41b3f6c954eb=Self administered treatment (SAT)
ui.i18n.Concept.name.39e54ecb-6af7-4fc3-9276-b62a364c3d0d=Other treatment delivery method
ui.i18n.Concept.name.c35e626a-f9eb-401c-a7a6-e8a74bbb8837=Treatment facility
ui.i18n.Concept.name.b0853e07-5fe5-4e57-b4cd-91e88647e55d=No Food in House
ui.i18n.Concept.name.42f13c37-3636-4b29-85de-c97e0109ebe6=Hungry at Night
ui.i18n.Concept.name.e11e743f-5b95-457c-9770-acb1ddd5d7fe=No Food for 1 Day and Night
ui.i18n.Concept.name.3890cb3c-ab3a-4932-aebf-561b2ed90d60=Last Drug-Susceptible TB Registration Number
ui.i18n.Concept.name.18278ac3-4534-4b60-809f-123f618dbf90=Start date of past TB treatment
ui.i18n.Concept.name.fd549667-a802-44a3-a69b-10c5ebaec6a2=End date of past TB treatment
ui.i18n.Concept.name.7b227eea-632a-45fb-bcf1-af92ae0ba11a=Type of treatment
ui.i18n.Concept.name.707645ae-3ef8-4375-97c4-e2fe909851e8=Past TB Registration number
ui.i18n.Concept.name.575a21c7-f160-4a9a-bf98-c4ac82d820f5=Regimen type
ui.i18n.Concept.name.13ccb7ce-52fc-4e39-9fa2-767675ef0b8d=Past TB Drug regimen
ui.i18n.Concept.name.1484c3b6-d11f-4a04-a5b3-370da2027b27=Past TB outcome
ui.i18n.Concept.name.c09d663f-30cc-483f-9b44-503afb1eaec1=Past TB Treatment Table
ui.i18n.Concept.name.351d2310-a2d4-44de-b9b9-b0fcd6703696=HIV number
ui.i18n.Concept.name.5b77641c-3ac3-43de-a12e-3360d753403d=Existing neuropathy
ui.i18n.Concept.name.1bec03f3-0f29-462c-910d-8a0dc050f949=1
ui.i18n.Concept.name.86c295d7-502e-43d3-819b-ed529dc15d82=2
ui.i18n.Concept.name.fec3b190-c6b3-4cfa-a2d4-deaf0f1e6f64=3
ui.i18n.Concept.name.42855619-c4df-4924-b662-2bb0dcf93ceb=4
ui.i18n.Concept.name.79b0373d-dc52-4cb1-b901-5974557d7e93=Neuropathy grading
ui.i18n.Concept.name.623e91ce-8b21-4a6b-af77-c3d00a9993e7=Other pre-existing disease
ui.i18n.Concept.name.8d3c7f8d-10c5-4a07-8f99-7fcb05f91547=Date examination
ui.i18n.Concept.name.64bffea7-f0bb-461c-8b2a-5d41681f202c=Left
ui.i18n.Concept.name.8f970e6f-a471-411b-9e5f-d5b7a4fd55a1=BPNS RIGHT pain, ache, burning
ui.i18n.Concept.name.303a6ffc-ffcd-4e5c-9f21-e372add58f56=BPNS RIGHT pins needles
ui.i18n.Concept.name.5139abee-d6a1-4d1e-911e-eb532ef996fc=BPNS RIGHT numbness
ui.i18n.Concept.name.4e32e93c-c162-4a05-9770-7d3647788d47=Right
ui.i18n.Concept.name.1c54bbaa-8ff7-4dfc-a98f-26f5bd86f051=BPNS LEFT vibration
ui.i18n.Concept.name.cb3d99ac-089f-4c84-b1c0-a001b4d25d3a=Felt > 10 seconds
ui.i18n.Concept.name.5f34db7c-8703-4aef-9ab0-ca871bb977e7=Felt 6-10 seconds
ui.i18n.Concept.name.543290a6-75d0-4b9d-b1b5-11344fed86d8=Felt < 5 seconds
ui.i18n.Concept.name.4bf9adf9-e07b-4ee9-91f4-72835688e882=BPNS RIGHT vibration
ui.i18n.Concept.name.3483fcb5-3f4e-4f9c-a453-9692fb4b17cd=BPNS LEFT reflexes
ui.i18n.Concept.name.67dd2abb-a239-4f03-9fd2-e8ab57b5ead2=BPNS RIGHT reflexes
ui.i18n.Concept.name.41d57106-32a0-4508-89ac-623fbac45437=Drug resistance profile
ui.i18n.Concept.name.0c754ca0-fe6c-486e-87a4-db848a2ccecf=Sub-class of drug resistance profile
ui.i18n.Concept.name.f04702bf-0296-4ab5-af47-2644f67f905f=Sputum Test Ordered at This Visit : Smear?
ui.i18n.Concept.name.ba1e43c1-27f3-4c11-9b41-bfc10fc45f2b=Sputum Test Ordered at This Visit : Culture?
ui.i18n.Concept.name.0d61401a-d591-4452-acb4-346ba2ba9f9d=Sputum Test Ordered at This Visit : DST?
ui.i18n.Concept.name.45f3f196-6b2d-4791-80dd-41f701df1361=Requested Tests
ui.i18n.Concept.name.de46d166-0b76-49bd-b360-a634598fe123=Type of visit
ui.i18n.Concept.name.393e2400-69e0-4a6c-93fb-37cdfe8000d1=Change in TB regimen since last visit?
ui.i18n.Concept.name.38ae0acd-0939-4a62-9d5e-fe56cc6e626b=BPNS LEFT reflexes
ui.i18n.Concept.name.bacba565-8f27-49fd-8116-aa3389a04753=BPNS LEFT vibration
ui.i18n.Concept.name.0ff88adc-3f9a-4e03-87b8-4ee1ece13303=Left
ui.i18n.Concept.name.611be430-f7dd-4418-9b46-4d4a3ff588ae=BPNS RIGHT pain, ache, burning
ui.i18n.Concept.name.bab36d3b-b98f-431e-bfa7-a50592aa7ce3=BPNS RIGHT pins needles
ui.i18n.Concept.name.c481bc6a-f126-4203-9117-a983c5d568d8=BPNS RIGHT numbness
ui.i18n.Concept.name.6b95b70f-141f-474a-829c-36667a717836=BPNS RIGHT vibration
ui.i18n.Concept.name.546f91be-5ac1-4621-a297-33bd2464f53d=BPNS RIGHT reflexes
ui.i18n.Concept.name.081ca012-20a1-4d91-9bf7-435c840a75e9=Right
ui.i18n.Concept.name.48e34c41-dc98-4e77-8275-54e46ad21f08=Optional Followup Questions
ui.i18n.Concept.name.4e973e9e-c1e5-4c8e-9157-709a6ceae46e=Date of hospital admission
ui.i18n.Concept.name.5e3fe181-5df5-45b5-8a69-feaead329f8f=Sputum smear ordered?
ui.i18n.Concept.name.81508b88-9060-4db5-9def-a51f68b6c3d6=Sputum culture ordered?
ui.i18n.Concept.name.02779663-226e-4e05-b88d-25d0a411b3d3=Sputum DST ordered?
ui.i18n.Concept.name.21bd9196-5d61-4e6c-bcae-69d41bed4c53=Alcohol intake?
ui.i18n.Concept.name.45731ffc-08c3-4297-9301-6447380ab937=How many drinks per week?
ui.i18n.Concept.name.59243513-cd6a-448f-ae25-04b63c21f4de=Sputum Test Ordered At This Visit
ui.i18n.Concept.name.3f6f8493-a88f-4a6a-ade1-46a1788d75d4=Type of visit
ui.i18n.Concept.name.a9dd59a3-48a3-4d6b-a7c5-1243c7af2928=Lab Name
ui.i18n.Concept.name.017cd9b9-3a0c-4f49-aebf-360b9e3f4035=Lab identification number
ui.i18n.Concept.name.b8132315-27e3-4d77-a74f-c2d097292f85=Sample ID #
ui.i18n.Concept.name.ae52a55b-0911-480f-9c6a-7e3af4e81bf5=Unit
ui.i18n.Concept.name.f1f8dea6-28e0-4e15-9024-7aa2c7a20665=ESR
ui.i18n.Concept.name.0569ba37-a589-46dc-be72-2bbcf307884b=Sodium
ui.i18n.Concept.name.45358ba3-509e-4b95-90ae-8b97ce93a52c=Magnesium result
ui.i18n.Concept.name.758ccf9c-1c2d-49b9-a610-cb0cf6d71aaa=Ionized Calcium result
ui.i18n.Concept.name.a4c38777-de22-4086-ab98-e5f9501c3a39=Total Calcium result
ui.i18n.Concept.name.0521cf87-5f7b-4b77-a918-3da05409bc9c=Creatinine Clearance
ui.i18n.Concept.name.67934033-0b7b-49e6-bed6-3b46ba016cb8=GGT
ui.i18n.Concept.name.7e9c962d-7ade-4972-ae64-53bfa1aaed3f=Alk-Phosphatase
ui.i18n.Concept.name.1fcf14ae-48de-4ff0-a886-5669066b2270=Lipase Result
ui.i18n.Concept.name.93460b08-c29b-4bf9-9948-dbff55513677=Amylase
ui.i18n.Concept.name.05faf1ea-1b15-42f5-9a31-3d547b932d1c=Creatinine Kinase
ui.i18n.Concept.name.7e38b7bd-a950-447b-82b5-1a2c6539a76f=Conjugated Bilirubin
ui.i18n.Concept.name.64593631-7428-4037-835b-ee42e078be57=Non-Conjugated Bilirubin
ui.i18n.Concept.name.6033254d-4b66-43b9-b562-38196860f873=Uric Acid
ui.i18n.Concept.name.5e19c64c-2c98-4976-9ce7-af188ecfb6e4=Glucose (Fasting)
ui.i18n.Concept.name.92dad43e-afb4-4f40-8dbb-a6b33ec38231=Consent form upload
ui.i18n.Concept.name.152ee077-f6a8-4802-8ac0-735888accf5d=Visit Details
ui.i18n.Concept.name.1fe36c37-f0ce-4b87-b61c-12a3424024e0=Non-TB drugs
ui.i18n.Concept.name.2fde62f0-aff6-42d3-a03e-e25564180ec9=Type of visit
ui.i18n.Concept.name.b8db2240-ae01-48f8-9886-87bc2daf2016=Which month
ui.i18n.Concept.name.84e89899-22b2-4aea-8a5d-4107efc6494a=Sample details
ui.i18n.Concept.name.7707a382-ad3b-44f5-a82e-8ee334e3b901=Glucose (Fasting)
ui.i18n.Concept.name.494a0ec9-b831-49a7-9858-1fb4cc2ecc39=Lipase
ui.i18n.Concept.name.c6dc0498-54be-47bb-b686-6d5898b4c84a=Magnesium
ui.i18n.Concept.name.6769c931-2f77-45a8-b003-45a674bebf96=Ionized Calcium
ui.i18n.Concept.name.28dc72a5-86cc-481b-9b5a-d2241120b9fe=Total Calcium
ui.i18n.Concept.name.1fd7e0ed-c576-4515-a47f-31298db0e9ba=Test Name
ui.i18n.Concept.name.eb8de73e-42d4-4dca-a42c-f7c8a213f7ea=Test Result
ui.i18n.Concept.name.f00206fe-a3d7-4c94-b92c-bd11e167fad1=Test Unit
ui.i18n.Concept.name.d46b781c-c1a6-40b9-be07-eaebbb975b11=Other Test Details
ui.i18n.Concept.name.da363695-348c-4e3d-b8c3-359488c311fb=Type of visit
ui.i18n.Concept.name.2b4d2192-b871-4fce-9e99-f39762efcb66=Audiometry date
ui.i18n.Concept.name.25add77a-8f66-49e4-a000-30728af989e2=Left Ear : dB at 250Hz
ui.i18n.Concept.name.e271ddbf-1521-4de1-844a-86fa41932534=Audio assessment comment
ui.i18n.Concept.name.3c0d09c3-df30-4c9d-b60e-dd50eb24a10f=Audiometry
ui.i18n.Concept.name.e5eb9144-c3dc-4c15-bb5e-28dbe3f6ccfa=Eligible for new drugs?
ui.i18n.Concept.name.ff7ee925-c1a7-4e55-a8df-beb1f06552a3=Type of visit
ui.i18n.Concept.name.cdd41dea-047c-4d11-a20f-2cb8243a804f=Assessment date
ui.i18n.Concept.name.3eb26e5d-34b3-4580-9191-2935cc9f7b37=Performance Status
ui.i18n.Concept.name.517c3b50-eaed-4581-8fbe-9c0a9358943b=Hospital admission date
ui.i18n.Concept.name.238dfa34-33e9-4afb-bef7-7e7dbeabd8d1=Hospital name
ui.i18n.Concept.name.564a0195-ebd3-4ebe-bce3-727ad97d1170=Admission diagnosis
ui.i18n.Concept.name.66803c50-8a92-4dd8-8cd9-401efef7f8a2=Hospital Admission Notification
ui.i18n.Concept.name.7f1d939b-32f5-4c47-86e4-dae10d58e306=Hospital admission date
ui.i18n.Concept.name.922b9edb-ce5c-4f02-a5b1-ef82b4818102=Hospital name
ui.i18n.Concept.name.60e9ea14-0cb4-418f-b1c0-3d876316b7c6=Hospital discharge date
ui.i18n.Concept.name.8ed62df1-ae77-4164-9525-1e0772d581f4=Discharge diagnosis
ui.i18n.Concept.name.2b7504e8-c17e-4a22-b1c2-b852da875165=Main reason for hospitalisation
ui.i18n.Concept.name.338586c3-4fd7-4c7d-8155-02ba49561e4b=Reporting New SAE?
ui.i18n.Concept.name.fc589c5c-c83e-46f3-8c82-62d8a5abfc56=If AE/SAE then Case Number
ui.i18n.Concept.name.d05b5416-16f9-41af-a6bb-bf3dc4ca9300=Ongoing AE/SAE?
ui.i18n.Concept.name.4b94baea-b8c7-458e-bdd3-3c2fbf0352af=Existing AE/SAE ID number
ui.i18n.Concept.name.43450485-7ec4-4eb8-b8ed-db204b0a3c7b=Medication change?
ui.i18n.Concept.name.ccd51b71-2dc1-4525-aafd-5155455c67d0=Did patient have TB surgery?
ui.i18n.Concept.name.35acb56f-3549-497e-9220-5eb100e91aef=Date of TB surgery
ui.i18n.Concept.name.6c8f046b-cd4f-4ccd-a9d0-c0bb66cfb7bc=Type of TB surgery
ui.i18n.Concept.name.31898646-3da9-487c-9e68-7f3994630026=Side of TB surgery
ui.i18n.Concept.name.aee0c6b9-c668-40c9-b46b-be550cd2c464=Other type of TB surgery
ui.i18n.Concept.name.c1e2e8c5-bd29-4c39-b1f0-cf2327a13a9d=Indication for TB surgery
ui.i18n.Concept.name.d42a4289-10ec-4399-b912-590d1a6719b3=Other indication for TB surgery
ui.i18n.Concept.name.36594d88-eb9b-4fe9-b0d9-699c456be840=Hospital Discharge Summary
ui.i18n.Concept.name.d653dfd1-c314-4946-984d-f5ac23b730f4=Treatment Outcome Decision Date
ui.i18n.Concept.name.ef69d778-bc5c-45ca-aa21-b234d51e6dec=Outcome
ui.i18n.Concept.name.1543AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Date of death
ui.i18n.Concept.name.312ce815-d27c-4089-80b8-45610ea18dc1=Cause of death
ui.i18n.Concept.name.ffbed515-41df-4736-92f9-2d1a57940cc7=Type of surgery related to death
ui.i18n.Concept.name.b72dab95-a9c4-48de-9d05-6805e45d9fc7=Non TB cause of death
ui.i18n.Concept.name.2d0a8d0b-37d4-463d-8a62-a2700a074b08=Reasons for failure definition
ui.i18n.Concept.name.a65a2a1d-cfe3-442b-9683-7b2063bbc3c6=Other reasons for failure definition
ui.i18n.Concept.name.a89630a2-1f5a-4cf7-96c2-0e8679483ac6=Reason for Loss to Follow up (LTFU)
ui.i18n.Concept.name.34b1cc3f-5034-4496-92c4-fcca882aa078=Other Reasons For Loss to Follow up (LTFU)
ui.i18n.Concept.name.3612aadd-1f3e-4bcf-b730-abf1139de98c=Additional Information For Loss to Follow up (LTFU)
ui.i18n.Concept.name.02430294-eb72-4154-affe-d17597924670=Transferred?
ui.i18n.Concept.name.c2db595c-818e-48d3-a4ec-2b2a0ed90d22=If Yes, Transferred To Where?
ui.i18n.Concept.name.234754cd-dd8a-4687-8922-0ec6153c0b35=If No, Other Reasons for No Evaluation of Outcome
ui.i18n.Concept.name.bb80d45d-e4c5-4ce0-bb7c-0a34d2635ea5=Outcome - End of Treatment
ui.i18n.Concept.name.87cf0187-c1f1-4e1e-a340-64856e45e023=6 month post treatment outcome date
ui.i18n.Concept.name.dacf7c58-49a4-4c40-8c54-733931ae9b08=6 month post treatment outcome
ui.i18n.Concept.name.9da85962-5965-415a-b5df-89a08052b5b5=Cause of death post treatment
ui.i18n.Concept.name.b5d76729-5b6b-4175-9661-84ee4d6ac6a5=Type of surgery related to post treatment death
ui.i18n.Concept.name.3d052998-58ba-4b8d-8ce8-5cbb3ab107fd=Non TB cause of post treatment death
ui.i18n.Concept.name.4aa6c1cc-204d-4382-b27f-8e9e74743674=Reasons for no post treatment followup
ui.i18n.Concept.name.518bc972-4d93-4c82-9ba6-7af1cd40b478=Other reasons for no post treatment followup
ui.i18n.Concept.name.1724dd9a-3dc7-40a2-8841-5253f00ff9ff=Loss to follow up Post Treatment Comment
ui.i18n.Concept.name.7fc89d51-2b1c-4b1e-8a15-c9bc1d859eb8=Transfer out post treatment?
ui.i18n.Concept.name.fca290c1-c4f6-4613-a467-1ce0703a3859=If Yes, Transferred to where post treatment?
ui.i18n.Concept.name.dceddfd8-b86d-4eb7-a214-90356ac0951a=If No, Other reasons for no post treatment outcome
ui.i18n.Concept.name.e10823bd-2991-46ad-a846-05d8d1f9ac42=6 month Post Treatment Outcome
ui.i18n.Concept.name.d5e9a429-178e-40f5-a84f-2f732ffe4819=Type of visit
ui.i18n.Concept.name.97689468-b7e8-4975-9aba-5dc5edba8e4f=Month being reported
ui.i18n.Concept.name.9dbc1335-a95d-4cfc-87b4-00e9f4011434=Year
ui.i18n.Concept.name.776f73da-9fee-470f-bb73-ac963c4319e6=Treatment delivery method
ui.i18n.Concept.name.f31edf6f-ac9f-4590-9083-0697fb05b12a=Other treatment delivery method
ui.i18n.Concept.name.771532de-9959-437b-8dd3-10219f7d3ae0=Ideal treatment days in month (a)
ui.i18n.Concept.name.79bf31e9-b794-4188-97fc-a5f6a8b3f7ed=Non prescribed days (b)
ui.i18n.Concept.name.28f15ee4-5009-4f17-954f-f392159fe105=Missed prescribed days (c)
ui.i18n.Concept.name.c309fe72-0965-4801-9fb5-77634e064ec9=Incomplete prescribed days (d)
ui.i18n.Concept.name.d984b43d-0bd4-4946-a601-221c571c58c5=Fully Observed Days
ui.i18n.Concept.name.5787cf61-238e-442a-bf19-a0ebae0ff31c=Completeness rate (%)
ui.i18n.Concept.name.fa434ea5-b8cc-4c30-9638-bce0dfeb150e=Adherence rate
ui.i18n.Concept.name.7afe2396-a8c8-44d0-9a8e-0304991c63ed=Principal reason for non complete treatment
ui.i18n.Concept.name.daf6033e-bf02-4aab-9988-949b81f071f4=Other Contributing Reasons for Non Complete Treatment
ui.i18n.Concept.name.1bd3ca4c-fc63-42f5-a1db-a6eca8839ebc=Program related
ui.i18n.Concept.name.1f4ad0a9-ea68-4ef6-bafa-3bf3f9f332a5=Medical or treatment related
ui.i18n.Concept.name.a2f9c7f8-07bc-4e5b-93fa-391b2547725b=Patient related
ui.i18n.Concept.name.d5058e68-4a18-4b1f-900b-c1d9d487f4d8=Details Of Reason For Non Complete Treatment
ui.i18n.Concept.name.f2a585ac-3b95-491d-8f8a-a8d7c6785b9f=Other reasons for treatment not being complete
ui.i18n.Concept.name.e66b9a70-b06f-4f67-87e4-c6913b6ad07d=Drug name
ui.i18n.Concept.name.20799fcd-1533-4bf3-99a5-848d01860ee6=Prescribed days (f)
ui.i18n.Concept.name.01bf2729-e05b-43c5-af05-8bfd782c5298=Missed days (g)
ui.i18n.Concept.name.8743457d-62ba-4e15-9e16-5bb24b1b3760=Observed days (h)
ui.i18n.Concept.name.0b98b0ee-444a-46f4-9f4a-6d341f6fd3c0=DOT rate (i)
ui.i18n.Concept.name.f881546b-3830-4831-bb1d-d462ee6722aa=DOT Rate
ui.i18n.Concept.name.3b61c830-9d24-48a7-996f-41991324af51=Monthly Treatment Completeness
ui.i18n.Concept.name.b80d122a-e6b6-447e-9ff0-53314bd772aa=Chest X-ray ID #
ui.i18n.Concept.name.46e85f49-6b37-4366-a87b-9e1441e9e5df=Which month
ui.i18n.Concept.name.cbb6fb0f-4580-4d63-94d4-e61693197d9f=Chest X-ray Date
ui.i18n.Concept.name.48b72613-0bd9-420e-93a6-164935605d26=Extent of disease
ui.i18n.Concept.name.9de7066f-10d9-4b36-ac0c-5ec4775a2146=<5cm
ui.i18n.Concept.name.4937d2a8-18c1-4daf-8998-167d02379813=>=5cm
ui.i18n.Concept.name.514b77c1-4021-479a-9ac9-9136a984b8df=Maximum cavity size
ui.i18n.Concept.name.577e9721-ed9a-4c32-91fd-c0a9fe049ae5=Fibrosis
ui.i18n.Concept.name.2bc20fb7-259b-45f1-9dac-647ba86857d0=Comparison with last Xray
ui.i18n.Concept.name.9d8a1e2a-14cd-441d-92e0-bc8a3cd69a2e=Cavity left side
ui.i18n.Concept.name.d96e558d-29e2-42ff-b5ae-2a91950a61b0=Cavity right side
ui.i18n.Concept.name.2dfa44f9-e1a7-4f6e-a8b2-cf7f9896c235=Maximum cavity size left side
ui.i18n.Concept.name.e07883ea-f61c-40fd-b182-d99428b55058=Maximum cavity size right side
ui.i18n.Concept.name.b3705752-fb40-419d-8fed-b76a1d460dd5=Fibrosis left side
ui.i18n.Concept.name.97345614-9f41-4751-89d5-692bbf2c411f=Fibrosis right side
ui.i18n.Concept.name.e32d789c-368f-428c-a78a-21d1168fd740=Infiltrate left side
ui.i18n.Concept.name.352599c1-0249-49c2-9b4a-b6e4a4f921fd=Infiltrate right side
ui.i18n.Concept.name.ee9ec2b5-4c3b-4f15-a21c-46d71fa1c3bb=Tuberculoma left side
ui.i18n.Concept.name.eea37460-511f-4d94-8833-c2422ca5ff9d=Tuberculoma right side
ui.i18n.Concept.name.e978bca6-3ebc-4b87-b97a-e621c5cfe3d0=Disseminated left side
ui.i18n.Concept.name.303bb76d-1330-437e-971c-d343aa4023ad=Disseminated right side
ui.i18n.Concept.name.f917a185-a53b-4a56-b297-4f8f219ddb54=Nodule left side
ui.i18n.Concept.name.a4099c23-8e70-4488-9241-582aeb6bb5ab=Nodule right side
ui.i18n.Concept.name.6320d1e0-6935-4d4a-b870-fb191d533db2=Pleural effusion left side
ui.i18n.Concept.name.ecda03dc-ec8e-408e-9d85-d5c9e4f555b5=Pleural effusion right side
ui.i18n.Concept.name.a9a78898-d112-4b88-a44c-d18715feac03=lymphadenopathy left side
ui.i18n.Concept.name.9292bc9d-12a5-4906-8e41-57f902063ecc=Lymphadenopathy right side
ui.i18n.Concept.name.819880fa-0479-4a94-abc1-51851f38a3b7=Pneumothorax left side
ui.i18n.Concept.name.a1082d1c-574a-401d-9cea-cba3192bc60c=Pneumothorax right side
ui.i18n.Concept.name.ef75b0d1-2c4c-429f-9491-6bab3b2f3351=Miliary
ui.i18n.Concept.name.995c4a4a-8d90-4ba7-9a90-ca76fd576837=X-Ray and Radiology
ui.i18n.Concept.name.d7e46f02-fd9a-45ee-9df6-fdd5713e682d=Is pregnancy reported in a patient or partner?
ui.i18n.Concept.name.284ddb14-d617-498f-a044-3d8a01ddadde=Partner intials
ui.i18n.Concept.name.af07cd78-a46c-4043-8356-1f874a2a1e93=Partner date of birth
ui.i18n.Concept.name.30f170bf-b7a3-40ee-9bd5-dd305aa35048=Pregnancy case ID number
ui.i18n.Concept.name.04e389a9-4c27-444f-8a0c-dfeb8f6a3756=Date reporter aware
ui.i18n.Concept.name.89b07f1a-53e3-417b-921d-846057c3e4c4=Estimated date of delivery
ui.i18n.Concept.name.4810d010-1603-4745-acbc-d152e9b4fa4b=Drug name
ui.i18n.Concept.name.7cfac255-d083-47c3-a4f5-a4e93abb85f2=Dose maintained
ui.i18n.Concept.name.51acb7e6-16aa-4512-98c9-f4100db06672=Final action taken in response to pregnancy
ui.i18n.Concept.name.fa9e5fa7-b480-4978-981b-563e4e0b4376=TB Drug Exposed
ui.i18n.Concept.name.350d7699-f3e9-4fcf-b473-8fce42955a9b=Drug name
ui.i18n.Concept.name.944d96db-191d-460a-ac4e-d1871b04aff9=Final action taken in response to pregnancy
ui.i18n.Concept.name.4f0704c6-8ee3-4051-b1cf-cf88f03d4888=Non TB Drug Exposed
ui.i18n.Concept.name.d8193261-54e5-4952-8834-2b8f8fde2443=Was there any complication during pregnancy?
ui.i18n.Concept.name.5023a8bb-596c-45f7-927b-f86f03eaeea4=If yes, explain complications
ui.i18n.Concept.name.834f7e5c-fd1a-4067-bd14-0ba3b20cb148=Did the person give birth to a live child?
ui.i18n.Concept.name.c62c650e-cc90-41e2-b605-e2a4fc1273ac=If yes, date of delivery
ui.i18n.Concept.name.63a35f5c-31ba-4fb4-9a9c-1ac40eebd700=If no, reason why
ui.i18n.Concept.name.495725d2-7ac9-4c85-8e9e-6364544986d1=Was infant normal at birth?
ui.i18n.Concept.name.214d1e2c-bb50-4bc5-9c7c-f3f057b42db4=If infant not normal at birth, give reason why
ui.i18n.Concept.name.9095f2d1-cbc9-4653-87ed-c20458f34bcc=Child sex
ui.i18n.Concept.name.ab2a41ef-5d49-4392-9ec4-2bba9ce2c130=Exposure During Breast Feeding
ui.i18n.Concept.name.84784c51-b398-4d82-83a0-e9184e03228a=Infant Details
ui.i18n.Concept.name.a2dc7a94-c644-463e-a564-33f08270fbd7=Birth Details
ui.i18n.Concept.name.9e093c61-f79d-498c-bb1d-2d073f74c5fc=Outcome Information From PV Unit Summary
ui.i18n.Concept.name.e77b8214-77b4-4435-a9a8-e8f328485c18=Summary Information From Pregnancy Form
ui.i18n.Concept.name.fdedc3a8-0a21-44ff-822c-ac1eb47ad5b1=Pregnancy Report Form
ui.i18n.Concept.name.0a50e748-831e-41c6-85c7-55d22193b57f=Xray image
ui.i18n.Concept.name.dc22aeb8-be33-4a04-a686-3ec97b823dee=Respiratory rate Abnormal
ui.i18n.Concept.name.d0c6dfa5-7b7a-4215-92e9-3faf9de1fa63=Respiratory Rate (RR)
ui.i18n.Concept.name.7ee8906f-6211-40de-b50c-6f333b4e5963=Type of visit
ui.i18n.Concept.name.b76c57f3-6464-4c81-8146-9e20069f1a09=Which month
ui.i18n.Concept.name.8f0af6c9-8959-4fa2-a5f0-cbdc1c8a999c=Laboratory Name
ui.i18n.Concept.name.b83e7bea-1111-420e-a7b8-fc8cb31d1fe9=Sample ID number
ui.i18n.Concept.name.20ea0455-4d2e-484c-a314-210dc6bd517b=Sputum
ui.i18n.Concept.name.b2a044d6-6d4f-403b-a321-47d34c620b36=Pleura fluid
ui.i18n.Concept.name.4cb6eb5d-d9e7-44fe-9b00-89500f79e8a1=CSF
ui.i18n.Concept.name.4aabb71c-ccb9-4754-9b31-5bb8baff7e55=Gastric aspirate
ui.i18n.Concept.name.a5b9c80d-d1f7-4970-9c9a-b77adb0438ef=Urine
ui.i18n.Concept.name.7c21355d-3281-48b8-97cd-f8e066dc0ed9=Type of Sample
ui.i18n.Concept.name.26a7995c-369b-4b70-bb40-c5747bccef36=Other type of samples
ui.i18n.Concept.name.cdd85aab-7feb-4f85-939b-7affca2e232d=Date Of AFB Smear Done
ui.i18n.Concept.name.c5d787c2-3476-4ac2-bd7e-a47d06ded247=Smear test ID number
ui.i18n.Concept.name.99a45ed4-01d8-4203-8132-b9d26063e138=Smear result
ui.i18n.Concept.name.48e4d05e-d31d-4b24-b7da-bfa377e124b9=1+
ui.i18n.Concept.name.44f37543-c5f4-4a16-a369-a43eea647133=2+
ui.i18n.Concept.name.3cd6ca33-de53-45c3-bfc3-d922ad72f768=3+
ui.i18n.Concept.name.3087fcae-05e0-4b40-ae35-230a3acc1a52=Smear result positivity
ui.i18n.Concept.name.f4551f93-3189-45cf-affc-9696c54f3dee=Date of Xpert test done
ui.i18n.Concept.name.32d2c3fe-c768-430f-bac0-a3bf2c94c480=Xpert test ID number
ui.i18n.Concept.name.e0678def-3934-45d3-9584-e5ea4db66893=Xpert MTB result
ui.i18n.Concept.name.e79894b9-8406-4088-a99e-d3edd9f16738=Xpert MTB burden
ui.i18n.Concept.name.e5bec4ae-acc0-4306-b9e5-0d86d331d68e=Xpert Rif Resistance
ui.i18n.Concept.name.f3cd60a9-69a0-4ef9-8267-fd052bb61bce=Date of M.Tuberculosis Complex Done
ui.i18n.Concept.name.25881d88-c016-41a1-a4ec-b9fb2f483691=M.Tuberculosis Complex Test ID
ui.i18n.Concept.name.7075e067-2de4-410c-91fa-780fddc8746d=M.Tuberculosis Complex Test Result
ui.i18n.Concept.name.223fa1ce-e9d1-4101-80e5-ba3932899fe4=R (resistant)
ui.i18n.Concept.name.2fe25253-0789-4c84-a02e-f04c7743bcab=Isoniazid Result
ui.i18n.Concept.name.159162fa-6b10-445e-867b-a4b8eb244e35=Rifampicin Results
ui.i18n.Concept.name.904a4914-abc2-4ed7-9407-06de9fd21230=Date Of HAIN MTBDRsl Test Done
ui.i18n.Concept.name.355ba3c6-de2e-45be-97d9-8550e733a04d=HAIN MTBDRsl Test ID
ui.i18n.Concept.name.f864acf6-6802-4f7e-8061-c74d3cf87f48=M.Tuberculosis Complex Test Result
ui.i18n.Concept.name.6b64b5bb-8945-411e-a212-91399807ae50=Fluoroquinolone Result
ui.i18n.Concept.name.5ac6c408-6f9f-4fd1-94b6-48910a546918=Aminoglycoside Result
ui.i18n.Concept.name.34197cdf-a0e5-4415-8602-322bdafda104=Date Of Culture Innoculation Done
ui.i18n.Concept.name.43be0150-402b-4d80-adf0-22a07edf68b3=Culture test lab ID#
ui.i18n.Concept.name.41af2103-ce94-470f-8666-8e85ed2eb271=Type of culture medium
ui.i18n.Concept.name.aa93260a-d95a-4a61-8b89-7ea7a5dfd7d0=Culture medium if other
ui.i18n.Concept.name.7a1d53e0-068c-4d6a-bd4f-44772d5c04ac=Culture Result
ui.i18n.Concept.name.b129674b-7bd7-45a0-b00d-1eab9f1554ea=< 10 colonies
ui.i18n.Concept.name.12e9abc0-de27-4ed1-a916-417787013587=1+ (10-100)
ui.i18n.Concept.name.50f3d449-2cc8-4996-a8a2-34abd9c86183=2+ (>100)
ui.i18n.Concept.name.d3daa561-d606-48c1-aa80-1fc2cbe073f8=3+ (>200)
ui.i18n.Concept.name.3b1fbadc-9ca7-4b36-a1d6-8f0d3668f3cc=Number of MTB colonies
ui.i18n.Concept.name.e0921371-d376-4fbc-adc0-9e59627b9d6b=Type of media for DST
ui.i18n.Concept.name.8a8e95bc-561c-40da-88db-8e22d234b3ef=S (sensitive)
ui.i18n.Concept.name.8f091eaa-deec-4b25-bf7d-4dbd1490b962=H 0.2 μg/ml
ui.i18n.Concept.name.5eba5e83-6c4a-4ef2-99fb-121d9d36764b=H 1 µg/ml
ui.i18n.Concept.name.b2576ac0-1848-4911-8b34-7260228090cc=R
ui.i18n.Concept.name.bb5eb5b1-7c26-49d3-afe6-c2607aca76c6=E
ui.i18n.Concept.name.fbd41f52-9312-4be4-bdc0-5b17329e7e4b=Z
ui.i18n.Concept.name.6bccb568-43a3-45e2-b5e5-2ea3c20ae664=Ofx
ui.i18n.Concept.name.d467ae33-b0b3-4c45-ba9f-f064d95d77ca=Lfx
ui.i18n.Concept.name.379a37a2-a4a3-40ed-acdb-818060bea3db=Mfx 0.5 µg/ml
ui.i18n.Concept.name.ba91be7d-54ab-4229-a299-ae97d6d975b0=Mfx 2 µg/ml
ui.i18n.Concept.name.302701fb-c806-4709-aafd-c2303a54b74b=Am
ui.i18n.Concept.name.3f37ff1c-b27b-4e45-a345-5edb97242a85=Km
ui.i18n.Concept.name.c49eeb03-8ea8-400d-af6f-ae156098971f=Cm
ui.i18n.Concept.name.286c9992-176b-4c87-b8c1-7a0f6a571404=Eto
ui.i18n.Concept.name.8effc37d-74f1-4e04-b802-b6c1d343cc6f=Cs
ui.i18n.Concept.name.aebd0939-cee1-402c-b627-b7fcb94f3722=PAS
ui.i18n.Concept.name.88d3bd17-a90c-43d9-99ae-1a78d6368518=Drug name
ui.i18n.Concept.name.26ac3f67-143f-4d42-88cf-4932f31e1627=Drug result
ui.i18n.Concept.name.3b02af70-4d10-46fd-b37e-7188abd5c5c2=Other Drug
ui.i18n.Concept.name.1cebbfec-b036-4eef-b550-8b9d629ada5d=Drug name
ui.i18n.Concept.name.e95f7179-4f1f-4804-8b65-8375908c65f9=MIC technique/medium
ui.i18n.Concept.name.3b8eded6-6ade-4009-9422-7104313241fe=Minimum inhibitory concentration
ui.i18n.Concept.name.285c1a79-0f32-4b43-b8db-cd2dab38d27a=MIC interpretation
ui.i18n.Concept.name.90377062-40bc-4a85-9455-91b8d934ecf4=DST With MIC
ui.i18n.Concept.name.05c72ff6-9513-4770-9f90-c241742d4ed4=Mixed mutation/wild type
ui.i18n.Concept.name.408d7bdd-efb1-45e5-9ad8-f057cc4a39e5=Gene name/locus
ui.i18n.Concept.name.259dd81d-179d-4aeb-a867-3542fee9b735=Mutation result
ui.i18n.Concept.name.dd7ed190-7eb1-4cb3-9410-808b9b61e4e4=Sequencing
ui.i18n.Concept.name.5702066c-6214-4397-b2b8-ce9c5c44d75f=DST Results
ui.i18n.Concept.name.df60db89-ae5e-49ab-8d12-7349898b29d9=Culture Results
ui.i18n.Concept.name.63467800-bd3e-48c6-afed-ef538334f52b=HAIN MTBDRsl
ui.i18n.Concept.name.2c4d8cee-3aae-41c3-85a4-5005e4583be6=HAIN MTBDRplus
ui.i18n.Concept.name.eb9a9952-d772-4354-a32a-3f54a21e0567=Hain Test / PCR Results
ui.i18n.Concept.name.dcc401c9-7650-46c2-9b0f-0e16685c9141=Xpert Test Results
ui.i18n.Concept.name.ef0b7642-a852-433f-922f-585fdb57b304=Smear Microscopy Test Results
ui.i18n.Concept.name.05fb0515-abe7-40ca-b0e0-964146cd378c=Sample details
ui.i18n.Concept.name.0652c77f-6ac6-4499-a93f-37fb4a40ed3e=Bacteriology
ui.i18n.Concept.name.7d28552b-7234-11e5-af64-0050568236ae=Bacteriology Concept Set
ui.i18n.Concept.name.7d28e8f7-7234-11e5-af64-0050568236ae=Sample Collection Date
ui.i18n.Concept.name.7d3309c1-7234-11e5-af64-0050568236ae=Sample Source
ui.i18n.Concept.name.7d33d700-7234-11e5-af64-0050568236ae=Id
ui.i18n.Concept.name.7d34a176-7234-11e5-af64-0050568236ae=Additional Attributes
ui.i18n.Concept.name.7d34ec7d-7234-11e5-af64-0050568236ae=Results
ui.i18n.Concept.name.159599AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=ARV start date
ui.i18n.Concept.name.856AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=HIV Viral Load
ui.i18n.Concept.name.119481AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Diabetes
ui.i18n.Concept.name.159644AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=HbA1c
ui.i18n.Concept.name.5089AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Weight
ui.i18n.Concept.name.1342AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=BMI
ui.i18n.Concept.name.159976AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Previously treated group
ui.i18n.Concept.name.5090AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Height
ui.i18n.Concept.name.5596AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Expected Delivery Date
ui.i18n.Concept.name.1113AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Treatment start date
ui.i18n.Concept.name.159431AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=End of treatment date
ui.i18n.Concept.name.5096AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Next scheduled visit date
ui.i18n.Concept.name.678AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=WBC
ui.i18n.Concept.name.679AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=RBC
ui.i18n.Concept.name.1133AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=K
ui.i18n.Concept.name.160912AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Fasting Blood Glucose Measurement
ui.i18n.Concept.name.161505AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=TSH Test
ui.i18n.Concept.name.653AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=SGOT
ui.i18n.Concept.name.654AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=SGPT
ui.i18n.Concept.name.790AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=CR
ui.i18n.Concept.name.857AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=BUN
ui.i18n.Concept.name.887AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=GLU
ui.i18n.Concept.name.160379AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Performance Status (ECOG)
ui.i18n.Concept.name.767AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Rifampicin (R)
ui.i18n.Concept.name.78280AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Isoniazid (H)
ui.i18n.Concept.name.81458AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Para-aminosalicylic acid - sodium (PAS-Na)
ui.i18n.Concept.name.104315AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Imipenem/Cilastatin (Imp/Cln)
ui.i18n.Concept.name.70056AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=ABC
ui.i18n.Concept.name.74807AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=DDI
ui.i18n.Concept.name.75523AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=EFV
ui.i18n.Concept.name.75628AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=FTC
ui.i18n.Concept.name.78643AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=3TC
ui.i18n.Concept.name.84309AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=D4T
ui.i18n.Concept.name.86663AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=AZT
ui.i18n.Concept.name.71647AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=ATV
ui.i18n.Concept.name.794AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=LPV/R
ui.i18n.Concept.name.80586AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=NVP
ui.i18n.Concept.name.83412AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=RTV
ui.i18n.Concept.name.5497AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=CD4
ui.i18n.Concept.name.21AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=HGB
ui.i18n.Concept.name.1015AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=HCT
ui.i18n.Concept.name.655AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=TBILI
ui.i18n.Concept.name.848AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Serum Albumin
ui.i18n.Concept.name.c1362329-9ec2-4d59-b989-96470037b934=Bedaquiline (Bdq)
ui.i18n.Concept.name.60c0edeb-a0ed-4530-937e-1ace45a48715=Delamanid (Dlm)
ui.i18n.Concept.name.2806a470-57e1-44fe-8c7b-a6f43044ff89=TB Treatment Start
ui.i18n.Concept.name.aa838e86-d2a6-4641-8d50-28c4cd1197ee=tiw
ui.i18n.Concept.name.fe2d8199-0d18-4617-ac15-1e775dfafaf4=Which month
ui.i18n.Concept.name.b6f123d8-0759-4727-b0ee-2ad09d40b80a=Which month
ui.i18n.Concept.name.fa2952c6-8e54-416f-8ce4-50cffd88ac81=Which month
ui.i18n.Concept.name.43390bcb-4a77-4701-bb7d-8119b3cc84f3=Left Ear : dB at 500Hz
ui.i18n.Concept.name.54b6cb7f-4763-4104-a54b-a5f153acdf96=Left Ear : dB at 1000Hz
ui.i18n.Concept.name.f0740c2c-5bf2-44d4-b965-e2436c564d12=Left Ear : dB at 2000Hz
ui.i18n.Concept.name.9978adfb-8ef6-4a22-8cef-3dd0c8904897=Left Ear : dB at 4000Hz
ui.i18n.Concept.name.1a21bed3-e794-444b-b5b0-a6a0c7210ad7=Left Ear : dB at 6000Hz
ui.i18n.Concept.name.50fa61ad-9bc4-4785-9f83-8b6ab13f84ce=Left Ear : dB at 8000Hz
ui.i18n.Concept.name.c0b39a97-88d4-4cfd-8742-98994bebfe9b=Right Ear : dB at 250Hz
ui.i18n.Concept.name.5e36e7cc-3de1-4243-838a-1d912e48c827=Right Ear : dB at 500Hz
ui.i18n.Concept.name.bde56a51-26a1-4e68-8167-66a168aa471c=Right Ear : dB at 1000Hz
ui.i18n.Concept.name.9b72499c-0959-4b21-a607-d9689f287466=Right Ear : dB at 2000Hz
ui.i18n.Concept.name.f1c783e5-fc19-483d-98c1-e3c0331b507e=Right Ear : dB at 4000Hz
ui.i18n.Concept.name.c8362726-508f-46e4-be1b-c4e1395a80c4=Right Ear : dB at 6000Hz
ui.i18n.Concept.name.8c968c42-cf46-444e-8cac-40ff7d262647=Right Ear : dB at 8000Hz
ui.i18n.Concept.name.d264c8e5-30f8-452d-8aa5-890de449ac94=Left Ear Audiometry Screen
ui.i18n.Concept.name.5f4229a0-93b0-4c3b-afb9-c167b78bb112=Right ear audiometry screen
ui.i18n.Concept.name.9ac7afe4-a808-48a4-8fa5-1a853731d334=Reporting audiometry related AE?
ui.i18n.Concept.name.657c4d01-ebe1-4070-b218-68cd6c48318b=AE ID number
ui.i18n.Concept.name.d02b88f9-143d-4108-ae36-82fd89d42e69=Simplified Audiometry Screening
ui.i18n.Concept.name.34e19202-9e41-4d1f-9baf-870c45c07336=Comparison with last Xray
ui.i18n.Concept.name.59b3a908-dcb9-4888-948e-d4ef3d9effe3=Additional Details If Required
ui.i18n.Concept.name.ad626fba-8287-4973-958d-bf086e1cba90=Prison
ui.i18n.Concept.name.b6203c4c-da1d-4d52-aff6-0c0ca5a70e60=If Prison: Past or Present?
ui.i18n.Concept.name.a9a9e8e9-8801-49ab-b2ad-e84c30fbe16f=Is this result outside of normal range?
ui.i18n.Concept.name.bacd12ad-9787-49a2-94af-acaf4973efe5=Is this result outside of normal range?
ui.i18n.Concept.name.93955d11-5711-4c53-afc8-749e5bcf0b5a=Is this result outside of normal range?
ui.i18n.Concept.name.d2716ce5-3e7c-4bb0-84bd-af8c404b1188=Other employment
ui.i18n.Concept.name.3d110fbe-b86b-48f6-9f91-80ee3b625835=Past TB Registration number
ui.i18n.Concept.name.5562c7e2-811f-4f98-8198-2a28f09f1533=Type of heart disease
ui.i18n.Concept.name.d4803988-c900-4c14-ac89-00bdbf7c177f=BMI
ui.i18n.Concept.name.9d500ada-5d86-4441-bca0-856c4184bec7=MDRTB diagnosis date
ui.i18n.Concept.name.f9e4d712-7941-47e7-99ca-cb47fe081ca3=Is consent for new drugs signed
ui.i18n.Concept.name.41338de5-f0e8-4913-a189-880ee09088aa=Is this result outside of normal range?
ui.i18n.Concept.name.3889817f-44ae-4df2-8c0a-ea3a8c7e3071=Is this result outside of normal range?
ui.i18n.Concept.name.866430f7-a695-45de-8569-40e4feecdf90=Is this result outside of normal range?
ui.i18n.Concept.name.ff8d200d-e0fd-437d-b876-9c3f33b5083d=Is this result outside of normal range?
ui.i18n.Concept.name.03c31e3c-1a0e-44e1-a6c1-dbf80ae8f3b0=Is this result outside of normal range?
ui.i18n.Concept.name.d81320ab-ab69-4adc-8932-ed29e1e16e88=Is this result outside of normal range?
ui.i18n.Concept.name.33fe1280-6eb6-44e8-bc45-271d4577e832=Is this result outside of normal range?
ui.i18n.Concept.name.e2cc2a5f-a7a4-4055-927f-7c090765f4ad=Is this result outside of normal range?
ui.i18n.Concept.name.5ff13cd8-c6b6-4aec-aade-12efed011af2=Is this result outside of normal range?
ui.i18n.Concept.name.ac5314b8-f79d-485b-be84-71c8fba8b281=Is this result outside of normal range?
ui.i18n.Concept.name.4402be77-aaea-4b05-bbdb-8a5a80a0f8f9=Is this result outside of normal range?
ui.i18n.Concept.name.b31e6a57-34f3-4366-97fb-817f210b750c=Is this result outside of normal range?
ui.i18n.Concept.name.77933f39-c122-4a19-8ce3-81788bff2568=Is this result outside of normal range?
ui.i18n.Concept.name.ec2e2676-8c1c-4b86-bd09-902343593e56=Is this result outside of normal range?
ui.i18n.Concept.name.624b3ec7-f5d8-4205-a4ed-081f9636ba2e=Is this result outside of normal range?
ui.i18n.Concept.name.1c658401-ac0c-468e-913f-78e08b0f7e9f=Is this result outside of normal range?
ui.i18n.Concept.name.60ab1c67-bb66-4348-8515-35eb8793ead3=Is this result outside of normal range?
ui.i18n.Concept.name.97b1e88e-9054-4cde-b7df-5e23d300bd51=Consent For EndTB Signed?
ui.i18n.Concept.name.a638cc74-6566-487b-8f98-2dc995aa2ab8=date of death before treatment start
ui.i18n.Concept.name.b8ddb596-7d34-4749-9a45-ed47461fe61f=If Yes, New SAE Case Number
ui.i18n.Concept.name.6baf8cf4-f60a-4f76-8ded-3e30f694bf32=Hospital Course
ui.i18n.Concept.name.dc351729-1a4e-496e-8636-57e7e0f56ecc=Last Drug-Susceptible TB Treatment Registration Facility
ui.i18n.Concept.name.bec723a7-9668-4daf-8737-f43c860e3fd9=Last Drug-Resistant TB Treatment Registration Facility
ui.i18n.Concept.name.6a0be953-18b5-4750-982e-c89a0d56c8d3=Pregnant?
ui.i18n.Concept.name.08f900d8-a834-49d0-9d56-26e354af68d4=Pregnancy form case ID number
ui.i18n.Concept.name.e09b14de-dfda-4dd1-aa63-052130c7ef5c=Pain, aching or burning in Feet, Leg
ui.i18n.Concept.name.5ce0c137-29eb-4253-b2bc-f13b5690296d=Pins and Needles in Feet and Leg
ui.i18n.Concept.name.7faef284-26f7-42b4-80b0-0f7caaef1ec7=Numbness (lack of feeling) in Feet, Leg
ui.i18n.Concept.name.65f8a910-698b-4b87-9323-035c2c97b57e=Vibration perception
ui.i18n.Concept.name.7f0a34f5-553f-4998-8a51-38cf13ed4b0b=Ankle reflexes
ui.i18n.Concept.name.85c4d37c-0c48-4904-bc4a-144b9ee87cd1=Next Visit
ui.i18n.Concept.name.aaccd405-2b3c-47c3-91e9-1ba159db4b8f=Hearing impairment (hearing loss)
ui.i18n.Concept.name.65b0c88d-e7c0-4d56-a9f8-6fad452d321c=Increased liver enzymes (ALT increased or AST increased (>= 1.1 x ULN))
ui.i18n.Concept.name.1cc35cb1-2dcf-49ed-8234-3d2910a08b29=3
ui.i18n.Concept.name.2caadb20-9193-4a6e-9ec9-0730686defaa=Date of AE report
ui.i18n.Concept.name.670049f8-c95d-4092-a7c3-b4314069bc29=4
ui.i18n.Concept.name.67bfe0cf-ad74-4724-918d-41135ad6cb9d=AE ID number
ui.i18n.Concept.name.6f419e98-72a8-4ff2-bf39-ae582202295b=Date of AE onset
ui.i18n.Concept.name.b154b805-599c-40cd-9dca-9971d95c2ee0=1
ui.i18n.Concept.name.bb7b314a-c929-4145-a02e-0a9fc2ec5297=2
ui.i18n.Concept.name.fed9950c-9eac-4ba9-b232-7ad556842135=All drugs suspended?
ui.i18n.Concept.name.01e4ab9f-8f06-4a17-b944-8c041064795b=Other AE term
ui.i18n.Concept.name.1163926d-b95c-4285-8a15-35b84b358f69=Date of AE outcome
ui.i18n.Concept.name.207fbed8-d48b-441f-8e1c-27392ae0e670=AE grade
ui.i18n.Concept.name.373ced96-5dcd-42f2-aae4-009fdc3df308=Maximum severity of AE
ui.i18n.Concept.name.443a1e0d-b451-4d24-adaa-d0599a8a9175=AE Related Test
ui.i18n.Concept.name.718796cd-06c1-4a31-b82f-234860d26f73=AE related test value
ui.i18n.Concept.name.76070a0d-3807-4817-8eaa-59e7dd8e5f7a=AE related to TB drugs?
ui.i18n.Concept.name.784c7c21-0f22-4ced-b5e1-91431b0eaeb1=AE related test date
ui.i18n.Concept.name.8ccfd9ab-4341-4ca9-b2f6-5cb0c2c1b097=AE review date
ui.i18n.Concept.name.a4769ed1-2315-45d4-89d2-ea13f6c51ad6=AE outcome
ui.i18n.Concept.name.b9fe1daf-2be7-44f5-b9f5-50650b050b55=AE severity at review
ui.i18n.Concept.name.f9d0ad77-7cf5-4f5f-ab77-ea4f1ed0115c=AE related test ID
ui.i18n.Concept.name.3a15213c-445d-4598-b1c9-c80603c372d2=Comorbidity
ui.i18n.Concept.name.52a804db-5629-4844-9e89-80f899c2f9f8=Other Causal Factors
ui.i18n.Concept.name.c378614a-f6cb-49ba-8731-d0c3ab5c41b6=Non-TB drug
ui.i18n.Concept.name.d6eb7fa5-f13f-4afb-8f34-cdb58867bcbe=TB drug: related?
ui.i18n.Concept.name.7efc4921-bc63-4fa9-b819-570515721cdf=AE term
ui.i18n.Concept.name.ba8b0d88-941b-493d-a5ee-0b7099cd0eaf=AE term comprehensive list
ui.i18n.Concept.name.42503fbc-bbee-4159-b648-eb8acb828c63=TB drug : final action
ui.i18n.Concept.name.aea612bc-d179-49dd-a9a4-7cb4ea025b46=TB drug
ui.i18n.Concept.name.c4425cb7-38d4-4634-97a1-df9f7abb4bcf=AE: Other causal factors?
ui.i18n.Concept.name.20743190-7eb5-4acc-95de-fd70b366e0ed=AE Severity Review
ui.i18n.Concept.name.26ad5a62-0676-406b-b065-942cf145f0b0=Related Test
ui.i18n.Concept.name.cf62f8bb-bd1f-401e-bcf5-6ed562830458=AE Review Log
ui.i18n.Concept.name.0fcd6a24-22dc-4020-b957-dae01b3bf97c=Adverse Event Outcome and Causality
ui.i18n.Concept.name.de05c9da-9ac4-415b-afb9-cf65f205ae90=TB Drug Treatment
ui.i18n.Concept.name.64f0a647-441e-443a-a2a7-1b34df71302d=Adverse Events
ui.i18n.Concept.name.fb79159d-1199-461a-8363-0d1b4f582f25=Adverse Event Details
ui.i18n.Concept.name.aaa4b3d3-656f-4cb0-be4d-8b898319abf4=Other causal factors
ui.i18n.Concept.name.18933c35-e416-4d3a-9b92-79c5a374916b=Event onset date
ui.i18n.Concept.name.22321c76-f483-4e46-aa19-c35f4cd8328f=SAE case number
ui.i18n.Concept.name.f40bf469-d5da-46f3-8a83-8835eb1515d3=Date of SAE report
ui.i18n.Concept.name.b2355be0-1a11-4705-9d57-d5308a47ed7c=SAE term
ui.i18n.Concept.name.29539b33-c406-4469-9868-781676f078dc=Other SAE term
ui.i18n.Concept.name.9025cfa1-2e45-4932-b6da-4e580c8d2c35=SAE term comprehensive list
ui.i18n.Concept.name.0e644a1d-1c5f-41e1-8a3a-96dd6149a9be=SAE outcome
ui.i18n.Concept.name.0ef73117-c447-4afe-b7b7-3a79c706b91c=Maximum  severity of SAE
ui.i18n.Concept.name.288b9257-bd98-4b30-b024-e19fa9ed339b=SAE related test date
ui.i18n.Concept.name.386e2350-8346-47b3-94ab-d0be3d337813=Seriousness criteria
ui.i18n.Concept.name.48a2d35f-eb68-4331-9078-fa4ea0122bf5=SAE related test value
ui.i18n.Concept.name.ce2fb2fd-c008-426e-ac60-3f8cf8b3130d=Event end date
ui.i18n.Concept.name.d92ee790-0b90-4f36-868c-7f22b3edde65=SAE related test
ui.i18n.Concept.name.deae022b-f46c-4a4c-b9c8-6309a9dc7c26=SAE related test ID
ui.i18n.Concept.name.0f86c79f-1b94-46ac-b2ae-c816fe0915cb=Comorbidity
ui.i18n.Concept.name.1d5fab37-6b2a-42f5-b034-5294a692cf95=TB drug
ui.i18n.Concept.name.6ce505c5-2b5b-4575-97a7-d6bbfc09b60e=Non-TB drug
ui.i18n.Concept.name.89f39610-4ca0-4476-9ff7-11cecc4b3b6c=TB drug : related?
ui.i18n.Concept.name.e4aa6943-905d-42ca-9bf5-745b47b3d513=Other causal factors
ui.i18n.Concept.name.4fac0b1b-f95b-4433-9302-160e853327b9=TB drug : final action
ui.i18n.Concept.name.6a5661dc-7a54-4d02-95f9-f113770faefa=SAE: Other causal factors?
ui.i18n.Concept.name.1631f397-d7fb-447c-bbbc-89649d0a1d6d=SAE description from SAE form
ui.i18n.Concept.name.7075a0a0-e398-4911-975c-eb3248bff0c5=Related tests (data from PV unit summary)
ui.i18n.Concept.name.06b7ed24-7739-415b-bc10-0fdcab1509f8=Serious Adverse Events
ui.i18n.Concept.name.47a436b9-d808-49e6-82d1-f11ca9dfcf9d=TB drug treatment (data from PV unit summary)
ui.i18n.Concept.name.c6bf37df-b6f1-4eb1-8bca-20475ee1e5b1=SAE outcome ( from PV unit summary)
ui.i18n.Concept.name.f76fb128-9377-4dd2-8e06-c4b63d56dd78=Other causal factors (data from PV unit summary)
ui.i18n.Concept.name.a6ec83ac-3afe-4710-bd14-4711bc2e09b6=Place of past TB treatment
ui.i18n.Concept.name.c36e79ab-ac68-4fe1-8d75-aafc27916189=History unclear/unknown
ui.i18n.Concept.name.985899a9-ed81-4a51-aae8-ec5b8f620eeb=Serious Adverse Event Details
ui.i18n.Concept.name.ad390cae-5983-40c9-b403-c0e7860c3222=Test done?
ui.i18n.Concept.name.bb4f6099-f67a-4f4e-9de0-7d815c5cc290=Test done?
ui.i18n.Concept.name.891dcde3-349d-4cb0-bbf0-a515bfe41d69=Test done?
ui.i18n.Concept.name.450bee6c-72e5-45b2-b699-102400f52613=Test done?
ui.i18n.Concept.name.eb4fa99f-926e-4fe0-a837-29d3b0357504=Test done?
ui.i18n.Concept.name.1afa1253-a6a9-4daa-a840-b4434ac7f399=Test done?
ui.i18n.Concept.name.79fcfc6e-5fd6-4d44-87d8-331f38db936a=Test done?
ui.i18n.Concept.name.7edd7e50-7cc8-4eb7-bf84-aa8587fe8abf=Test done?
ui.i18n.Concept.name.dde96b96-4d7d-4ce8-8cb7-76b43de12038=Test done?
ui.i18n.Concept.name.92cac8f6-2619-4c4e-a9ca-5e3545b4fc87=Test done?
ui.i18n.Concept.name.2e6bd593-1e46-44fb-9378-9badc55f9e89=Test done?
ui.i18n.Concept.name.d9b19c39-a928-4843-9920-810c62f94add=Test done?
ui.i18n.Concept.name.9f038d98-7771-4e1e-9e6f-f7d0ce74ccae=Test done?
ui.i18n.Concept.name.ef810338-8956-49fd-ab7e-29a19b8d2752=Test done?
ui.i18n.Concept.name.a2226506-3673-4012-9674-5731be435863=Test done?
ui.i18n.Concept.name.7619c9a3-804f-4d6e-b202-0f1dca575b39=Test done?
ui.i18n.Concept.name.605ab621-5d0e-42de-a9fc-16d11ceafd15=Test done?
ui.i18n.Concept.name.50dd4c24-f1f6-4ba3-9de1-61ec39750cfe=Test done?
ui.i18n.Concept.name.1a2f60ea-5f2b-4cec-a855-9cb5f70033c8=Test done?
ui.i18n.Concept.name.3141d8e0-421f-47e5-84ab-922994f22013=Test done?
ui.i18n.Concept.name.cd279706-affd-46d8-8343-fe8f7da9d486=Test done?
ui.i18n.Concept.name.3051e47d-1378-4659-9599-bcb7f13d76be=Test done?
ui.i18n.Concept.name.98d7f024-32d2-4d00-946a-06e007623361=Test done?
ui.i18n.Concept.name.ab5cbca5-abe0-4988-9212-3d74783aba1d=Test done?
ui.i18n.Concept.name.e74a6648-8cc4-4c5e-a8dd-875fb8596f4d=National DRTB Number
ui.i18n.Concept.name.914d06d6-0836-4276-b5a5-be978039db08=Diagnostic
ui.i18n.Concept.name.a925f28b-8d93-4918-a848-54306b16487d=DR Status
ui.i18n.Concept.name.31c72abf-5872-4bb9-973e-39346dde6955=Referred before TTR
ui.i18n.Concept.name.1d2838c2-d9c0-4078-a311-e4d6638107f4=Admission Status
ui.i18n.Concept.name.0a8c6dbb-4ac9-4963-bdb5-f4487461c781=National Identification Number
ui.i18n.Concept.name.e0cb54b4-b576-48f9-8f9c-d8c86515801c=Date of Registration in National DRTB Program
ui.i18n.Concept.name.4e96e371-a27f-4aee-956e-f8417ab65af3=R MIC
ui.i18n.Concept.name.b8d65b4b-6454-44e1-8aca-92f5df2afe1f=R
ui.i18n.Concept.name.cc7b85cd-1e71-4e63-a5c3-0d4d396864c7=Drug name
ui.i18n.Concept.name.a3190b4b-c03b-44c5-ace1-5859597f3013=Drug result
ui.i18n.Concept.name.057e5374-4e2d-4547-aa86-bff9e4764dc6=Results
ui.i18n.Concept.name.fca023eb-b5c8-4bee-801f-0e64f829e7d9=MIC
ui.i18n.Concept.name.7c62f5c9-911a-11e5-b218-0050568236ae=DrugOther
ui.i18n.Concept.name.992b024e-9727-11e5-b218-0050568236ae=Stopped Order Reason
ui.i18n.Concept.name.992bbb8b-9727-11e5-b218-0050568236ae=Refused To Take
ui.i18n.Concept.name.19c4dd33-772d-4ead-a464-95cde681c1f2=Huaraz Lab
ui.i18n.Concept.name.c1db0425-dc1d-4a3d-8124-5c5b5afc3ba3=Armenia Lab
ui.i18n.Concept.name.313d2f80-dd44-4d7e-8e21-1e9b57c2e10d=Sample ID #
ui.i18n.Concept.name.ed4ac0fc-0324-48e9-a687-c7733139f532=Sample Collection Date
ui.i18n.Concept.name.8b2fcb31-f611-4368-a7ba-fd7e63d9b9ae=Lab Name
ui.i18n.Concept.name.15552b66-c02e-4738-a34f-e1f9d7f5b4b6=Lab Identification number
ui.i18n.Concept.name.aad2c867-8d09-44ed-ba94-08bb08735eec=Sample details
ui.i18n.Concept.name.37d47e74-20d8-406a-b684-8fabd3c3c8c2=Lab Results - Serology
ui.i18n.Concept.name.e6368b14-b1c9-4752-97c4-9c2f278ef045=Lab Results - Other Tests
ui.i18n.Concept.name.d35aa9c9-893e-4f7c-ae27-51b856c56daa=Drug Allergies
ui.i18n.Concept.name.05524e94-8636-47f9-9433-ca98e7aa9312=Known Drug Allergies
ui.i18n.Concept.name.ffa05f26-7b19-4e7c-8a9a-52d6cdac80a2=Which Drug Allergies
ui.i18n.Concept.name.f4110669-711d-472a-aa32-4c5ad673ee59=Treatment After Failure
ui.i18n.Concept.name.144964d5-f7ca-451a-bf46-4e5c2b2a45fa=New AE Reported
ui.i18n.Concept.name.1bf2acda-86b3-4d70-8203-639db22a007b=If Yes, New AE ID number
ui.i18n.Concept.name.c23e412f-5785-419b-8d6a-3a0ec53aadee=Other Marital Status
ui.i18n.Concept.name.cbb4818a-79bd-4324-8a59-974121f27126=Has the patient ever been treated for TB in the past?
ui.i18n.Concept.name.753b5ff5-b213-4d59-ae9d-4bc72de95e0e=Pregnancy
ui.i18n.Concept.name.dcf5c555-3cb4-475c-8457-1cc4397ba6a2=Date of death post treatment
ui.i18n.Concept.name.533d2cf0-bb34-41c1-b4c5-407c41c3b655=Died
ui.i18n.Concept.name.8c09ec52-8238-4e8b-9fea-97f482939cc7=Failed
ui.i18n.Concept.name.f20631b4-7a94-4223-a835-eda0db473369=LTFU
ui.i18n.Concept.name.edbe1ff8-4f23-49a3-8efc-4a3650f34301=Not Evaluated
ui.i18n.Concept.name.768bf06b-2beb-4cf8-92c5-c665507971d8=Died Post Treatment
ui.i18n.Concept.name.a98ca5f1-2afd-49a5-8097-abc52ed21777=LTFU Post Treatment
ui.i18n.Concept.name.c830af7b-c1ee-4966-bb71-7849c2eeabb1=Not Evaluated Post Treatment
ui.i18n.Concept.name.34f4c30c-54a3-4b73-b04c-90443f291c4d=Ongoing AE?
ui.i18n.Concept.name.07b1818f-91ae-44c3-96e3-76edb6c736a3=Is Pregnancy In The TB Patient Or Partner
ui.i18n.Concept.name.6d33a21b-7d7a-46b4-ad56-94bb2bdaa204=Other Hospital Name
ui.i18n.Concept.name.c3ae4824-7b31-44d8-aef6-3a05555310bd=Other Hospital Name
ui.i18n.Concept.name.1dd37989-0192-46c3-8b18-9153ba941a06=If Other, Reason
ui.i18n.Concept.name.fb8f46df-af1b-48b9-b3d9-039283a1bb6b=AE/SAE
ui.i18n.Concept.name.b463c2b0-aa15-4fbb-9eb4-3caf03506c3c=Optional Followup Questions
ui.i18n.Concept.name.c06ef749-b5d1-4989-b5cd-46f33f9f3a5b=Hospital Course
ui.i18n.Concept.name.98690e31-b63b-41be-a54d-1a2cb5f82402=TB Related Surgery
ui.i18n.Concept.name.2e4f18e9-0bcc-4243-b16f-35b54ea708a8=X-Ray
ui.i18n.Concept.name.79b2b8bd-9c82-4527-bdb2-8e2cff77895d=Other Radiological Test
ui.i18n.Concept.name.2d78cd5d-6424-4c88-bac1-29a88fd86b79=Date Of Other Radiological Test
ui.i18n.Concept.name.dc967043-51dd-467a-911b-8388128ef41b=Results of Other Radiological Test
ui.i18n.Concept.name.43779096-5892-4cbb-a9fe-36c56bf53336=Other Radiological Tests
ui.i18n.Concept.name.3045c01f-e57e-4e63-800a-d3c32fb8694f=Audiometry Related AE
ui.i18n.Concept.name.367695cd-9dfa-42ce-8166-6108b611675e=Reporting ECG Related AE
ui.i18n.Concept.name.3ece8c28-0b8b-43ec-9386-a761299dec67=If Yes, AE ID Number
ui.i18n.Concept.name.60751928-1251-403d-a812-85ddf9536e0e=ECG Related AE
ui.i18n.Concept.name.5ccf3134-8fe1-42c6-b3b4-ccc79304230e=0 = Fully active, etc
ui.i18n.Concept.name.7838fb12-4c41-409e-a98d-185f0f550f2d=1 = Restricted, etc.
ui.i18n.Concept.name.94c6250d-33d9-4b06-bd1e-e4ca04c2831d=2 = Ambulatory, etc.
ui.i18n.Concept.name.f791614c-357d-4bc1-94f6-8ef1beb9ef59=3 = Capable, etc.
ui.i18n.Concept.name.90f44948-29ed-40ac-a6c1-b8c82f8ad3ac=4 = Completely disabled, etc
ui.i18n.Concept.name.54c448ce-c3f8-48c3-a175-f27466797d73=Lab Results - Pregnancy Test
ui.i18n.Concept.name.db5558f8-4252-43e7-82a7-e8077c52b92a=Is This AE an SAE?
ui.i18n.Concept.name.057bf04f-0bad-4d78-abd8-c40ab45be102=If Yes, SAE Case Number
ui.i18n.Concept.name.10f702a9-648c-4666-8d63-68c834df25cd=If Other Type of Media, Type
ui.i18n.Concept.name.004ad401-e762-45ea-8481-c27fb43cd253=Rejected by committee
ui.i18n.Concept.name.0125226a-a8e8-4b20-a1f6-eb319d09170b=Alkaline Phosphatase Increased
ui.i18n.Concept.name.01fd41bd-760b-40a8-a06d-43fb432ba706=Non Active
ui.i18n.Concept.name.02bbd152-1665-4ebf-8661-1b0bc19fc33b=Left eye administration
ui.i18n.Concept.name.02e3b32b-632f-45a2-93f6-d2ee0c21c25c=Confirmed MDR
ui.i18n.Concept.name.0373c728-0b73-45dd-976c-fde95cd2a821=RED BLOOD CELLS Abnormal
ui.i18n.Concept.name.03963b52-9cde-4bb4-a8c5-de3c0347abdd=2006
ui.i18n.Concept.name.04706fdb-ddba-40fc-bbfa-600e8c8a5655=00-Normal
ui.i18n.Concept.name.057a44cc-51b3-4a43-9971-80fa61911831=Referred to other facility
ui.i18n.Concept.name.0618c676-5342-4d6b-93a7-a97a330c8050=Unilateral disease
ui.i18n.Concept.name.06694eb0-f77e-455e-880a-3ec9bd09d7d8=DOTS defaulter
ui.i18n.Concept.name.069d9c00-6133-426b-b7bd-e1296af7ef2f=Not read
ui.i18n.Concept.name.0758f850-e260-4d61-8e60-b1fc75c3fd86=Surgery related death
ui.i18n.Concept.name.07601834-6afb-444b-b48c-1fe2c165be0f=Detection of DOTS failure or direct infection
ui.i18n.Concept.name.07612dd3-a985-4277-a77e-a8e0542de905=AST Increased
ui.i18n.Concept.name.07bef650-84ad-4d41-9d6f-64cf3fbeec11=Both
ui.i18n.Concept.name.07c4405e-c42b-4b80-ba93-6f10e5888ee1=No change in outcome since end of treatment
ui.i18n.Concept.name.07eafcd3-6cbb-40a3-acfc-a2eacff17b67=DR relapse after post ttr followup
ui.i18n.Concept.name.097f84ad-f1b7-4cd4-a19d-b49de335278f=Metformin
ui.i18n.Concept.name.099d964e-dac3-4d97-8d77-206f6caa26cd=Plasmodium Vivax
ui.i18n.Concept.name.09a3bf52-770e-4c21-8e51-66d927ac0058=Edema
ui.i18n.Concept.name.0a71ad9e-6610-4d91-80b4-12a3143f1e11=Magnesium test result Abnormal
ui.i18n.Concept.name.0a78b457-d7ee-434d-ae10-ea64f98722c7=Family problem
ui.i18n.Concept.name.0a933e6b-82cc-4bb6-a45c-669852496d20=Widowed
ui.i18n.Concept.name.0aaa8179-a3f2-4784-b626-a0a77f4d4bd3=Leukocytosis
ui.i18n.Concept.name.0ac4da9a-fb13-4835-8843-5980be3a1921=Left
ui.i18n.Concept.name.0af57dd3-a0e9-43c6-aaf1-4004cbfd0980=Vestibular Disorder
ui.i18n.Concept.name.0b413586-b47a-4d7d-9556-5457087b433a=Serum Albumin other Abnormal
ui.i18n.Concept.name.0b5cdc44-f073-4ec8-a0a2-0a992dc72456=Scanty 4-9
ui.i18n.Concept.name.0ba44f6b-e6f5-4445-a8b2-0d7b9b391612=Hyperglycemia (nonfasting and no prior diabetes)
ui.i18n.Concept.name.0bd3cf70-ddee-407a-87b8-107234884d65=Cat 1
ui.i18n.Concept.name.0c16fb40-23f9-4b21-8a32-18f29165a535=Suspected
ui.i18n.Concept.name.0c6ed357-ac48-4b7b-bfb4-efec2149d8c9=Nasal administration
ui.i18n.Concept.name.0c7201e5-efca-4cee-8dbb-fbc8914dde51=Prothrombin Time (PT) Prolonged
ui.i18n.Concept.name.0d21f093-47ad-4c3c-aee0-9f8f419c6296=Erythema
ui.i18n.Concept.name.0d42f04b-7679-41a8-af88-fd745c356d83=Chest, 2 views (X-ray)
ui.i18n.Concept.name.0d60799c-f000-4033-a78c-2229336d3a3c=Bronchospasm, Acute
ui.i18n.Concept.name.0ed73e90-79da-42b8-9722-cc38efeae065=Died post treatment
ui.i18n.Concept.name.0fae7bf6-f09d-4a4e-a1f8-31650a4115df=Empiric regimen
ui.i18n.Concept.name.109c0152-e764-4740-bd41-4dbcc922eadf=Activated Partial Thromboplastin Time (APPT) Prolonged
ui.i18n.Concept.name.10b6afea-a7e7-4ab0-8777-d38240535cd2=DOTS diagnosis
ui.i18n.Concept.name.10b9434e-7b04-4391-9c42-d6f96b863e32=Improved
ui.i18n.Concept.name.10f38df3-9524-40db-b278-b61b982b4bf9=Atrial fibrillation
ui.i18n.Concept.name.1152f111-ab07-4ab2-82fb-fabc3a6c12c8=mmol/L
ui.i18n.Concept.name.1172e56c-8404-436b-b5c8-c4cc33f38815=Short Treatment Program Outcome
ui.i18n.Concept.name.1248b315-c701-46aa-a817-ec1a4a4e6051=Pulmonary
ui.i18n.Concept.name.12a14e03-835c-43d0-ab7a-f38e3bc2316e=Error
ui.i18n.Concept.name.1336AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=NEUTROPHILS (%) - MICROSCOPIC EXAM
ui.i18n.Concept.name.134d73b7-ffba-44fb-834a-121fdbdea73b=Blood Bilirubin Increased
ui.i18n.Concept.name.159977AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=newly diagnosed TB without prior treatment
ui.i18n.Concept.name.159979AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Previously treated with second line drugs
ui.i18n.Concept.name.15b4682d-7791-45ad-a6f1-3372be735ac9=" Neutrophils test result Abnormal"
ui.i18n.Concept.name.15e766c4-f4b3-4ebe-af48-4cba67c3b25c=Neuro-Cerebellar Disorders
ui.i18n.Concept.name.15fc28f2-ee64-4dab-95bd-ca3fd678c428=2014
ui.i18n.Concept.name.160020AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Viomycin
ui.i18n.Concept.name.160103AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=CD4 date
ui.i18n.Concept.name.164a2d36-125b-4419-88c9-c05b44727ed7=Rarely (1-2 times)
ui.i18n.Concept.name.17f02ca7-b944-4ddf-a43e-cc6f8db2e6d8=Severe clinical condition
ui.i18n.Concept.name.17f93d19-3c9e-45de-a28f-67f1b8c650b5=Cured
ui.i18n.Concept.name.1823e0b2-3a92-11e5-b380-0050568236ae=Every other day
ui.i18n.Concept.name.194c88a8-219f-4daf-bad3-1e98c28f6de7=endTB Program Workflow
ui.i18n.Concept.name.1b034feb-d22a-4b74-b7c8-f028aabedc28=6-month post-treatment assessment
ui.i18n.Concept.name.1b17c7f0-9f3e-40b2-85c7-796fb0a92f07=Still on treatment
ui.i18n.Concept.name.1b1a2829-3667-4300-9279-8954ad34e9fb=Short Treatment Program State
ui.i18n.Concept.name.1b895d38-0866-429a-9ff9-4682487e8e17=Hypoglycemia
ui.i18n.Concept.name.1c473cda-b8d5-45d0-b023-2e19883ae86b=Patient refused
ui.i18n.Concept.name.1c6bca5e-fc0a-4de1-a20a-54bbc229e453=Totally Deaf
ui.i18n.Concept.name.1c9b9031-819a-4c65-9984-ca3f3dcf08b5=Patient admitted
ui.i18n.Concept.name.1cf7ffc7-5e47-4ae1-b65f-ae24c27c6c28=Oligospermia
ui.i18n.Concept.name.1d4a0e02-808f-4a47-8b16-b93db613f2ea=New
ui.i18n.Concept.name.1ee69d95-ef32-4f43-b6df-e05ae09380f7=Bacteriologically Confirmed
ui.i18n.Concept.name.1f00b61b-f78a-4fb9-b3f9-a3ccf04037fe=Cause related to TB treatment
ui.i18n.Concept.name.1f492571-f38c-40b4-a2f7-7f5fbb099074=Menorrhagia
ui.i18n.Concept.name.1fbf846c-91b6-4e90-aa27-7fb222e2cc32=Ejection Fraction Decreased
ui.i18n.Concept.name.1fc81455-2e58-4e8d-898b-94227bc0d716=Short Treatment Program
ui.i18n.Concept.name.2018d8c3-520e-469b-8154-03ed11270f8d=Low
ui.i18n.Concept.name.20899527-306d-4fe2-b552-9f083dfcc6ed=Electrocardiogram QT Corrected Interval Prolonged
ui.i18n.Concept.name.209cde69-d082-4b84-b584-560e19541cb0=One or more TB drugs were temporarily interrupted
ui.i18n.Concept.name.20cf1cbd-199a-471f-af32-42f582c8d90e=Allergic Reaction
ui.i18n.Concept.name.20d0679c-69ec-4686-8a41-7620140c1947=Thyroid stimulating hormone test Abnormal
ui.i18n.Concept.name.219bac71-253a-45db-a2ad-9d777d50eb10=Gynecomastia
ui.i18n.Concept.name.21b95915-f63c-4d45-8751-5e0aed2c15ff=MGIT
ui.i18n.Concept.name.21f0727e-d7d5-4549-8902-a32d310069f6=Combination of SAT and DOT
ui.i18n.Concept.name.22063d09-30a2-46f9-bba5-f86234338cc3=2000
ui.i18n.Concept.name.2206bd32-bd25-4c96-bd92-de87d5510715=Vital Capacity Abnormal
ui.i18n.Concept.name.2207f76f-b2cf-46cd-8405-d686c5552021=MDR
ui.i18n.Concept.name.2245d421-8da6-4ff6-8975-31f34da1d716=Lowenstein-Jensen
ui.i18n.Concept.name.236ed490-e8b4-4234-b91d-2f6bb976754d=Related
ui.i18n.Concept.name.2386e7fb-e4e6-4ec4-9ff6-bdd77bbf34b2=Haptoglobin Decreased
ui.i18n.Concept.name.241fde5f-dcb2-4156-a856-d32f9c148180=20-month Regimen Program
ui.i18n.Concept.name.2446dc44-6f28-4028-898a-3ff8ecc034a6=TB Treatment completed
ui.i18n.Concept.name.245175ba-bef3-44ef-a531-9cef19091c82=Scheduled monthly visit
ui.i18n.Concept.name.249b5b2b-7971-45f1-b4ae-b62c8303dc3e=Other but only 1st line drugs
ui.i18n.Concept.name.250fbf4a-7d0f-456d-9c6b-0c7f123d14fc=Chicken Pox
ui.i18n.Concept.name.2547ed53-9ca9-413c-9eaa-4548f2b12d41=Dose reduced temporarily
ui.i18n.Concept.name.25f88822-c38e-43a3-a337-11526473d241=2018
ui.i18n.Concept.name.25ff651a-1795-43cb-899d-eb568f20bcb1=Never
ui.i18n.Concept.name.265c18b2-c109-41db-afbe-cdce084ce3bb=Drug shortage
ui.i18n.Concept.name.28d4d9ec-4efc-43d3-92eb-5e866bb64418=Dose reduced
ui.i18n.Concept.name.28df4fdc-6295-40f9-ae79-14771046768f=LTFU post treatment
ui.i18n.Concept.name.292259ad-b6cb-4a6b-ba89-9686e8925dad=Treatment Failed
ui.i18n.Concept.name.2983df56-1468-4bd3-a7d7-d56a3b2461cb=Nausea
ui.i18n.Concept.name.2a13a9d8-0e52-4d81-b7ac-aa37aaa10283=Social reason
ui.i18n.Concept.name.2b06c1ef-6155-4086-a82a-ccb340e110e0=TB immediate cause of death
ui.i18n.Concept.name.2b712265-7213-4b3d-9c3e-99fa3f98f094=2 week visit
ui.i18n.Concept.name.2bdddc81-c3ae-4a6c-a9ff-7a8d1290a3c8=Marital Status
ui.i18n.Concept.name.2c5cb5de-fe82-4c32-ac63-73317b433ccb=RapidTest (only R resistance results)
ui.i18n.Concept.name.2c8e93a0-7bec-4f91-a204-879154a89868=Creatinine Increased
ui.i18n.Concept.name.2c9f25a6-c414-4854-8f00-bba25470f3fb=Cardiac Troponin I Increased
ui.i18n.Concept.name.2d30a9fe-e7cf-4152-992a-c94f47c8d4dd=End of treatment
ui.i18n.Concept.name.2d41938b-2969-41ec-9541-194eb2871e75=Cataract
ui.i18n.Concept.name.2d7157dc-8ab8-4f85-9224-d4928402ba66=Monthly
ui.i18n.Concept.name.2d9dac38-d724-4217-9225-5c03e48d7cc9=Diptheria
ui.i18n.Concept.name.2da4c89f-b42a-4c83-8551-8a8a1c004339=Fatigue
ui.i18n.Concept.name.2e43a1b1-1df2-4ad5-a14f-d9f5bf9da859=Rubella
ui.i18n.Concept.name.2f06ad6c-6c97-48f6-ab84-c9d0aa757f91=Extrapulmonary
ui.i18n.Concept.name.301ce26b-39c3-4638-b8fa-8240f21ef11f=Non-DOTS
ui.i18n.Concept.name.30904f8a-637e-4d46-8e20-0e7682935247=Total Bilirubin other Abnormal
ui.i18n.Concept.name.30bc8853-a5cd-40a7-a896-4b2501c940df=Plasmodium Falciparum
ui.i18n.Concept.name.30c8cc36-442f-4d0c-bd0f-04b9dcd2b042=No result
ui.i18n.Concept.name.31370ad4-94be-4dce-adf1-55003733dd3b=AGAR PLATE
ui.i18n.Concept.name.31e2e06d-6331-45c9-817b-87b34441cca4=Date of registration in DR-TB national program
ui.i18n.Concept.name.32dec6fa-4ef8-47b6-a88b-2c47be9ea6ec=Obesity
ui.i18n.Concept.name.33cebed0-91a2-45be-91c0-6cfc0b553bb2=Arthralgia
ui.i18n.Concept.name.343971b5-22e5-47c0-b86e-37f9c6903d48=Co-morbidity
ui.i18n.Concept.name.349ac61e-681c-476b-832d-dd3d60096d6e=Confirmed pre-XDR (Inj)
ui.i18n.Concept.name.35c82be1-2f8a-4b44-b82a-72746036dddb=6-month assessment
ui.i18n.Concept.name.35f0649e-6adc-41a5-a13e-7a310fbe4321=Unmarried
ui.i18n.Concept.name.35fe1ef4-5fee-42b4-94c4-d6d1afe869a7=CD4 Lymphocytes Decreased
ui.i18n.Concept.name.3651c8f5-eeea-4412-9fa5-140cd00c2fa8=Mild
ui.i18n.Concept.name.36ff895b-3f5a-11e5-b380-0050568236ae=Unemployed
ui.i18n.Concept.name.37002694-3f5a-11e5-b380-0050568236ae=Student
ui.i18n.Concept.name.37027ace-3c26-4264-9043-f562b0bdc2e8=Regimen dispensed from pharmacy
ui.i18n.Concept.name.37c8167d-742a-4362-a062-11fe0a59ed12=Whooping Cough
ui.i18n.Concept.name.38483eab-a3d4-4340-9d81-afcf73cf2f9f=Syncope
ui.i18n.Concept.name.38af42a5-3d2a-47a9-a1a1-cec005e21aa3=Fatal
ui.i18n.Concept.name.38d5c991-525a-43fa-9f48-f522c0fb6a22=2017
ui.i18n.Concept.name.392a974f-bcee-427c-8ed1-98aa87c0c5ee=Psychosis
ui.i18n.Concept.name.39304898-f8bf-46c4-b47c-09dcbc358616=Second-line TB treatment register
ui.i18n.Concept.name.39752b46-f3ac-4970-9cb6-83765f5b5943=Basic management unit TB register Outcome
ui.i18n.Concept.name.398ca9d5-845a-4a8c-b4b4-285f80182bc9=Bilateral eye administration
ui.i18n.Concept.name.39c9b399-0f3e-4269-99cc-3b60204ca1f0=20-month Regimen Program Outcome
ui.i18n.Concept.name.39d6e9e1-8379-4888-8362-b6c5ef299d9c=DST performed
ui.i18n.Concept.name.39f3d38a-0a1f-4143-af3a-df01e9521cf0=Hematuria
ui.i18n.Concept.name.3a57db35-0ee5-431e-a4bc-4f3d2055d030=Otherwise medically important
ui.i18n.Concept.name.3b1ea665-8a23-4017-a49a-0814dbf88fc1=Drug interrupted
ui.i18n.Concept.name.3b63091e-be5c-4738-8a1b-4f974fa7cd07=Surgical operation
ui.i18n.Concept.name.3b9b1ff5-3f3f-4106-bf7b-c120f47416d5=Fever (oral)
ui.i18n.Concept.name.3bcf530b-b8ca-4a62-b23a-a05df2e49528=Transferred back to DSTB
ui.i18n.Concept.name.3c67c84c-99a7-4750-adcf-297f0032ea7d=MDR regimen
ui.i18n.Concept.name.3c77ff30-50e5-4970-b1af-d857d9ee47d8=Fasting blood glucose measurement (mg/dL) Abnormal
ui.i18n.Concept.name.3c8619c7-ffbb-4de9-8394-4427b0aacba4=Hematocrit Abnormal
ui.i18n.Concept.name.3dc4fabc-dc91-4b86-acb0-c44a8e987164=Drug-sensitive TB
ui.i18n.Concept.name.3e0b3195-bd3b-4b24-b97c-0f5a669a72e3=Scheme B
ui.i18n.Concept.name.3f40c491-ce99-408a-a6b4-33c33b4588df=Dyspnea
ui.i18n.Concept.name.3fbfb30c-914e-4627-82a0-9ab9f2be1a88=Not related
ui.i18n.Concept.name.407c64e4-64f8-4cfc-b476-91d34de1a6bc=Platelet count Abnormal
ui.i18n.Concept.name.4126d663-3d4e-49c2-9a3b-106c810daa40=In more than 1 lobe
ui.i18n.Concept.name.41e5e686-3255-4681-87c9-83b379f025c8=Amylase Increased
ui.i18n.Concept.name.41fc3e2f-bf0b-4d33-a740-bc202465ed6a=End of treatment assessment
ui.i18n.Concept.name.42a37046-2cbb-4093-b3d4-6dc710e91d95=Transdermal administration
ui.i18n.Concept.name.42a44fc0-8bce-4769-bba4-6bde42ae6f93=BMI Status Abnormal
ui.i18n.Concept.name.42be894c-ac3c-4861-a77e-f2487b9b47c3=Hypertension
ui.i18n.Concept.name.42c1f253-a475-4e0f-a9ff-9530583c9912=Contraindication
ui.i18n.Concept.name.433ebabc-b2c4-403c-a575-b5f8a3a03240=Transferred Out
ui.i18n.Concept.name.43acdfa6-6228-452b-a401-3b0cda126580=Hemoglobin Abnormal
ui.i18n.Concept.name.4424cba9-03c0-4dcd-9508-75a0952d78a6=Infections
ui.i18n.Concept.name.44af36ca-2110-4005-a430-edd5cd055359=2009
ui.i18n.Concept.name.44ba6b34-33fa-4f85-a55b-ae28287810ef=Every other day1
ui.i18n.Concept.name.44d8d0fd-8b86-4c6b-ace8-d157a17e405e=Carbon Monoxide Diffusing Capacity Decreased
ui.i18n.Concept.name.44e3639b-a2ef-46de-9ca7-b53af38a478a=Bangladesh Program Workflow
ui.i18n.Concept.name.45bc567a-10c9-4a07-9957-0b320a0c789c=Anxiety
ui.i18n.Concept.name.461602b3-0931-4693-9cd2-46317b09e5c7=Constipation
ui.i18n.Concept.name.46425796-aec2-460a-8d94-3cb129d648d7=2 = Normal
ui.i18n.Concept.name.466b9209-14c0-43de-8edf-512ed5a86a22=Wild type
ui.i18n.Concept.name.46788801-6505-47c9-a198-81e4857c0610=Bangladesh
ui.i18n.Concept.name.469724af-700b-4994-bcc1-2e181ce03394=Bangladesh Program Outcome
ui.i18n.Concept.name.473310cf-f2b6-411f-822b-dd43192db69b=DOTS
ui.i18n.Concept.name.47c14d2b-51a6-4d23-bd2f-ffd0197e9ed7=Antacid
ui.i18n.Concept.name.47c2e80b-baf4-455d-b894-5a7c00e60e0b=Non TB drugs
ui.i18n.Concept.name.486a4dfa-96af-4500-b4b4-8d08e717c0aa=Cat 3
ui.i18n.Concept.name.492bb5c0-1f01-4a03-aff7-7786fb31ebe0=Irregular Menstruation
ui.i18n.Concept.name.4954b1cf-522b-4acc-918c-687063cf0f00=Infection control
ui.i18n.Concept.name.49ef7f48-ff1b-4605-acf4-642fcf79deff=Right
ui.i18n.Concept.name.4a489d10-d0d2-46d4-894f-956b070c4944=PDR scheme C - 3 Cm (or Km)-Lfx-HZ (+/-E)/12 Lfx-HZ (+/- E)
ui.i18n.Concept.name.4a930278-58bb-4ca5-8d71-981f55cbb846=H(S) resistance
ui.i18n.Concept.name.4b406d64-8def-44d0-a367-2f0e6577f89a=Hepatic Failure
ui.i18n.Concept.name.4b742e68-aca5-4ad7-b179-81c7816c7426=Patient related
ui.i18n.Concept.name.4c177c28-7fde-4225-b5d3-a9ee02392ec2=Severe condition
ui.i18n.Concept.name.4c280445-0500-470c-a265-fe1d87481ad6=2001
ui.i18n.Concept.name.4c4bc06a-b39e-4855-a2c3-7f647086f959=Tunit123
ui.i18n.Concept.name.4d27ba13-6e48-4b90-ab2d-f70c402705d6=DR defaulter
ui.i18n.Concept.name.4d8198aa-d000-4725-bb2f-87b2393b8b64=Rash At Injection Site
ui.i18n.Concept.name.4dcf1968-a3d0-4cca-8285-8c114156740f=Abnormal
ui.i18n.Concept.name.4e024f9c-a77b-4783-8eb8-3cfa21d6ade9=Very low
ui.i18n.Concept.name.4e043dfe-6e48-43e6-b9b7-a7f5a9b8175e=Regimen with new TB drug(s)
ui.i18n.Concept.name.4e1e8dcc-9791-4cb8-835b-fc895fb09526=Hyperbilirubinemia (when other liver function are in the normal range)
ui.i18n.Concept.name.4ee570c0-c4f2-47f3-af36-87be320e224a=High
ui.i18n.Concept.name.4f0a9e5e-7c75-4342-b20a-12343dd66e6d=Hypocalcemia (corrected for albumin)
ui.i18n.Concept.name.4f378a36-7947-4894-8c61-0a4dc9f03932=2003
ui.i18n.Concept.name.4f47a32a-f83c-421a-8973-97c68313436c=Female
ui.i18n.Concept.name.4fcb9fbb-f2c4-47df-a468-28500b7a62fa=Arthralgia (joint pain)
ui.i18n.Concept.name.504e1a94-e371-4656-af71-0747fc6f1f35=Not defined
ui.i18n.Concept.name.507fa9af-b8bc-4533-96b2-f0fc926057f9=Serum creatinine (umol/L) Abnormal
ui.i18n.Concept.name.5099deea-a9d8-4cbd-bb5d-f871d4c90564=2012
ui.i18n.Concept.name.513fbbae-fbc5-4ba7-91da-c2765a4c3c87=Drug Sensitive
ui.i18n.Concept.name.516bfb41-0452-4c30-a4d1-71caa15bfc93=Thoracostomy
ui.i18n.Concept.name.51b4ddb7-1de9-4687-80d1-1cd65006be52=2015
ui.i18n.Concept.name.51cb765d-1936-4abf-8bfa-3f98e80d8b4f=Paracetamol
ui.i18n.Concept.name.51ce1906-7b79-4f1d-a4fb-ee99f69c42ac=Not Employed
ui.i18n.Concept.name.51fa815f-6d0e-4884-a53f-7691487e0290=Suicidal ideation
ui.i18n.Concept.name.5242AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Respiratory rate
ui.i18n.Concept.name.5599575a-b711-4381-b300-68dd9f6cd6a5=Hypermagnesemia
ui.i18n.Concept.name.55c9ae81-af79-43e2-9c3c-632c4a26b074=Is alcoholic
ui.i18n.Concept.name.5632AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=CURRENTLY BREASTFEEDING CHILD
ui.i18n.Concept.name.57d9d5c1-5a15-42c7-abcc-cc791f69e1f3=Intraosseous administration
ui.i18n.Concept.name.5898c458-2c1b-4231-b996-216d9c7529f8=mg/dL
ui.i18n.Concept.name.596d1459-157c-481d-847c-cace8c5841bb=Contaminated
ui.i18n.Concept.name.59e13291-37bb-4d02-a74b-d0f5a45c456c=Failure
ui.i18n.Concept.name.5ad7dd1a-468b-420a-b16e-848347342ead=Not MDR
ui.i18n.Concept.name.5b6b47b7-699f-47a5-8c62-103cb29868a4=DST Survery
ui.i18n.Concept.name.5beaa945-62f7-4e5b-86a3-c290575d1a2d=Profile unconfirmed
ui.i18n.Concept.name.5c06c8f2-9fb6-406d-bc03-93acad4b49da=Other patient related
ui.i18n.Concept.name.5c70ef4e-07a1-4565-a91d-e700626a4d2c=Second-line TB treatment register Outcome
ui.i18n.Concept.name.5cc18104-2dcf-4923-9170-81a6f47d0820=Only 1st line drugs
ui.i18n.Concept.name.5cf6d70b-8958-401d-8654-b423c96c81b6=Alanine Aminotransferase (ALT or SGPT) Increased
ui.i18n.Concept.name.5e1621f1-008b-4d6d-b6b6-6e51e2c858e8=Empyema
ui.i18n.Concept.name.60099fc1-f290-41d5-9c04-c41ccf8ea9f3=Treatment Completed
ui.i18n.Concept.name.602e0bdb-723f-48fc-8a49-a2cef08d591b=Seizure
ui.i18n.Concept.name.603cf5fa-937f-471a-a13c-90b3f7de76e0=Lack of conversion
ui.i18n.Concept.name.60439034-2a48-4ecc-82b3-f06dabba626c=Abnormal but extent not defined
ui.i18n.Concept.name.61b2062f-19fb-4bb6-9f86-baddfbf83e62=Pancreatic Enzymes Decreased
ui.i18n.Concept.name.620ab0f8-c1ad-4e1d-a214-e24bf62edee8=Congenital abnormality
ui.i18n.Concept.name.62893475-c946-4c82-aef0-48caf3c41dbc=Borderline
ui.i18n.Concept.name.62a70aa2-9744-43d6-b0bf-a42cc86aba43=Other medical or treatment related
ui.i18n.Concept.name.6303f1d8-c91c-4cf2-873a-8b208f73842e=Dose maintained (no changes)
ui.i18n.Concept.name.635be60f-23f0-4f07-b0dd-c136367da5d2=Relapse or recurrence
ui.i18n.Concept.name.64d2e282-a8e7-4e8e-8259-5315713e1e48=Muscle Strength Disorders
ui.i18n.Concept.name.64e8de1b-bb18-4235-915f-0f09ae1da5c2=Lobectomy
ui.i18n.Concept.name.657837b7-9bf2-42eb-b61b-20569f1cfc97=Positive
ui.i18n.Concept.name.65b6d894-3bd7-433a-800e-707e7bd16131=Scheme C
ui.i18n.Concept.name.663c88a9-4260-4281-8ed2-025a804fe094=Right eye administration
ui.i18n.Concept.name.665e6fc4-d2ea-47b5-810a-7af67b7754d8=Patient Died
ui.i18n.Concept.name.668b7b7c-3c52-4fa9-be4b-e8a850949132=Proteinuria
ui.i18n.Concept.name.66ebb4a0-bb6a-47f8-bb5c-26192e0fd438=Lipase test result Abnormal
ui.i18n.Concept.name.67c671e2-c1f7-4e40-ab0f-8574189a9201=Middlebrook 7H11S
ui.i18n.Concept.name.684dc924-77fd-4b17-b66d-3b59c744c0cb=2019
ui.i18n.Concept.name.686a5254-5bbe-4254-ab59-cb059a4aaba1=Right ear administration
ui.i18n.Concept.name.68aeed7b-6f7b-4646-b782-6d3cbb1afbfb=Pregnancy
ui.i18n.Concept.name.69cc81b0-b92e-4070-9ca2-9593f1cf0945=% Polymorphonuclear Leucocytes + Band Cells Increased
ui.i18n.Concept.name.6a13dab4-dfe3-4408-b6c9-a15b4d954797=Hypoalbuminemia
ui.i18n.Concept.name.6a426a1a-d04c-4546-b99d-e6a1be59072b=Reintroduction/replacement of stopped drug
ui.i18n.Concept.name.6a4aacbf-0761-40d3-9521-26973f5f3f46=Hypophosphatemia
ui.i18n.Concept.name.6a7baf59-fb27-466f-8424-eb67279541e4=Severe
ui.i18n.Concept.name.6b98634e-3429-4d59-a82c-31a8cd0c14e8=Sinus rhythm
ui.i18n.Concept.name.6c3feaf8-f9b0-4c78-88af-4d037cafbb60=Low Fibrinogen
ui.i18n.Concept.name.6cde0e03-2dea-4362-9e18-8ff3524030dd=TB contributing to death
ui.i18n.Concept.name.6d223242-1e48-4740-95d7-9aae0907007c=Often (more than 10 times)
ui.i18n.Concept.name.6d2fe590-1276-41bd-b122-52dc6b34582f=Severe condition of patients
ui.i18n.Concept.name.6e10c60a-d796-4ff4-b455-8fcc21f15bca=Premature Delivery
ui.i18n.Concept.name.6e6e35b1-968f-4077-8bec-ccee0b8f8775=Short Treatment
ui.i18n.Concept.name.6eda5e1b-1343-4ba9-92e8-87740c3bde1d=Divorced
ui.i18n.Concept.name.6f2187ba-8a5d-419b-974b-f9d8fe396663=Detected
ui.i18n.Concept.name.6fa9b39f-fe5e-4027-ab5c-e798dd688896=Left ear administration
ui.i18n.Concept.name.70ed9aae-97ec-4de0-bb35-827e8dde4674=Pott’s disease or meningitis - 2 (HRZE) / 10 (HR)
ui.i18n.Concept.name.722e5600-8fdf-4c6d-a302-0add56334396=glycosylated hemoglobin A measurement Abnormal
ui.i18n.Concept.name.7258dd0e-9318-4947-b9a2-7775dfef2667=5 or more
ui.i18n.Concept.name.729AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Platelets
ui.i18n.Concept.name.72bb6c16-4962-4373-9758-8d52756c1059=Measles
ui.i18n.Concept.name.72d9420a-755c-4914-8baa-67f14e1df590=Housework
ui.i18n.Concept.name.737daf08-6067-43ac-8d02-5f2666edf63c=Currently
ui.i18n.Concept.name.73ae5bb2-487d-436b-8391-db7532b02bac=Rectal administration
ui.i18n.Concept.name.73af4b91-cd00-42e6-abcf-de945ef4ab60=Tetanus
ui.i18n.Concept.name.74921f8b-8413-47a2-9920-b293c4e98951=Prolonged QT Interval
ui.i18n.Concept.name.74a0939c-0260-4302-9a19-c55cbddfd3d4=Medical or treatment related
ui.i18n.Concept.name.74b28975-6517-4fd5-8509-73ff9c335324=Creatinine other Abnormal
ui.i18n.Concept.name.755ff10f-fbe5-4fd4-88f2-9aa9712c659c=Normal
ui.i18n.Concept.name.757012d7-bd29-4c56-b25e-67e1b5a8ddd2=Scanty 1-3
ui.i18n.Concept.name.760169d9-4b7e-47f8-8183-a21f6bc7ca01=Ionized Calcium other Abnormal
ui.i18n.Concept.name.76835AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Gatifloxacin
ui.i18n.Concept.name.76862AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Gemifloxacin
ui.i18n.Concept.name.769fa7a4-c92f-4daa-a2a7-e2bcd9e6ab38=Health Worker
ui.i18n.Concept.name.77308d5d-4ca6-40ff-8fdd-1112b0cbc547=Resistance to drug
ui.i18n.Concept.name.773232e8-9337-4879-b5dc-2172cc026c52=One or more TB drugs were permanently discontinued
ui.i18n.Concept.name.77549d43-b8be-4474-bbc9-6f02982e4408=Pericarditis
ui.i18n.Concept.name.77750e22-a8bf-4676-a04b-c6879170cf7f=Failure of culture conversion
ui.i18n.Concept.name.782096ac-81ca-4039-ad8b-62b69ee8cf61=Autoimmune Disorder
ui.i18n.Concept.name.78eff390-5e79-4611-9e87-fcd0c9a9a89f=Febrile Neutropenia
ui.i18n.Concept.name.7aba77c0-29f2-4a79-8bdd-389f12a213e6=Previously treated case - 2 S(HRZE)/1 (HRZE)/5 (HR)E or wo S
ui.i18n.Concept.name.7befb249-898b-4ae8-9bce-f8538a807545=6 days per week1
ui.i18n.Concept.name.7c80b1a5-da6a-4865-8afa-970b35a3b9c5=Cat 2
ui.i18n.Concept.name.7c9d476a-52e5-4982-be7d-c024935f8cfb=DOTS diagnosis - end of intensive phase
ui.i18n.Concept.name.7ca25b3c-e0ee-4666-a3c9-78b9f6b75d1a=Reactive
ui.i18n.Concept.name.7d0fab03-875c-4313-b5f2-5c098974bc5a=ALT Increased
ui.i18n.Concept.name.7d97408b-4394-401e-b731-f28ca7ed5d8d=Scheduled
ui.i18n.Concept.name.7e01c24d-5869-4e67-8b15-481d146d1911=Invalid
ui.i18n.Concept.name.800270e3-3e0e-4d0d-9c4a-257b8502becf=Injection Site Reaction
ui.i18n.Concept.name.80363AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Nalidixic Acid
ui.i18n.Concept.name.80792AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Norfloxacin
ui.i18n.Concept.name.8093186c-8029-49d8-94a0-95778524ff58=No cavities
ui.i18n.Concept.name.80a92d69-3510-4e58-b5ba-b47b46e12eaf=Induration
ui.i18n.Concept.name.80c75bd2-bc55-4caa-a7b7-cd1d9481b956=Basic management unit TB register
ui.i18n.Concept.name.80d00656-d10e-4641-8055-eb0373c908d8=Profound
ui.i18n.Concept.name.81354576-64d0-4ee7-8470-39c87e396d92=Active Chronic non-DOTS
ui.i18n.Concept.name.8152e2a0-5622-468a-b9d1-0397fcea11e3=Magnesium other Abnormal
ui.i18n.Concept.name.818bee29-804d-400f-a3b4-974b863040b0=Sometimes (3-10 times)
ui.i18n.Concept.name.81d77bab-1425-42d1-b84c-ed7baa74e82a=Indeterminate
ui.i18n.Concept.name.81ea1e9e-22cf-47d1-b3c0-0fc0a913775a=Unscheduled visit
ui.i18n.Concept.name.82216e09-d80f-43dd-99a6-6052c0d46a19=Dysgeusia
ui.i18n.Concept.name.83cb7c5e-dc1e-4642-a967-26e548b58b7b=All Other Drugs
ui.i18n.Concept.name.83cd2020-bee4-462f-81fd-77e0b2c90f68=Hypercalcemia (corrected for albumin)
ui.i18n.Concept.name.83fa775a-f4ed-42f2-adb4-7a5b4406f3f8=Re-operation for complication
ui.i18n.Concept.name.84206AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Sparfloxacin
ui.i18n.Concept.name.845cf61a-d288-4bfe-8014-776bb5260e19=Defaulted
ui.i18n.Concept.name.845f82fd-8eca-4884-97c1-25e2947ded27=Patient behavior
ui.i18n.Concept.name.01c9e3a3-aae0-458c-b310-a1b6fab56458=Total bilirubin
ui.i18n.Concept.name.0205eaa5-07b6-4867-8a2f-0b95815ef0c3=Test Frequency
ui.i18n.Concept.name.034d4f24-7c40-4433-b037-c909cfb80d77=Hemoglobin (g/L)
ui.i18n.Concept.name.042110ff-7aa6-492d-895c-79b9a472a6ab=HbA1C (% of total Hb)
ui.i18n.Concept.name.0477d885-c6a9-40a3-8b5e-2f83cd4e02ba=CR
ui.i18n.Concept.name.04b8cfc2-7462-4f8c-a763-4b3254ffa2f5=QtcF
ui.i18n.Concept.name.0546e994-2c24-4a4a-8973-b1a2e983cce6=WBC count
ui.i18n.Concept.name.05f9f5e2-2c9a-4cc2-b3dd-bdcb9a3652e7=Unknown
ui.i18n.Concept.name.07feb250-fe99-41e5-a194-111c39a085c3=GLU
ui.i18n.Concept.name.08589414-4551-43c2-be86-caae9eea66bf=Additional contributing program related reasons
ui.i18n.Concept.name.0889a9fa-00e6-4289-88d4-c032f75e1143=Total Bilirubin
ui.i18n.Concept.name.0983bdfa-b5db-408b-93ae-f3aae7434463=Absolute Neutrophil Count
ui.i18n.Concept.name.0a45f075-afb5-4353-a657-de053e8f8638=Diagnosis Set of Sets
ui.i18n.Concept.name.0b9d5bd5-3c9f-42f5-938f-ea9b3022e126=WBC Count (x10^9/L)
ui.i18n.Concept.name.0b9e6fa1-12f8-4a54-bea1-bbec0b340e1d=SAE review log
ui.i18n.Concept.name.0bd7d283-4fc5-4d73-a46d-4e7fbb5eaec2=Serum Albumin
ui.i18n.Concept.name.0c6759f1-be41-4a2f-ab95-d2f03309e24b=Reasons for less than 100% completeness
ui.i18n.Concept.name.0d184c89-7fec-4eba-91c0-289141726ecc=Dec
ui.i18n.Concept.name.0f3e4b08-efbc-4988-93b6-5715cd9593f9=Additional contributing reasons for less than 100% completeness
ui.i18n.Concept.name.0f744448-82e7-4a07-947c-1df86bdf3452=RBC count
ui.i18n.Concept.name.0f84ec03-6307-4f9a-a741-c52317215c92=9
ui.i18n.Concept.name.0fb832b1-73f9-4aab-8aa7-39167cd30f55=CD4 Count (x10^9/L)
ui.i18n.Concept.name.11f174ea-8d2e-404e-a4eb-a98c32624c7c=CD4
ui.i18n.Concept.name.139fd2da-5290-4f1b-8be1-66f335655a0b=4
ui.i18n.Concept.name.154378AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Raltegravir (RAL)
ui.i18n.Concept.name.159810AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Etravirine (ETV)
ui.i18n.Concept.name.159978AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Previously treated only with first line drugs
ui.i18n.Concept.name.15bafc6f-65dd-4cf8-a6a7-24aaf20799f6=Hospitalisation
ui.i18n.Concept.name.15f24a7e-1935-4c34-b446-81514ccea941=Mar
ui.i18n.Concept.name.160554AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=HIV diagnosis date
ui.i18n.Concept.name.163143AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Bedaquiline (Bdq)
ui.i18n.Concept.name.163144AAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Delamanid (Dlm)
ui.i18n.Concept.name.164875d8-82fa-4bd6-9b39-40a4265d37e0=Pregnancy test
ui.i18n.Concept.name.1662cbbc-12a2-41dd-9109-5d9736214897=SAE related to TB drugs?
ui.i18n.Concept.name.17fc8bc7-bdbb-4038-b6d5-d6e672d69ae3=ALT (SGPT) (U/L)
ui.i18n.Concept.name.1808b173-3a92-11e5-b380-0050568236ae=
ui.i18n.Concept.name.1843db3c-6ce4-42cd-9b61-f823c5dc8891=Streptomycin
ui.i18n.Concept.name.18e54577-3a92-11e5-b380-0050568236ae=All Orderables
ui.i18n.Concept.name.19a9e000-20bc-4a87-9236-1820cc6990ab=0 = Absent
ui.i18n.Concept.name.19cf5868-89eb-4178-adcd-bdf95077efbe=HbA1c
ui.i18n.Concept.name.1be47bef-b5f3-4b34-8361-c7514408b37a=Creatinine
ui.i18n.Concept.name.1c17006d-fb2b-4195-8904-75512bdfd585=Sep
ui.i18n.Concept.name.1c8e5fbe-5724-4277-8b03-8777f9c69ba3=SAE severity review
ui.i18n.Concept.name.1d5bc94d-2993-459e-9c70-b0bd4b212002=Potassium (g/L)
ui.i18n.Concept.name.1d86ce9e-5fc0-44af-9d95-98d1851d16bb=All drugs suspended?
ui.i18n.Concept.name.1e338dda-83cf-4e56-9786-e3499960b91a=Chronic Diseases
ui.i18n.Concept.name.1fbea0e8-5818-4be8-8bcc-eb29da4d0ae2=Fasting Blood Glucose Measurement
ui.i18n.Concept.name.1fcf9faf-2e0c-4cd7-adb3-cb44c9f58f59=Glucose
ui.i18n.Concept.name.24ad9c5e-cea7-41cf-bc89-6da1af6a5513=Nov
ui.i18n.Concept.name.27fbb327-7301-47be-b64c-98d71a1e3a82=Bronchial lavage
ui.i18n.Concept.name.287d223a-54ad-4866-8c04-3d297f19fba1=Hemoglobin
ui.i18n.Concept.name.28c76ddf-6f58-4291-868a-c362648ed048=Oct
ui.i18n.Concept.name.291ac02f-376e-4b4a-a6aa-e4db1bde6e23=Magnesium
ui.i18n.Concept.name.2987e7be-2f40-4f93-9d7a-25d2c8dfa427=SAE review date
ui.i18n.Concept.name.29d1e063-ab0c-43e2-a17b-2821ffd5efb8=Ionised Calcium
ui.i18n.Concept.name.2a8c9deb-fb6c-4abe-be4e-55b36d490c9c=Additional contributing reasons for less than 100% completeness
ui.i18n.Concept.name.2ac521a1-312a-426b-a1e4-71b40d0a4887=3 = Not felt
ui.i18n.Concept.name.2ca339ac-1158-4d08-84e4-de75a55222fd=BPNS
ui.i18n.Concept.name.2e2e33ae-887f-48a3-9e58-9aa05f0f8096=TSH (mIU/L)
ui.i18n.Concept.name.2ed64d2f-948c-4600-b7b2-8e1fd7cb58c0=1
ui.i18n.Concept.name.304c4751-74ea-4acd-b51a-018aae5d19d4=ND
ui.i18n.Concept.name.311295fd-c937-4743-bca2-1eea184a80c4=Lipase
ui.i18n.Concept.name.324fce09-3c18-4119-8406-f35a442de9e3=Aug
ui.i18n.Concept.name.3516e44b-bfd0-42e0-b49f-90af86520d7a=Additional contributing patient related reasons
ui.i18n.Concept.name.364d5280-9110-47e7-b5cf-49fce9b20005=RBC Count (x10^6/µL)
ui.i18n.Concept.name.39450272-7fdd-47bf-9d2f-74a4aed4e694=Absolute neutrophil count
ui.i18n.Concept.name.39c72e18-652c-4d05-8257-aa2e87a2f3d2=Cardiovascular Disease
ui.i18n.Concept.name.3a8e0986-f554-4a18-b424-ae1925cffdb5=Viral load year
ui.i18n.Concept.name.3ce8f93c-6b0d-4aa6-aeec-67b5a1908633=Jun
ui.i18n.Concept.name.3d88fea1-12ed-4794-b478-3620f687d247=Glucose (mmol/L)
ui.i18n.Concept.name.3efc540c-c0ee-4197-b9a7-614e98514315=Previously reported as AE?
ui.i18n.Concept.name.41335cfb-e089-41fa-bba7-7e25899c9708=Potassium (mEq/L)
ui.i18n.Concept.name.416e4514-2afd-4fd9-82ed-5d3a0c2303ca=Hematocrit (% vol)
ui.i18n.Concept.name.42bd63ad-de51-4f74-a9a6-8e0661510920=8 = Unable to or did not access
ui.i18n.Concept.name.45d41243-5ed3-4deb-8d11-29b82fff9e0a=Glucose (Fasting)
ui.i18n.Concept.name.48df8a34-8be4-4834-beeb-3ae321630f0d=% neutrophils
ui.i18n.Concept.name.491c6d45-fc21-4d1f-9683-b78c9a8dfb0a=TSH
ui.i18n.Concept.name.4b3019a0-1ce0-430b-a755-ac5b140726e6=Glucose
ui.i18n.Concept.name.4b916537-eb21-4cf1-939c-946cc9149823=Apr
ui.i18n.Concept.name.4c394810-32a4-475b-ac10-01b1b1c108f8=Serum albumin
ui.i18n.Concept.name.4c6b4488-d02e-4ff6-aa3b-f2261e8e6a34=5
ui.i18n.Concept.name.4cb6eb5d-d9e7-44fe-9b00-89500f79e8a1=CSF
ui.i18n.Concept.name.4cb8775c-e707-401e-bcec-f4e6551e4acb=7
ui.i18n.Concept.name.4d428d5a-2313-4108-bcc5-3e994ce8494b=CD4 count
ui.i18n.Concept.name.4debf985-ea9c-4944-bbf3-acd7fe6bdc80=Neurological
ui.i18n.Concept.name.4ec22662-8675-433e-b4c8-1d771ac6be65=Other ECG
ui.i18n.Concept.name.50030753-a820-4501-b67a-298ee13a95eb=K
ui.i18n.Concept.name.50e6308c-9544-4fca-b15e-38cef781b852=Ishihara test
ui.i18n.Concept.name.513fcd4a-f64b-4a81-8231-0aa9f2135bde=RBC
ui.i18n.Concept.name.520ecc0a-edf5-4004-9845-1011e4778464=10
ui.i18n.Concept.name.53976677-7508-4c57-abfe-9fb3bfd75f17=Urea
ui.i18n.Concept.name.54a8e084-68e6-4497-b1dc-c2f6c5f3da12=Other assessment reason
ui.i18n.Concept.name.5858c45d-a311-4ff7-b0b9-9857a3dc95e6=4 = Clonus
ui.i18n.Concept.name.58cc113c-33f6-4f96-a22f-4da36265af57=Total Bilirubin
ui.i18n.Concept.name.5c042cb5-8605-4ef1-b65b-315e1e35b258=Unknown
ui.i18n.Concept.name.5e2b5e16-393f-4540-90d4-af8d5d96235a=6
ui.i18n.Concept.name.6045fc99-1a63-4cd2-8537-61f8a23ad5bf=CD4 Count
ui.i18n.Concept.name.6230a2fb-567c-48b3-9029-ac9ee3cf31c7=Additional acquired resistance to FQ or injectables
ui.i18n.Concept.name.6466f52e-fc62-43ef-8eb9-c29f337d974e=Date event became serious
ui.i18n.Concept.name.6576e2b0-32f6-48f5-8a9b-77797ff54e75=AST (SGOT)
ui.i18n.Concept.name.65bc9305-2413-4abb-a8d2-044d831a561b=SAE severity grade
ui.i18n.Concept.name.674f6a10-8d44-4156-bdef-922b9e3c2ecd=Month and Year
ui.i18n.Concept.name.67a2b547-d151-11e5-ab2e-005056826881=Current month of treatment
ui.i18n.Concept.name.69961bbb-a494-4536-a5f9-5ae20fd18028=1 = Hypoactive
ui.i18n.Concept.name.69dd8304-1b8d-4960-86eb-6d03b896988b=WBC
ui.i18n.Concept.name.6bb89c4e-c5e8-43a3-8520-e8bf1672d575=Last Drug sensitiveTB treatment outcome
ui.i18n.Concept.name.6bc30e48-f59c-419d-ab51-87202f58425a=Magnesium (mEq/L)
ui.i18n.Concept.name.6c11fc09-c202-4de7-a9f6-d37668c90bda=CD4 Count (cells/µL)
ui.i18n.Concept.name.6d08d12a-cb80-4760-a4b4-360e3f4e2b8c=Platelets (x10^3/µl)
ui.i18n.Concept.name.6e827961-e4c0-4e73-872b-02e0bb18a135=Audiometry Details
ui.i18n.Concept.name.6f12b6bd-6261-460f-838a-8b8a2b21fe97=Route testing short
ui.i18n.Concept.name.717566b6-2eb8-4fc7-84f2-f3682c439080=Last Drug-Resistant TB Registration Number
ui.i18n.Concept.name.73449AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Ciprofloxacin (Cfx)
ui.i18n.Concept.name.74258AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Darunavir (DRV)
ui.i18n.Concept.name.7495eb99-7cb3-4576-97c7-c31b77760d7d=Absolute Neutrophil Count (cells/mm³)
ui.i18n.Concept.name.750825d4-0d65-4ca7-9ad0-7d2d2bc07ad4=Reason for next visit
ui.i18n.Concept.name.75ba3847-181f-4650-9b74-d66f0a72c86d=Jul
ui.i18n.Concept.name.75da234f-9ac8-47a7-bc91-7d363c238c43=Neutrophils
ui.i18n.Concept.name.7618fdc1-34a0-42d0-80c1-8ab25769568a=Unknown
ui.i18n.Concept.name.76658AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Fosamprenavir (FPV)
ui.i18n.Concept.name.787d95c4-ff87-4751-8bce-d8a0ed5555b5=Ionised Calcium (mg/dL)
ui.i18n.Concept.name.78c32b3f-ac54-4945-8db7-097056e5e1a4=3 = Hyperactive
ui.i18n.Concept.name.79611AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Meropenem (Mpm)
ui.i18n.Concept.name.79caa7d0-8b2f-4357-95b9-4ccfc1689e42=Hemoglobin
ui.i18n.Concept.name.79ccfb3b-0f17-4c79-a552-170fdcf2e2b3=Used atleast one of the drugs in past one year</br>Cannabis</br> Cocaine</br> Prescription stimulants without a prescription</br> Methamphetamine</br> Inhalants</br> Sedatives</br> Hallucinogens</br> Street opioids
ui.i18n.Concept.name.7a2cccdd-92b9-406e-b509-04bf2a622c64=Hepatitis
ui.i18n.Concept.name.7c359a1b-94c8-4f04-945b-19c86dc50b4f=Year first TB treatment
ui.i18n.Concept.name.7c3c9d5b-b369-4f22-9a53-ce3e5903ad56=AST (SGOT) (U/L)
ui.i18n.Concept.name.7d28552b-7234-11e5-af64-0050568236ae=Bacteriology Concept Set
ui.i18n.Concept.name.7dc18258-71f3-4dfc-81d8-eced088a9fe1=ALT (SGPT)
ui.i18n.Concept.name.7e5d3913-9fd9-4b92-8d5a-9e5a7da46f34=Visual acuity
ui.i18n.Concept.name.7f524c82-f80c-47ba-aa28-1083c1a99e23=Absolute Neutrophil Count (x10^9/L)
ui.i18n.Concept.name.7fd09bcc-6da2-4281-b332-4dd6d46f19eb=Additional contributing medical or treatment related reasons
ui.i18n.Concept.name.81022AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Ofloxacin (Ofx)
ui.i18n.Concept.name.83352AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Rifabutin (Rfb)
ui.i18n.Concept.name.83360AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Rifapentine (Rpt)
ui.i18n.Concept.name.83690AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA=Saquinavir (SQV)
ui.i18n.Concept.name.1808b173-3a92-11e5-b380-0050568236ae=IU
ui.i18n.Concept.description.89fb323c-3a91-11e5-b380-0050568236ae="EVERY DAY"
ui.i18n.Concept.description.89fc05c3-3a91-11e5-b380-0050568236ae="TWICE A DAY"
ui.i18n.Concept.description.8a0b784c-3a91-11e5-b380-0050568236ae="THREE A DAY"
ui.i18n.Concept.description.8a0c7489-3a91-11e5-b380-0050568236ae="FOUR A DAY"
ui.i18n.Concept.description.8a168b90-3a91-11e5-b380-0050568236ae="BEFORE A MEAL"
ui.i18n.Concept.description.8a176bde-3a91-11e5-b380-0050568236ae="AFTER A MEAL"
ui.i18n.Concept.description.8a1e375d-3a91-11e5-b380-0050568236ae="AT BEDTIME"
ui.i18n.Concept.description.8a32fec2-3a91-11e5-b380-0050568236ae="Consultation Note"
ui.i18n.Concept.description.9571becb-c91c-432d-8c51-5f143b60d2ba="Cannabis</br>
Cocaine</br>
Prescription stimulants without a prescription</br>
Methamphetamine</br>
Inhalants</br>
Sedatives</br>
Hallucinogens</br>
Street opioids"
ui.i18n.Concept.description.ad448c54-cb35-478d-a35e-b915193e5770="Not employed within past 1 year"
ui.i18n.Concept.description.1fb34b74-49c1-4364-bca9-49499dc1cfef="If abnormal, fillout the baseline section of Adverse Events Log"
ui.i18n.Concept.description.f1d9c32f-be5b-44e5-9c0f-009929703b6d="1-11 in the book of 14 plates"
ui.i18n.Concept.description.57e19920-7445-401b-b2a6-364d6781b3d6="Date of first result indicateing MDR: could be micro/molucular test or clinical diagnosis of MDR-TB"
ui.i18n.Concept.description.5d224be5-9130-4258-a552-cc8f12a2c2f1="If abnormal, fillout the baseline section of Adverse Events Log"
ui.i18n.Concept.description.7c867cf8-e66c-4356-a92c-22099bdadb0f="If abnormal, fillout the baseline section of Adverse Events Log"
ui.i18n.Concept.description.d3c4be03-7ea3-4184-af5f-7b2b3e4a14e6="1-11 in the book of 14 plates"
ui.i18n.Concept.description.744ec780-c315-4196-974a-2ae86d5377d2="<b>Instructions:</b> This log is a list of all the medications that the patient is currently taking. Record all medication changes on a new line. Record the date that any medication is  stopped or has a change in dose."
ui.i18n.Concept.description.8a8797f5-3bfb-45c5-b81c-089efa54539e="RR = (60/HR)"
ui.i18n.Concept.description.641ed23f-357e-46ba-bd06-ea2b8eb08c10="<b>Planned change </b>includes for example BDQ dose change, end of injectable, end of treatment <br/><b>Adverse event</b> includes changes due to contraindicatins as all drug changes will be adverse events"
ui.i18n.Concept.description.623ff678-a655-4528-99d4-3d45f3f2e41f="In the past 30 days, was there ever no food to eat of any kind in your house because of lack of resources to get food?"
ui.i18n.Concept.description.ae866b6e-f99e-4510-82f5-4b8d80870a6e="In the past 30 days, did you or any household member go to sleep at night hungry because there was not enough food?"
ui.i18n.Concept.description.4205ed43-acfd-40b0-88d1-99215910bd25="In the past 30 days, did you or any household member go a whole day and night without eating anything at all because there was not enough food?"
ui.i18n.Concept.description.b718204f-161d-45ee-a570-e81dc22ebb06="For each previous treatment list the following information"
ui.i18n.Concept.description.9cf1b1df-193d-499c-8737-47ece5048ce5="1=Patient refused followup, 2=Substance abuse, 3=Social problem: family, financial, complex social situation, 4=Left region, country, 5=Adverse events, 6=No confidence in treatment, 7=Other, 8=Unknown, 99 not entered"
ui.i18n.Concept.description.0bc71027-99fc-40e5-8ab4-2d66f7b5e0bf="<b>Relapse:</b> patient previously cured or treatment completed who is rediagnosed with TB (defintion to define if this includes patient who are re-diagnosed with a different resistant strain- ie re-infection)"
ui.i18n.Concept.description.90076c7c-fa3c-48c1-9d9e-35396be93202="Body Mass Index (BMI) is a relationship between weight and height that is associated with body fat and health risk.

The equation is BMI = body weight in kilograms/height in meters squared."
ui.i18n.Concept.description.22c7d3a1-6dba-4c00-b807-6c1301dc36b8="Question on encounter form: ""Is the child currently being breastfed?"""
ui.i18n.Concept.description.b5efa248-a4f0-49ca-aaec-6e5deeb0b5d0="Type of MDR-TB."
ui.i18n.Concept.description.1119f9db-5342-487a-8454-37e08fbef959="Type of MDR-TB."
ui.i18n.Concept.description.19d58f0b-51e5-43fb-9f12-e84420283661="Classification of MDR-TB without prior treatment or with less than one month of anti-tubercular drugs"
ui.i18n.Concept.description.b0161932-b130-48fa-806c-f08e51c885d5="Classification of MDR-TB according to previous drug use. A WHO-defined set of categorizations of new MDR-TB patients."
ui.i18n.Concept.description.24406355-5523-4985-98b4-4ef7ea20563c="Encounter form question.  Date in which tuberculosis treatment was started."
ui.i18n.Concept.description.b295ee59-e74e-4dd7-b500-4736a9fcee5d="The last day the patient received treatment"
ui.i18n.Concept.description.df282e33-b190-44b7-a259-9cad8b752c71="Minute, nonnucleated, disklike cytoplasmic bodies found in the blood plasma of mammals, derived from a megakaryocyte and function to promote blood clotting."
ui.i18n.Concept.description.0985fb55-4b96-49ae-9933-edfaffe31dfd="Blood test to measure the number of red blood cells."
ui.i18n.Concept.description.6793db3d-0a88-4d6f-92a5-b1702819b186="Blood test to measure the number of white blood cells."
ui.i18n.Concept.description.16a980a1-2aba-4c6f-90ae-e122c13360fe="Absolute neutrophil count (ANC) is a measure of the number of neutrophil granulocytes (also known as polymorphonuclear cells, PMN's, polys, granulocytes, segmented neutrophils or segs) present in the blood. Neutrophils are a type of white blood cell that fights against infection.

ANC = (%neutrophils + %bands) x WBC"
ui.i18n.Concept.description.e6ae49ef-46c7-4ed6-b67b-e8511bbca2c4="Test to find, count and examine Neutrophils the type of white blood cell which form an early line of defence against bacterial infections by using microscopic exam"
ui.i18n.Concept.description.3241d901-2ef2-4bb2-8fa2-a9aca2c6a95f="Laboratory test that determines a blood serum potassium level."
ui.i18n.Concept.description.95ca4c95-8900-4a1b-864d-8957f74b8cc7="Measure of urea levels in the blood often used to assess kidney status."
ui.i18n.Concept.description.c50ae3bf-6457-4521-8c26-ec787fee5d42="Laboratory test that determines a blood serum creatinine level.  Often used with BUN to assess kidney function."
ui.i18n.Concept.description.4b3eb94f-4258-4760-b977-ce66972ff95d="Laboratory measurement of the glucose level in the blood in mg/ml"
ui.i18n.Concept.description.a94f80a7-177c-4936-b23b-3a503dc425fa="Liver function test, which usually is used to detect liver injury."
ui.i18n.Concept.description.6df93b8b-c88b-46c2-a210-54b68ab62fd6="Liver function test, which usually is used to detect liver injury."
ui.i18n.Concept.description.4c9db1a7-4797-4829-bafa-13e815a0603c="A crystalline antibacterial compound (C6H7N3O) used in the treatment of tuberculosis."
ui.i18n.Concept.description.ff0231db-25a8-49eb-923e-977d838119f5="Semisynthetic antibiotic often used in tuberculosis, leprosy and meningococcal treatment/prophylaxis.  Also commonly known as Rifampin."
ui.i18n.Concept.description.c5142213-8e6a-4179-9872-75dca2276598="Anti-mycobaterial drug used to treat active tuberculosis. Always used with other antimycobacterial agents."
ui.i18n.Concept.description.d5518289-8764-4f56-bd8b-f1eeb28605c3="Antituberculosis agent used to treat patients with active tuberculosis, usually in combination with other agents."
ui.i18n.Concept.description.66a74f7a-a129-4632-8d0b-71bffa0490cd="Injectable aminoglycoside used in drug-resistant TB treatment. Inhibits protein synthesis through disruption of ribosomal function. (Short name from WHO)"
ui.i18n.Concept.description.4b3ef1d7-6aa4-45e3-8e47-871a116cdf93="Aminoglycoside used in drug-resistant TB treatment. (Short name from WHO)"
ui.i18n.Concept.description.da4bb82a-3d5c-4448-82d3-0f081e844cea="Isonicotinic acid derivative used in drug-resistant TB treatment. (Short name Pto from WHO)"
ui.i18n.Concept.description.59f005d5-36d2-4863-910a-3ed1126a31c3="Isonicotinic acid derivative used in drug-resistant TB treatment. (Short name from WHO)"
ui.i18n.Concept.description.3daab8a2-29ec-44f5-9756-cf20326ff5a7="D-Alanine analog used in drug-resistant TB treatment. (Short name from WHO)"
ui.i18n.Concept.description.724b18aa-2f22-408c-a611-7f359910788f="Terizidone is a combination of two cycloserine molecules. It is an anti-tuberculous drug used in treating multidrug-resistant TB. TERIZIDONE is considered effective in the treatment of TB and may also be useful for the treatment of urinary tract infections including those due to TB. It is recommended for the treatment of MDR-TB patients in both the intensive and continuation phases. Oral bacteriostatic second-line TB med."
ui.i18n.Concept.description.7c1c612d-a1dd-4dc2-a05d-1dab41aa247b="Anti-folate used in drug-resistant TB treatment. (Short name from WHO)"
ui.i18n.Concept.description.ec45f450-ec2a-4e70-b309-28a9d6880a58="Phenazine derivative used in drug-resistant TB treatment. (Short name from WHO)"
ui.i18n.Concept.description.0ca66e59-40f9-445d-a37b-940c22e62463="A preparation of amoxicillin and the potassium salt of clavulanic acid to overcome beta-lactam resistance."
ui.i18n.Concept.description.b2764996-336c-4b76-80f0-654a3d194b5a="A thiosaemicarbazone that is used in association with other antimycobacterial agents in the initial and continuation phases of antituberculosis regimens"
ui.i18n.Concept.description.9c789a50-1df5-4cfe-ace8-f9bd96e6bf5d="a drug in a group of NNRTI"
ui.i18n.Concept.description.310070c5-230e-4971-803e-d9a0270148bb="Protease inhibitor"
ui.i18n.Concept.description.e5eee9d4-df9e-4ed6-b285-38f3d7ec332b="Retroviral drug which acts as protease inhibitor"
ui.i18n.Concept.description.a09f6397-0716-4ac0-92fb-16c523319ee4="Combination of two medications in a category of HIV antriretrovirals called protease inhibitors. Lopinavir and ritonavir prevent HIV from multiplying."
ui.i18n.Concept.description.e0e32251-8ad8-43a1-a7b2-ac1bd8bcf651="Integrase inhibitor drug"
ui.i18n.Concept.description.3199e0fa-aae2-498a-ae0b-5ffcb6fb97d0="A basic polypeptide antibiotic (trade name Viocin) administered intramuscularly (along with other drugs) in the treatment of tuberculosis"
ui.i18n.Concept.description.c81e732f-a04f-4833-9a5e-6a26ad167ca6="Fluoroquinolone used in drug-resistant TB treatment. (Short name from WHO)"
ui.i18n.Concept.description.bab26542-6ee4-433f-a3d0-2e9e92f4df59="Reinforcement TB med with unclear efficacy. Rifabutin is a bactericidal antibiotic drug primarily used in the treatment of tuberculosis."
ui.i18n.Concept.description.440ecb2f-5c03-4d66-9388-113b5c7a56ef="The iron-containing respiratory pigment in red blood cells of vertebrates, consisting of about 6 percent heme and 94 percent globin."
ui.i18n.Concept.description.acfc56e4-0396-466a-be84-587b55b6c56b="Percent of whole blood that is composed of red blood cells."
ui.i18n.Concept.description.8b279abb-3e5a-4373-9d21-6c8d9c8807a9="Bilirubin level assay from blood"
ui.i18n.Concept.description.25f134ba-f78d-427c-90d7-b46c34d9550c="Laboratory test for measuring albumin levels in serum."
ui.i18n.Concept.description.73900aa0-ee8f-4609-8c63-0b26d45bde9f="<b>Cured:</b> Treatment completed as recommended by the national policy without evidence of failure AND 3 three or more consecutive cultures take at least 30 days apart are negative after the intensive phase.<br/>
<b>Completed:</b> Treatment completed as recommended by the national policy without evidence of failure BUT no record that three or more consecutive cultures taken at least 30 days apart are negative after the intensive phase."
ui.i18n.Concept.description.bea35d20-7208-478c-a211-728451bdd8ee="Date that AE began (could be before the AE open/report date)"
ui.i18n.Concept.description.df5a13a6-1335-40ac-bafe-6001b9c5e4d4="DMID/CTCAE standardized list for endTB"
ui.i18n.Concept.description.91e252c9-18e5-42e0-8bcd-471e6b4e6422="Date that AE began (could be before the AE open/report date)"
ui.i18n.Concept.description.c61955a0-0d02-46fa-b028-6cabb4c9dbd7="The following section is to be filled out when the SAE is closed"
ui.i18n.Concept.description.409531e1-5dc3-452d-a27a-7473c75ccf46="Within the last year"
ui.i18n.Concept.description.c9cae995-4a64-4a35-b55d-10268801e59b="Current employment status"
ui.i18n.Concept.description.a6367ee4-59df-44f1-8216-3c2e4cb2f4bf="Ever been in prison?"
ui.i18n.Concept.description.7bb9d182-563a-4d80-8bd8-e209710e0274="Does patient drink alcohol?"
ui.i18n.Concept.description.20eb9d9a-8908-4664-a88d-a2223285b806="Refer to completion guidelines for the definition of a standard drink"
ui.i18n.Concept.description.224de581-c26f-4f34-bd0a-beff15d54d8b="Does patient smoke at least 1 cigarette per day?"
ui.i18n.Concept.description.3cdca3a6-ed6b-4474-a111-130c2c92d2ed="Has patient use IV drugs in the past 1 year"
ui.i18n.Concept.description.c2b84bb5-38f5-421b-a177-711191011cdd="Has patient used non prescribed non-IV drugs in the past 1 year"
ui.i18n.Concept.description.38cb0f31-3e9f-4c8e-b0c3-7253b45e4ba8="Group 1: Ethambutol, Isoniazid, Pyrazinamide, Rifampicin/Rifampin, Rifabutin, Rifapentine 
Group 2 : Amikacin, Capreomycin, Kanamycin, Streptomycin
Group 3 : Ciprofloxacin, Gatifloxacin, Levofloxacin, Moxifloxacin, Ofloxacin
Group 4 : Cycloserine, Ethionamide, Para-aminosalicylic acid, Para-aminosalicylic sodium, Prothionamide, Terizidone
Group 5 : Amoxicillin/Clavulanate, Bedaquiline, Clarithromycin, Clofazimine, Delamanid, Imipenem/cilastatin, Linezolid, Meropenem,Thioacetazone"
ui.i18n.Concept.description.cf0b1bd1-26de-46f1-b730-9631dca18765="Brief peripheral neuropathy screen: LEFT</br>
a. Pain, aching, or burning in feet, legs"
ui.i18n.Concept.description.2b1cb119-6d77-43f4-aef4-e78a0ab2bc6f="Brief peripheral neuropathy screen: RIGHT</br>
a. Pain, aching, or burning in feet, legs"
ui.i18n.Concept.description.4704e706-e8d6-4f41-bd66-8acdd89ddceb="Brief peripheral neuropathy screen: LEFT </br>
b. ""Pins and needles"" in feet, legs"
ui.i18n.Concept.description.a3969ad1-2cac-45a1-a369-5b170ee072cc="Brief peripheral neuropathy screen: RIGHT</br>
b. ""Pins and needles"" in feet, legs"
ui.i18n.Concept.description.662aa8a9-64d9-4b1b-a669-1050561253ce="Brief peripheral neuropathy screen: LEFT</br>
c. Numbness (lack of feeling) in feet, legs"
ui.i18n.Concept.description.5d7b66d4-1aa6-4970-8a7d-dd1eea6bab4c="Brief peripheral neuropathy screen: RIGHT</br>
c. Numbness (lack of feeling) in feet, legs"
ui.i18n.Concept.description.ae020459-89ad-442f-b484-eddb2e5f9cb6="Brief peripheral neuropathy screen: vibration perception LEFT"
ui.i18n.Concept.description.0ffdd96e-0231-43b9-9cb3-a70b12bb3eb3="Brief peripheral neuropathy screen: vibration perception RIGHT"
ui.i18n.Concept.description.a35baeb4-bd74-46bf-8220-21182a4e5fd7="Brief peripheral neuropathy screen: ankle reflexes LEFT"
ui.i18n.Concept.description.baf0621d-b3f5-4b1f-914d-a8f4d37343ab="Brief peripheral neuropathy screen: ankle reflexes RIGHT"
ui.i18n.Concept.description.1ea59b72-4818-4337-b262-21e9211aa8d3="VA=Visual acuity"
ui.i18n.Concept.description.bd114112-4c5d-4aba-b1d9-48298bcd3f47="VA=Visual acuity"
ui.i18n.Concept.description.0841cac7-4e52-4186-b0ce-ee509fbc175c="1= Smear positive, 2=Xpert MTB/RIF positive for M. tuberculosis, 3=Hain test positive for M. tuberculosis, 4=Culture (solid or MGIT) positive for M. tuberculosis, 5=Other"
ui.i18n.Concept.description.66b23c2f-b654-4bfe-8610-8b25b7593efc="Is the patient eligible for treatment with new drugs (according to WHO indications)?"
ui.i18n.Concept.description.f05cd7ed-1cf6-4c50-97eb-dcff4a7921af="If Yes, Date that patient was determined to be eligible for new drugs"
ui.i18n.Concept.description.ef13db29-f446-43f5-b629-d2ccbcc85300="1= XDR (resistance to a fluoroquinolone and at least one injectable)</br>
2= Pre-XDR - fluoroquinolone (resistance to a fluoroquinolone, but susceptible to second-line injectables)</br>
3= Pre-XDR - injectable (resistance to at least one second-line injectable, but susceptible to a fluoroquinolone)</br>
4= Other patterns of resistance that are not XDR or pre-XDR (two or more Group 4 drugs)</br>
5= Contact with a patient infected with a strain with one of the above resistance patterns</br>
6= Unable to tolerate MDR drugs necessary for construction of the regimen</br>
7= Patients who have ""failed"" an MDR regimen"
ui.i18n.Concept.description.18bdf522-d9be-4802-a095-978099b94bad="Date outcome was decided"
ui.i18n.Concept.description.0d2e9e7d-4dc0-4b88-b0d8-9c0332222eaf="Patient for whom no treatment outcome is assigned (this includes cases transferred out to another treatment unit and whose treatment outcome is unknown)"
ui.i18n.Concept.description.140cfa0e-0d24-4140-8f35-9eac15576b1c="Patient for whom no treatment outcome is assigned (this includes cases transferred out to another treatment unit and whose treatment outcome is unknown)"
ui.i18n.Concept.description.8f2bf583-7d78-4a5f-8f10-87135c4af854="Does patient have an ongoing AE that does not have a final outcome? (check AE log)"
ui.i18n.Concept.description.e71cb0fc-c9b8-471b-8030-eb4be22db557="Has there been a change in the TB regimen, including dosage adjustment, stopping a medication, or adding a new medication?"
ui.i18n.Concept.description.8ca3529d-fb1c-40a1-915c-dad490206b47="Does patient have an ONGOING ADVERSE EVENT without outcome (check the ""Adverse Events Log"")?"
ui.i18n.Concept.description.cac9c021-afb4-4ee6-aeb9-a63fb64d6ecc="If yes, ""check AE log"""
ui.i18n.Concept.description.bedcb0e3-738b-4777-9e3d-19ecabf684ae="If yes, ""check AE log"""
ui.i18n.Concept.description.dda4ed73-4c56-4a12-9453-ef44a62a3c30="Total number of treatment days in the month (depends on whether treatment is given 6 or 7 days per week and when the treatment was started)"
ui.i18n.Concept.description.7ac79bf0-d135-411f-b28b-d0c23e823a7b="Number of days where treatment was not prescribed by the clinician during this month (Sunday should not be counted if day off treatment)"
ui.i18n.Concept.description.e13b3eaa-2af1-4614-ac13-65f33b886143="Number of days patient did not take any of the prescribed treatment- All TB drugs are missing"
ui.i18n.Concept.description.a1b9d8d1-ad39-450a-af2b-ceab1800ac7e="Number of days patient did not take all prescribed TB drugs- Some TB drugs are missing but not all"
ui.i18n.Concept.description.f3602a21-b9ac-42d5-a9c7-d8c3376a5a96="""Brief peripheral neuropathy screen: LEFT
a. Pain, aching, or burning in feet, legs"""
ui.i18n.Concept.description.02c30684-9cef-4fe0-b21f-d3ed803ef760="""Brief peripheral neuropathy screen: LEFT
b. """"Pins and needles"""" in feet, legs"""
ui.i18n.Concept.description.e8ad6f9b-1979-466d-b9e8-50f5c0a15fc6="""Brief peripheral neuropathy screen: LEFT
c. Numbness (lack of feeling) in feet, legs"""
ui.i18n.Concept.description.9acc0165-29bf-4d5e-9687-397cd467b5d8="Brief peripheral neuropathy screen: vibration perception LEFT"
ui.i18n.Concept.description.7b99a7dd-219d-4fce-b758-987c1b2807e7="Brief peripheral neuropathy screen: ankle reflexes LEFT"
ui.i18n.Concept.description.da5b9778-79c9-4ce1-a489-852c278a37a2="""Brief peripheral neuropathy screen: RIGHT
a. Pain, aching, or burning in feet, legs"""
ui.i18n.Concept.description.f8ea0d87-816e-4d6e-b5c3-97e3124366c1="Brief peripheral neuropathy screen: RIGHT
b. ""Pins and needles"" in feet, legs"
ui.i18n.Concept.description.c81df150-f302-4fdd-8803-552076a452cd="Brief peripheral neuropathy screen: RIGHT
c. Numbness (lack of feeling) in feet, legs"
ui.i18n.Concept.description.a489fe19-2bd3-41fa-8b45-420130bfa7ac="Brief peripheral neuropathy screen: vibration perception RIGHT"
ui.i18n.Concept.description.fc8e1704-ff7f-4a94-a21c-b2b0445bef09="Brief peripheral neuropathy screen: ankle reflexes RIGHT"
ui.i18n.Concept.description.a0c9ec39-b6f0-4d42-b5bc-d74fd561274d="Did the patient start treatment?"
ui.i18n.Concept.description.3171d452-b579-4051-8e31-4d6db7e35216="""Not read"" includes samples with insufficient sample, saliva or other"
ui.i18n.Concept.description.f9392907-1228-4f06-9c43-48c4c3dedad9="enter name and concentration of drug"
ui.i18n.Concept.description.6109b101-60e9-43df-9a06-1d511f8acaa6="Ever been a health worker?"
ui.i18n.Concept.description.b7e163d8-71ec-4e67-9a47-777ef6ff86b6="""8=Extensive or advanced disease
9=Drug intolerance or contraindication, patients with low body mass index (BMI), HIV, diabetes
10=Patients coming from catchment areas that have poor MDR-TB treatment outcomes despite good programmatic conditions (e.g. sites with extensive second-line drug resistance background)"""
ui.i18n.Concept.description.8fd95384-08da-40e6-b070-1a44e3588418="If yes, ""check AE log"""
ui.i18n.Concept.description.ea75cb86-ecf8-4180-83d3-7817304b7f69="If yes, ""check AE log"""
ui.i18n.Concept.description.26a47d40-6ca0-4e97-bdbe-5a2121390c70="Date 6 month post treatment outcome was decided"
ui.i18n.Concept.description.cd4e70c3-fc02-4da6-9c20-8b7161d6f1e1=Tunit
ui.i18n.Concept.description.8423fa1a-55dd-463d-bf29-0cfdf29141ee="0=Fully active, able to carry on all pre-disease performance without restriction <br> 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature, i.e., light housework, office work <br> 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours <br>
3=Capable of only limited self-care, confined to bed or chair more than 50% of waking hours <br> 4=Completely disabled. Cannot carry out any self-care. Totally confined to bed or chair"""
ui.i18n.Concept.description.4c7076c1-a401-4946-be06-3dcc9e81855d="If date is not known exactly then use the first day of the month ( if month unknown then use July)"
ui.i18n.Concept.description.08a6e17d-2dc3-460f-8114-16f0513ec4a4="ONLY enter results documented in the medical record, if there is no record then enter unknown and repeat the test"
ui.i18n.Concept.description.9124cfc1-9403-4b22-adc9-160dbd0d6804="If date is not known exactly then use the first day of the month ( if month unknown then use July)"
ui.i18n.Concept.description.1936c908-71f8-4b74-a0e6-f4f123829a00="(a – (b+c+d)) / a"
ui.i18n.Concept.description.735d00c5-0bf3-480f-9185-65a493345bc5="(a - (b+c+d)) / (a-b)"
ui.i18n.Concept.description.eb0b67d9-6c26-4d11-8ae2-e1abc11e327e="ONLY enter results documented in the medical record, if there is no record then enter unknown and repeat the test."
ui.i18n.Concept.description.25ef0086-e97b-4875-8f0b-39cf1e6ec3eb="ONLY enter results documented in the medical record, if there is no record then enter unknown and repeat the test."
ui.i18n.Concept.description.fac80457-276d-460b-8954-d9c55feb0e6f="If date is not known exactly then use the first day of the month ( if month unknown then use July)"
ui.i18n.Concept.description.d00e4584-9509-41aa-b88e-0eb57633a733="If date is not known exactly then use the first day of the month ( if month unknown then use July)"
ui.i18n.Concept.description.8673c34b-1ccb-4450-84ce-b1ed1b5eec16="ONLY enter results documented in the medical record, if there is no record then enter unknown and repeat the test."
ui.i18n.Concept.description.22e0b4d9-dd77-4413-b024-f16e490f3ade="ONLY enter results documented in the medical record, if there is no record then enter unknown and repeat the test."
ui.i18n.Concept.description.f4e77376-eec2-416d-a698-8e137bcfe342="help note to be defined but will be something like  ""normal range for adult male range"""
ui.i18n.Concept.description.c1f869f2-ddd6-4054-83c4-2ffac7856bfa="observed days / prescribed days x 100"
ui.i18n.Concept.description.13f6307c-5c75-4e86-baf0-1d325fbfc3cd="Is the patient  or partner pregnant at the time of starting treatment?"
ui.i18n.Concept.description.e1a2cb83-d471-416a-a715-5ca0a00bc209="Is the patient or partner breastfeeding at the time of starting treatment?"
ui.i18n.Concept.description.e541b6ea-15ec-4588-b678-117288f04978="1=Lack of conversion, 2=Bacteriological reversion after conversion to negative, 3=Evidence of additional acquired resistance to fluoroquinolones or second-line injectable drugs, 4=Adverse drug reactions, 5=Other"
ui.i18n.Concept.description.32a463bf-ffef-4177-9e3c-6ca3b8640224="1=Patient refused followup, 2=Substance abuse, 3=Social problem: family, financial, complex social situation, 4=Left region, country, 5=Adverse events, 6=No confidence in treatment, 7=Other, 8=Unknown, 99 not entered"
ui.i18n.Concept.description.144cc94f-daad-4c96-b806-dfe7d85c60c2="during followup as compared to original"
ui.i18n.Concept.description.f3ff839f-07ef-4291-9908-c9d79df9008d="1. death 2= Life threatening 3= Hospitalisation required or prolonged 4= Persistant or significant disability/incapacity 4=congenital abnormality 5=otherwise medically important"
ui.i18n.Concept.description.0930deb7-2db0-4b71-9d97-09a746866c00="The following section is to be filled out when the AE is closed"
ui.i18n.Concept.description.d83aff4a-3ca4-439b-bcba-8e586a79832d="DMID/CTCSAE standardized list for endTB"
ui.i18n.Concept.description.23bbd3a8-f2f0-454f-ab93-c065c4f4dccb="Is the patient (if female) or the patient's (if male) partner currently pregnant?"
ui.i18n.Concept.description.89fb323c-3a91-11e5-b380-0050568236ae=EVERY DAY
ui.i18n.Concept.description.89fc05c3-3a91-11e5-b380-0050568236ae=TWICE A DAY
ui.i18n.Concept.description.8a0b784c-3a91-11e5-b380-0050568236ae=THREE A DAY
ui.i18n.Concept.description.8a0c7489-3a91-11e5-b380-0050568236ae=FOUR A DAY
ui.i18n.Concept.description.8a168b90-3a91-11e5-b380-0050568236ae=BEFORE A MEAL
ui.i18n.Concept.description.8a176bde-3a91-11e5-b380-0050568236ae=AFTER A MEAL
ui.i18n.Concept.description.8a1e375d-3a91-11e5-b380-0050568236ae=AT BEDTIME
ui.i18n.Concept.description.8a32fec2-3a91-11e5-b380-0050568236ae=Consultation Note
ui.i18n.Concept.description.9571becb-c91c-432d-8c51-5f143b60d2ba=Cannabis</br>Cocaine</br>Prescription stimulants without a prescription</br>Methamphetamine</br>Inhalants</br>Sedatives</br>Hallucinogens</br>Street opioids
ui.i18n.Concept.description.ad448c54-cb35-478d-a35e-b915193e5770=Not employed within past 1 year
ui.i18n.Concept.description.1fb34b74-49c1-4364-bca9-49499dc1cfef=If abnormal= fillout the baseline section of Adverse Events Log
ui.i18n.Concept.description.f1d9c32f-be5b-44e5-9c0f-009929703b6d=1-11 in the book of 14 plates
ui.i18n.Concept.description.57e19920-7445-401b-b2a6-364d6781b3d6=Date of first result indicateing MDR: could be micro/molucular test or clinical diagnosis of MDR-TB
ui.i18n.Concept.description.5d224be5-9130-4258-a552-cc8f12a2c2f1=If abnormal= fillout the baseline section of Adverse Events Log
ui.i18n.Concept.description.7c867cf8-e66c-4356-a92c-22099bdadb0f=If abnormal= fillout the baseline section of Adverse Events Log
ui.i18n.Concept.description.d3c4be03-7ea3-4184-af5f-7b2b3e4a14e6=1-11 in the book of 14 plates
ui.i18n.Concept.description.744ec780-c315-4196-974a-2ae86d5377d2=<b>Instructions:</b> This log is a list of all the medications that the patient is currently taking. Record all medication changes on a new line. Record the date that any medication is  stopped or has a change in dose.
ui.i18n.Concept.description.8a8797f5-3bfb-45c5-b81c-089efa54539e=RR = (60/HR)
ui.i18n.Concept.description.641ed23f-357e-46ba-bd06-ea2b8eb08c10=<b>Planned change </b>includes for example BDQ dose change= end of injectable= end of treatment <br/><b>Adverse event</b> includes changes due to contraindicatins as all drug changes will be adverse events
ui.i18n.Concept.description.623ff678-a655-4528-99d4-3d45f3f2e41f=In the past 30 days= was there ever no food to eat of any kind in your house because of lack of resources to get food?
ui.i18n.Concept.description.ae866b6e-f99e-4510-82f5-4b8d80870a6e=In the past 30 days= did you or any household member go to sleep at night hungry because there was not enough food?
ui.i18n.Concept.description.4205ed43-acfd-40b0-88d1-99215910bd25=In the past 30 days= did you or any household member go a whole day and night without eating anything at all because there was not enough food?
ui.i18n.Concept.description.b718204f-161d-45ee-a570-e81dc22ebb06=For each previous treatment list the following information
ui.i18n.Concept.description.9cf1b1df-193d-499c-8737-47ece5048ce5=1=Patient refused followup= 2=Substance abuse= 3=Social problem: family= financial= complex social situation= 4=Left region= country= 5=Adverse events= 6=No confidence in treatment= 7=Other= 8=Unknown= 99 not entered
ui.i18n.Concept.description.0bc71027-99fc-40e5-8ab4-2d66f7b5e0bf=<b>Relapse:</b> patient previously cured or treatment completed who is rediagnosed with TB (defintion to define if this includes patient who are re-diagnosed with a different resistant strain- ie re-infection)
ui.i18n.Concept.description.90076c7c-fa3c-48c1-9d9e-35396be93202=Body Mass Index (BMI) is a relationship between weight and height that is associated with body fat and health risk. The equation is BMI = body weight in kilograms/height in meters squared. 
ui.i18n.Concept.description.22c7d3a1-6dba-4c00-b807-6c1301dc36b8=Question on encounter form: Is the child currently being breastfed?
ui.i18n.Concept.description.b5efa248-a4f0-49ca-aaec-6e5deeb0b5d0=Type of MDR-TB.
ui.i18n.Concept.description.1119f9db-5342-487a-8454-37e08fbef959=Type of MDR-TB.
ui.i18n.Concept.description.19d58f0b-51e5-43fb-9f12-e84420283661=Classification of MDR-TB without prior treatment or with less than one month of anti-tubercular drugs
ui.i18n.Concept.description.b0161932-b130-48fa-806c-f08e51c885d5=Classification of MDR-TB according to previous drug use. A WHO-defined set of categorizations of new MDR-TB patients.
ui.i18n.Concept.description.24406355-5523-4985-98b4-4ef7ea20563c=Encounter form question.  Date in which tuberculosis treatment was started.
ui.i18n.Concept.description.b295ee59-e74e-4dd7-b500-4736a9fcee5d=The last day the patient received treatment
ui.i18n.Concept.description.df282e33-b190-44b7-a259-9cad8b752c71=Minute= nonnucleated= disklike cytoplasmic bodies found in the blood plasma of mammals= derived from a megakaryocyte and function to promote blood clotting.
ui.i18n.Concept.description.0985fb55-4b96-49ae-9933-edfaffe31dfd=Blood test to measure the number of red blood cells.
ui.i18n.Concept.description.6793db3d-0a88-4d6f-92a5-b1702819b186=Blood test to measure the number of white blood cells.
ui.i18n.Concept.description.16a980a1-2aba-4c6f-90ae-e122c13360fe=Absolute neutrophil count (ANC) is a measure of the number of neutrophil granulocytes (also known as polymorphonuclear cells= PMN's= polys= granulocytes= segmented neutrophils or segs) present in the blood. Neutrophils are a type of white blood cell that fights against infection.ANC = (%neutrophils + %bands) x WBC
ui.i18n.Concept.description.e6ae49ef-46c7-4ed6-b67b-e8511bbca2c4=Test to find= count and examine Neutrophils the type of white blood cell which form an early line of defence against bacterial infections by using microscopic exam
ui.i18n.Concept.description.3241d901-2ef2-4bb2-8fa2-a9aca2c6a95f=Laboratory test that determines a blood serum potassium level.
ui.i18n.Concept.description.95ca4c95-8900-4a1b-864d-8957f74b8cc7=Measure of urea levels in the blood often used to assess kidney status.
ui.i18n.Concept.description.c50ae3bf-6457-4521-8c26-ec787fee5d42=Laboratory test that determines a blood serum creatinine level.  Often used with BUN to assess kidney function.
ui.i18n.Concept.description.4b3eb94f-4258-4760-b977-ce66972ff95d=Laboratory measurement of the glucose level in the blood in mg/ml
ui.i18n.Concept.description.a94f80a7-177c-4936-b23b-3a503dc425fa=Liver function test= which usually is used to detect liver injury.
ui.i18n.Concept.description.6df93b8b-c88b-46c2-a210-54b68ab62fd6=Liver function test= which usually is used to detect liver injury.
ui.i18n.Concept.description.4c9db1a7-4797-4829-bafa-13e815a0603c=A crystalline antibacterial compound (C6H7N3O) used in the treatment of tuberculosis.
ui.i18n.Concept.description.ff0231db-25a8-49eb-923e-977d838119f5=Semisynthetic antibiotic often used in tuberculosis= leprosy and meningococcal treatment/prophylaxis.  Also commonly known as Rifampin.
ui.i18n.Concept.description.c5142213-8e6a-4179-9872-75dca2276598=Anti-mycobaterial drug used to treat active tuberculosis. Always used with other antimycobacterial agents.
ui.i18n.Concept.description.d5518289-8764-4f56-bd8b-f1eeb28605c3=Antituberculosis agent used to treat patients with active tuberculosis= usually in combination with other agents.
ui.i18n.Concept.description.66a74f7a-a129-4632-8d0b-71bffa0490cd=Injectable aminoglycoside used in drug-resistant TB treatment. Inhibits protein synthesis through disruption of ribosomal function. (Short name from WHO)
ui.i18n.Concept.description.4b3ef1d7-6aa4-45e3-8e47-871a116cdf93=Aminoglycoside used in drug-resistant TB treatment. (Short name from WHO)
ui.i18n.Concept.description.da4bb82a-3d5c-4448-82d3-0f081e844cea=Isonicotinic acid derivative used in drug-resistant TB treatment. (Short name Pto from WHO)
ui.i18n.Concept.description.59f005d5-36d2-4863-910a-3ed1126a31c3=Isonicotinic acid derivative used in drug-resistant TB treatment. (Short name from WHO)
ui.i18n.Concept.description.3daab8a2-29ec-44f5-9756-cf20326ff5a7=D-Alanine analog used in drug-resistant TB treatment. (Short name from WHO)
ui.i18n.Concept.description.724b18aa-2f22-408c-a611-7f359910788f=Terizidone is a combination of two cycloserine molecules. It is an anti-tuberculous drug used in treating multidrug-resistant TB. TERIZIDONE is considered effective in the treatment of TB and may also be useful for the treatment of urinary tract infections including those due to TB. It is recommended for the treatment of MDR-TB patients in both the intensive and continuation phases. Oral bacteriostatic second-line TB med.
ui.i18n.Concept.description.7c1c612d-a1dd-4dc2-a05d-1dab41aa247b=Anti-folate used in drug-resistant TB treatment. (Short name from WHO)
ui.i18n.Concept.description.ec45f450-ec2a-4e70-b309-28a9d6880a58=Phenazine derivative used in drug-resistant TB treatment. (Short name from WHO)
ui.i18n.Concept.description.0ca66e59-40f9-445d-a37b-940c22e62463=A preparation of amoxicillin and the potassium salt of clavulanic acid to overcome beta-lactam resistance.
ui.i18n.Concept.description.b2764996-336c-4b76-80f0-654a3d194b5a=A thiosaemicarbazone that is used in association with other antimycobacterial agents in the initial and continuation phases of antituberculosis regimens
ui.i18n.Concept.description.9c789a50-1df5-4cfe-ace8-f9bd96e6bf5d=a drug in a group of NNRTI
ui.i18n.Concept.description.310070c5-230e-4971-803e-d9a0270148bb=Protease inhibitor
ui.i18n.Concept.description.e5eee9d4-df9e-4ed6-b285-38f3d7ec332b=Retroviral drug which acts as protease inhibitor
ui.i18n.Concept.description.a09f6397-0716-4ac0-92fb-16c523319ee4=Combination of two medications in a category of HIV antriretrovirals called protease inhibitors. Lopinavir and ritonavir prevent HIV from multiplying.
ui.i18n.Concept.description.e0e32251-8ad8-43a1-a7b2-ac1bd8bcf651=Integrase inhibitor drug
ui.i18n.Concept.description.3199e0fa-aae2-498a-ae0b-5ffcb6fb97d0=A basic polypeptide antibiotic (trade name Viocin) administered intramuscularly (along with other drugs) in the treatment of tuberculosis
ui.i18n.Concept.description.c81e732f-a04f-4833-9a5e-6a26ad167ca6=Fluoroquinolone used in drug-resistant TB treatment. (Short name from WHO)
ui.i18n.Concept.description.bab26542-6ee4-433f-a3d0-2e9e92f4df59=Reinforcement TB med with unclear efficacy. Rifabutin is a bactericidal antibiotic drug primarily used in the treatment of tuberculosis.
ui.i18n.Concept.description.440ecb2f-5c03-4d66-9388-113b5c7a56ef=The iron-containing respiratory pigment in red blood cells of vertebrates= consisting of about 6 percent heme and 94 percent globin.
ui.i18n.Concept.description.acfc56e4-0396-466a-be84-587b55b6c56b=Percent of whole blood that is composed of red blood cells.
ui.i18n.Concept.description.8b279abb-3e5a-4373-9d21-6c8d9c8807a9=Bilirubin level assay from blood
ui.i18n.Concept.description.25f134ba-f78d-427c-90d7-b46c34d9550c=Laboratory test for measuring albumin levels in serum.
ui.i18n.Concept.description.73900aa0-ee8f-4609-8c63-0b26d45bde9f=<b>Cured:</b> Treatment completed as recommended by the national policy without evidence of failure AND 3 three or more consecutive cultures take at least 30 days apart are negative after the intensive phase.<br/>
<b>Completed:</b> Treatment completed as recommended by the national policy without evidence of failure BUT no record that three or more consecutive cultures taken at least 30 days apart are negative after the intensive phase.
ui.i18n.Concept.description.bea35d20-7208-478c-a211-728451bdd8ee=Date that AE began (could be before the AE open/report date)
ui.i18n.Concept.description.df5a13a6-1335-40ac-bafe-6001b9c5e4d4=DMID/CTCAE standardized list for endTB
ui.i18n.Concept.description.91e252c9-18e5-42e0-8bcd-471e6b4e6422=Date that AE began (could be before the AE open/report date)
ui.i18n.Concept.description.c61955a0-0d02-46fa-b028-6cabb4c9dbd7=The following section is to be filled out when the SAE is closed
ui.i18n.Concept.description.409531e1-5dc3-452d-a27a-7473c75ccf46=Within the last year
ui.i18n.Concept.description.c9cae995-4a64-4a35-b55d-10268801e59b=Current employment status
ui.i18n.Concept.description.a6367ee4-59df-44f1-8216-3c2e4cb2f4bf=Ever been in prison?
ui.i18n.Concept.description.7bb9d182-563a-4d80-8bd8-e209710e0274=Does patient drink alcohol?
ui.i18n.Concept.description.20eb9d9a-8908-4664-a88d-a2223285b806=Refer to completion guidelines for the definition of a standard drink
ui.i18n.Concept.description.224de581-c26f-4f34-bd0a-beff15d54d8b=Does patient smoke at least 1 cigarette per day?
ui.i18n.Concept.description.3cdca3a6-ed6b-4474-a111-130c2c92d2ed=Has patient use IV drugs in the past 1 year
ui.i18n.Concept.description.c2b84bb5-38f5-421b-a177-711191011cdd=Has patient used non prescribed non-IV drugs in the past 1 year
ui.i18n.Concept.description.38cb0f31-3e9f-4c8e-b0c3-7253b45e4ba8=Group 1: Ethambutol= Isoniazid= Pyrazinamide= Rifampicin/Rifampin= Rifabutin= Rifapentine Group 2 : Amikacin= Capreomycin= Kanamycin= Streptomycin Group 3 : Ciprofloxacin= Gatifloxacin= Levofloxacin= Moxifloxacin= Ofloxacin Group 4 : Cycloserine= Ethionamide= Para-aminosalicylic acid= Para-aminosalicylic sodium= Prothionamide= Terizidone Group 5 : Amoxicillin/Clavulanate= Bedaquiline= Clarithromycin= Clofazimine= Delamanid= Imipenem/cilastatin= Linezolid= Meropenem=Thioacetazone
ui.i18n.Concept.description.cf0b1bd1-26de-46f1-b730-9631dca18765=Brief peripheral neuropathy screen: LEFT</br>a. Pain= aching= or burning in feet= legs
ui.i18n.Concept.description.2b1cb119-6d77-43f4-aef4-e78a0ab2bc6f=Brief peripheral neuropathy screen: RIGHT</br>a. Pain= aching= or burning in feet= legs
ui.i18n.Concept.description.4704e706-e8d6-4f41-bd66-8acdd89ddceb=Brief peripheral neuropathy screen: LEFT </br>b. Pins and needles in feet= legs
ui.i18n.Concept.description.a3969ad1-2cac-45a1-a369-5b170ee072cc=Brief peripheral neuropathy screen: RIGHT</br>b. Pins and needles in feet= legs
ui.i18n.Concept.description.662aa8a9-64d9-4b1b-a669-1050561253ce=Brief peripheral neuropathy screen: LEFT</br>c. Numbness (lack of feeling) in feet= legs
ui.i18n.Concept.description.5d7b66d4-1aa6-4970-8a7d-dd1eea6bab4c=Brief peripheral neuropathy screen: RIGHT</br>c. Numbness (lack of feeling) in feet= legs
ui.i18n.Concept.description.ae020459-89ad-442f-b484-eddb2e5f9cb6=Brief peripheral neuropathy screen: vibration perception LEFT
ui.i18n.Concept.description.0ffdd96e-0231-43b9-9cb3-a70b12bb3eb3=Brief peripheral neuropathy screen: vibration perception RIGHT
ui.i18n.Concept.description.a35baeb4-bd74-46bf-8220-21182a4e5fd7=Brief peripheral neuropathy screen: ankle reflexes LEFT
ui.i18n.Concept.description.baf0621d-b3f5-4b1f-914d-a8f4d37343ab=Brief peripheral neuropathy screen: ankle reflexes RIGHT
ui.i18n.Concept.description.1ea59b72-4818-4337-b262-21e9211aa8d3=VA=Visual acuity
ui.i18n.Concept.description.bd114112-4c5d-4aba-b1d9-48298bcd3f47=VA=Visual acuity
ui.i18n.Concept.description.0841cac7-4e52-4186-b0ce-ee509fbc175c=1= Smear positive= 2=Xpert MTB/RIF positive for M. tuberculosis= 3=Hain test positive for M. tuberculosis= 4=Culture (solid or MGIT) positive for M. tuberculosis= 5=Other
ui.i18n.Concept.description.66b23c2f-b654-4bfe-8610-8b25b7593efc=Is the patient eligible for treatment with new drugs (according to WHO indications)?
ui.i18n.Concept.description.f05cd7ed-1cf6-4c50-97eb-dcff4a7921af=If Yes= Date that patient was determined to be eligible for new drugs
ui.i18n.Concept.description.ef13db29-f446-43f5-b629-d2ccbcc85300=1= XDR (resistance to a fluoroquinolone and at least one injectable)</br>2= Pre-XDR - fluoroquinolone (resistance to a fluoroquinolone= but susceptible to second-line injectables)</br>3= Pre-XDR - injectable (resistance to at least one second-line injectable= but susceptible to a fluoroquinolone)</br>4= Other patterns of resistance that are not XDR or pre-XDR (two or more Group 4 drugs)</br>5= Contact with a patient infected with a strain with one of the above resistance patterns</br>6= Unable to tolerate MDR drugs necessary for construction of the regimen</br>7= Patients who have failed an MDR regimen
ui.i18n.Concept.description.18bdf522-d9be-4802-a095-978099b94bad=Date outcome was decided
ui.i18n.Concept.description.0d2e9e7d-4dc0-4b88-b0d8-9c0332222eaf=Patient for whom no treatment outcome is assigned (this includes cases transferred out to another treatment unit and whose treatment outcome is unknown)
ui.i18n.Concept.description.140cfa0e-0d24-4140-8f35-9eac15576b1c=Patient for whom no treatment outcome is assigned (this includes cases transferred out to another treatment unit and whose treatment outcome is unknown)
ui.i18n.Concept.description.8f2bf583-7d78-4a5f-8f10-87135c4af854=Does patient have an ongoing AE that does not have a final outcome? (check AE log)
ui.i18n.Concept.description.e71cb0fc-c9b8-471b-8030-eb4be22db557=Has there been a change in the TB regimen= including dosage adjustment= stopping a medication= or adding a new medication?
ui.i18n.Concept.description.8ca3529d-fb1c-40a1-915c-dad490206b47=Does patient have an ONGOING ADVERSE EVENT without outcome (check the Adverse Events Log)?
ui.i18n.Concept.description.cac9c021-afb4-4ee6-aeb9-a63fb64d6ecc=If yes= check AE log
ui.i18n.Concept.description.bedcb0e3-738b-4777-9e3d-19ecabf684ae=If yes= check AE log
ui.i18n.Concept.description.dda4ed73-4c56-4a12-9453-ef44a62a3c30=Total number of treatment days in the month (depends on whether treatment is given 6 or 7 days per week and when the treatment was started)
ui.i18n.Concept.description.7ac79bf0-d135-411f-b28b-d0c23e823a7b=Number of days where treatment was not prescribed by the clinician during this month (Sunday should not be counted if day off treatment)
ui.i18n.Concept.description.e13b3eaa-2af1-4614-ac13-65f33b886143=Number of days patient did not take any of the prescribed treatment- All TB drugs are missing
ui.i18n.Concept.description.a1b9d8d1-ad39-450a-af2b-ceab1800ac7e=Number of days patient did not take all prescribed TB drugs- Some TB drugs are missing but not all
ui.i18n.Concept.description.f3602a21-b9ac-42d5-a9c7-d8c3376a5a96=Brief peripheral neuropathy screen: LEFT a. Pain= aching= or burning in feet= legs
ui.i18n.Concept.description.02c30684-9cef-4fe0-b21f-d3ed803ef760=Brief peripheral neuropathy screen: LEFT b. Pins and needles in feet= legs
ui.i18n.Concept.description.e8ad6f9b-1979-466d-b9e8-50f5c0a15fc6=Brief peripheral neuropathy screen: LEFT c. Numbness (lack of feeling) in feet= legs
ui.i18n.Concept.description.9acc0165-29bf-4d5e-9687-397cd467b5d8=Brief peripheral neuropathy screen: vibration perception LEFT
ui.i18n.Concept.description.7b99a7dd-219d-4fce-b758-987c1b2807e7=Brief peripheral neuropathy screen: ankle reflexes LEFT
ui.i18n.Concept.description.da5b9778-79c9-4ce1-a489-852c278a37a2=Brief peripheral neuropathy screen: RIGHT a. Pain= aching= or burning in feet= legs
ui.i18n.Concept.description.f8ea0d87-816e-4d6e-b5c3-97e3124366c1=Brief peripheral neuropathy screen: RIGHT b. Pins and needles in feet= legs
ui.i18n.Concept.description.c81df150-f302-4fdd-8803-552076a452cd=Brief peripheral neuropathy screen: RIGHT c. Numbness (lack of feeling) in feet= legs
ui.i18n.Concept.description.a489fe19-2bd3-41fa-8b45-420130bfa7ac=Brief peripheral neuropathy screen: vibration perception RIGHT
ui.i18n.Concept.description.fc8e1704-ff7f-4a94-a21c-b2b0445bef09=Brief peripheral neuropathy screen: ankle reflexes RIGHT
ui.i18n.Concept.description.a0c9ec39-b6f0-4d42-b5bc-d74fd561274d=Did the patient start treatment?
ui.i18n.Concept.description.3171d452-b579-4051-8e31-4d6db7e35216=Not read includes samples with insufficient sample= saliva or other
ui.i18n.Concept.description.f9392907-1228-4f06-9c43-48c4c3dedad9=enter name and concentration of drug
ui.i18n.Concept.description.6109b101-60e9-43df-9a06-1d511f8acaa6=Ever been a health worker?
ui.i18n.Concept.description.b7e163d8-71ec-4e67-9a47-777ef6ff86b6=8=Extensive or advanced disease 9=Drug intolerance or contraindication= patients with low body mass index (BMI)= HIV= diabetes 10=Patients coming from catchment areas that have poor MDR-TB treatment outcomes despite good programmatic conditions (e.g. sites with extensive second-line drug resistance background)
ui.i18n.Concept.description.8fd95384-08da-40e6-b070-1a44e3588418=If yes= check AE log
ui.i18n.Concept.description.ea75cb86-ecf8-4180-83d3-7817304b7f69=If yes= check AE log
ui.i18n.Concept.description.26a47d40-6ca0-4e97-bdbe-5a2121390c70=Date 6 month post treatment outcome was decided
ui.i18n.Concept.description.cd4e70c3-fc02-4da6-9c20-8b7161d6f1e1=Tunit
ui.i18n.Concept.description.8423fa1a-55dd-463d-bf29-0cfdf29141ee=0=Fully active= able to carry on all pre-disease performance without restriction <br> 1=Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature= i.e.= light housework= office work <br> 2=Ambulatory and capable of all self-care but unable to carry out any work activities. Up and about more than 50% of waking hours <br>3=Capable of only limited self-care= confined to bed or chair more than 50% of waking hours <br> 4=Completely disabled. Cannot carry out any self-care. Totally confined to bed or chair
ui.i18n.Concept.description.4c7076c1-a401-4946-be06-3dcc9e81855d=If date is not known exactly then use the first day of the month ( if month unknown then use July)
ui.i18n.Concept.description.08a6e17d-2dc3-460f-8114-16f0513ec4a4=ONLY enter results documented in the medical record= if there is no record then enter unknown and repeat the test
ui.i18n.Concept.description.9124cfc1-9403-4b22-adc9-160dbd0d6804=If date is not known exactly then use the first day of the month ( if month unknown then use July)
ui.i18n.Concept.description.1936c908-71f8-4b74-a0e6-f4f123829a00=(a – (b+c+d)) / a
ui.i18n.Concept.description.735d00c5-0bf3-480f-9185-65a493345bc5=(a - (b+c+d)) / (a-b)
ui.i18n.Concept.description.eb0b67d9-6c26-4d11-8ae2-e1abc11e327e=ONLY enter results documented in the medical record= if there is no record then enter unknown and repeat the test.
ui.i18n.Concept.description.25ef0086-e97b-4875-8f0b-39cf1e6ec3eb=ONLY enter results documented in the medical record= if there is no record then enter unknown and repeat the test.
ui.i18n.Concept.description.fac80457-276d-460b-8954-d9c55feb0e6f=If date is not known exactly then use the first day of the month ( if month unknown then use July)
ui.i18n.Concept.description.d00e4584-9509-41aa-b88e-0eb57633a733=If date is not known exactly then use the first day of the month ( if month unknown then use July)
ui.i18n.Concept.description.8673c34b-1ccb-4450-84ce-b1ed1b5eec16=ONLY enter results documented in the medical record= if there is no record then enter unknown and repeat the test.
ui.i18n.Concept.description.22e0b4d9-dd77-4413-b024-f16e490f3ade=ONLY enter results documented in the medical record= if there is no record then enter unknown and repeat the test.
ui.i18n.Concept.description.f4e77376-eec2-416d-a698-8e137bcfe342=help note to be defined but will be something like  normal range for adult male range
ui.i18n.Concept.description.c1f869f2-ddd6-4054-83c4-2ffac7856bfa=observed days / prescribed days x 100
ui.i18n.Concept.description.13f6307c-5c75-4e86-baf0-1d325fbfc3cd=Is the patient  or partner pregnant at the time of starting treatment?
ui.i18n.Concept.description.e1a2cb83-d471-416a-a715-5ca0a00bc209=Is the patient or partner breastfeeding at the time of starting treatment?
ui.i18n.Concept.description.e541b6ea-15ec-4588-b678-117288f04978=1=Lack of conversion= 2=Bacteriological reversion after conversion to negative= 3=Evidence of additional acquired resistance to fluoroquinolones or second-line injectable drugs= 4=Adverse drug reactions= 5=Other
ui.i18n.Concept.description.32a463bf-ffef-4177-9e3c-6ca3b8640224=1=Patient refused followup= 2=Substance abuse= 3=Social problem: family= financial= complex social situation= 4=Left region= country= 5=Adverse events= 6=No confidence in treatment= 7=Other= 8=Unknown= 99 not entered
ui.i18n.Concept.description.144cc94f-daad-4c96-b806-dfe7d85c60c2=during followup as compared to original
ui.i18n.Concept.description.f3ff839f-07ef-4291-9908-c9d79df9008d=1. death 2= Life threatening 3= Hospitalisation required or prolonged 4= Persistant or significant disability/incapacity 4=congenital abnormality 5=otherwise medically important
ui.i18n.Concept.description.0930deb7-2db0-4b71-9d97-09a746866c00=The following section is to be filled out when the AE is closed
ui.i18n.Concept.description.d83aff4a-3ca4-439b-bcba-8e586a79832d=DMID/CTCSAE standardized list for endTB
ui.i18n.Concept.description.23bbd3a8-f2f0-454f-ab93-c065c4f4dccb=Is the patient (if female) or the patient's (if male) partner currently pregnant?
